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General introduction
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Aggression
When most people think of aggression, they think of road rage, physical ﬁghts, and violent crime. 
However, not all aggression is bad. Aggression may be adaptive by for example, helping people and 
animals alike guard their homes from intruders and protect their children from threats. Problems 
arise when aggression is taken too far, escalating abnormally in a repeated way and becoming 
violent. Problems related to aggression in young people are traditionally included under the header of 
disruptive behaviour disorder (DBD), which include oppositional defiant disorder (ODD) and conduct 
disorder (CD). Both disorders are known to be highly complex and both clinically and aetiologically 
heterogeneous. More knowledge is needed about the genetic, biological, (neuro)cognitive, as well 
as behavioural bases of aggression in ODD and/or CD. In 2013, a new version of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5) was published and callous unemotional (CU) traits 
were added as a specifier for a more severe form of CD labelled ‘with limited prosocial emotions’. CU 
traits are described as: 1) lack of remorse or guilt, 2) callous lack of empathy, 3) lack of concern about 
performance, and 4) shallow or deficient affect (American Psychiatric Association [APA], 2013). This 
form of CD is associated with reductions in specific forms of empathy, in particular responding to 
the fear, sadness, pain and happiness of others (Blair, 2013). Decreased empathic functioning is also 
among the core symptoms of autism spectrum disorder (ASD) (Herpers, Klip, Rommelse, Greven, 
& Buitelaar, 2016; APA, 2013; Rogers, Viding, Blair, Frith, & Happe, 2006). Individuals with ASD also 
have elevated levels of aggressive behaviour compared to typically-developing individuals (Hill et al., 
2014), although the aggression is not a core symptom of ASD and is typically less severe in ASD than 
ODD/CD (APA, 2013). 
 We only have limited understanding of the behavioural, (neuro)cognitive, and biological 
processes that underpin CU traits/diminished empathy and aggressive behaviour in ODD/CD and 
ASD. CU traits and aggression, and their underlying processes, may act as trans-diagnostic markers 
that form a bridge between disorders and biological substrates of behaviour (Rodriguez-Seijas, 
Eaton, & Krueger, 2015; Walkup, Mathews, & Green, 2017). This in turn, may clarify heterogeneity, 
comorbidity and inform cross-disorder interventions in clinical practice. This thesis examines 
proactive and reactive subtypes of aggression, aggression with or without CU traits, and their genetic, 
(neuro)endocrine, (neuro)cognitive, and behavioural underpinnings as transdiagnostic markers. For 
example, there is an ongoing discussion on the need for defining CU traits as a transdiagnostic 
construct (Herpers et al., 2016; Jambroes et al., 2016; Scheepers, Buitelaar, & Matthys, 2010).
 The main aim of this thesis is to investigate the mechanisms of aggression and CU traits in 
a study that compares male adolescents with ODD/CD or ASD to typically developing individuals 
(TDI). Both, a categorical and a dimensional approach to ODD/CD and ASD, can provide new 
insights into the psychopathology of these three disorders. For example, the DSM-5, defines mental 
disorders as distinct binary constructs that are putatively unrelated to one another. In contrast, the 
Research Domain Criteria (RDoC) target specific feature domains as an approach to research across 
a range of mental disorders (Insel et al., 2010), which is an important consideration in light of the 
marked heterogeneity of ODD/CD, and ASD. RDoC integrates many levels of information (from 
genomics to self-report) to better understand basic dimensions of functioning underlying the full 
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range of human behaviour from normal to abnormal (Cuthbert & Insel, 2013; Insel et al., 2010), and 
seeks to unravel the fundamental mechanisms underlying psychopathology. In doing so, it has been 
creating a taxonomy of key functions (e.g. positive valence, social processes, cognition, arousal, 
regulatory systems) that, it is thought, correspond better to underlying mechanisms than does the 
existing system of discrete diagnoses. In the sections below, I will introduce the psychiatric disorders 
and theories of mechanisms underlying aggressive behaviour. To conclude, I will elaborate on the 
specific methods and aims of this thesis. 
Oppositional Defiant Disorder and Conduct Disorder
The diagnostic criteria of ODD include a recurrent pattern of at least four symptoms from the following 
categories 1) angry/irritable mood, 2) argumentative/defiant behaviour, or 3) vindictiveness, lasting 
at least six months, and exhibited during interaction with at least one individual who is not a sibling 
(APA, DSM–5, 2013). Frequently occurring symptoms within each of these three categories are: 1) 
loses temper, touchy or easily annoyed, angry and resentful, 2) argues with authority figures, or 
for children and adolescents with adults, actively defies or refuses to comply with requests from 
authority figures or with rules, deliberately annoys others, blames others for his or her mistakes 
or misbehaviour, 3) has been spiteful or vindictive at least twice within the past six months. The 
behaviours do not occur exclusively during the course of a psychotic, substance use, depressive, 
or bipolar disorder. Also, in this instance the criteria are not met for disruptive mood dysregulation 
disorder. Severity of the disorder is specified as mild, moderate and severe, based on the presence 
of symptoms in a single setting, two or more than three settings (e.g. at home, at school, at work, 
with peers), respectively. 
 CD is characterized by a repetitive and persistent pattern of anti-social and rule breaking 
behaviour. According to DSM-5, there are four generalized behavioural subtypes: 1) aggression to 
people and animals, 2) destruction of property, 3) deceitfulness or theft and 4) serious violations 
of rules (APA, 2013). The DSM-5 diagnostic criteria facilitate an age-related separation of CD cases, 
i.e. those with childhood onset (i.e. before 10 years of age) and adolescent onset (from 10 years of 
age) CD. Those with childhood onset CD have been found to display greater cognitive impairment, 
more psychiatric symptoms and to have committed more serious violent offences, compared to 
adolescent onset (Johnson, Kemp, Heard, Lennings, & Hickie, 2015; Moffitt, 2006). Some studies 
state that childhood-onset (but not adolescent-onset) CD is even a robust predictor of developing 
antisocial personality disorder in later life (Lahey, Loeber, Burke, & Applegate, 2005; Loeber, Burke, 
& Lahey, 2002; Zoccolillo, Pickles, Quinton, & Rutter, 1992). These studies seem to confirm the 
dual taxonomy model of Moffit (1993). Moffit states that life-course persistent antisocial behaviour 
begins in early childhood and continues throughout adulthood, while offenders with adolescent-
onset antisocial behaviour refrain from offending in young adulthood. However, recent research has 
questioned Moffit’s model by showing that both childhood- and adolescent-onset CD, have severe 
executive impairment, which challenges the assumption that adolescent onset antisocial behaviour 
is a normative process (Fairchild, van Goozen, Calder, & Goodyer, 2013; Johnson et al., 2015). 
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Whether the underlying biological substrates of childhood- versus adolescent-onset CD are similar or 
different is not yet clear.
 The DSM-5 further defines CD with or without CU traits. The latter marks a form of CD that is 
rather refractory to treatment and has a poor long-term prognosis (APA, 2013; Frick & White, 2008; 
Herpers et al., 2016; Scheepers et al., 2010) including elevated risk towards criminal activities and 
other negative outcomes in later life (Loeber & Stouthamer-Loeber, 1998). However, recent research 
has also suggested that children and adolescents with elevated CU traits are not “untreatable” and that 
these children can show reductions in both their CU traits and their antisocial behaviour (Wilkinson, 
Waller, & Viding, 2016), although they typically begin treatment with poorer premorbid functioning and 
can still end with higher levels of aggressive behaviour (Wilkinson et al., 2016). 
 In the current thesis, I will frequently refer to ODD and CD together for two reasons: First, in 
many cases, CD is preceded by ODD (Loeber, Burke, Lahey, Winters, & Zera, 2000), and both are part 
of the DBD header of DSM-5, and are frequently grouped together in the literature. Second, in the main 
study sample of this thesis, there were more individuals with ODD and rather fewer individuals with CD 
to investigate them as separate group. Nonetheless it is important to keep in mind that although ODD 
and CD are often described as different age-related manifestations of the same condition, with ODD 
preceding CD, a subgroup of children with ODD never transit to CD (50-76%) (Loeber & Farrington, 
2000; Matthys & Lochman, 2010; Lahey, Waldman, & McBurnett, 1999; Rowe, Maughan, Pickles, 
Costello, & Angold, 2002; Speltz, Greenberg, & Deklyen, 1990). 
Autism Spectrum Disorder
Individuals with ASD are characterised by impairments in reciprocal social interaction, deficits in verbal 
and non-verbal communication and presence of restricted or repetitive patterns behaviour, interests, 
and abnormal sensory behaviours that manifests in early childhood and persists through the entire 
life (APA, 2013). The previous version of DSM, DSM-IV-TR, had a category of Pervasive Developmental 
Disorders which included five separate diagnostic categories: Autistic Disorder, Asperger syndrome, 
Rett’s syndrome, Childhood Disintegrative Disorder, and pervasive developmental disorder not otherwise 
specified (PDDNOS) (APA, DSM-IV-TR, 2000). In the latest version of the DSM (DSM-5), Autistic Disorder, 
Asperger syndrome and PDDNOS were combined in one broad category of ASD with varying degrees of 
severity, and Rett’s syndrome and Childhood Disintegrative Disorder were removed. The rationale for this 
change of nomenclature is the high degree of similar clinical features between the disorders and concern 
for the validity of each of the disorders as separate entities, as it is now thought that the symptoms of the 
disorders are currently conceptualised to lie on a continuum of autism-specific traits. Additionally, a new 
diagnosis of Social Communication Disorder was added to include people who have persistent problems 
in social interaction, but do not meet the diagnostic criteria for ASD (APA, DSM-5, 2013). DSM-5 criteria for 
the diagnosis of ASD differ from the DSM-IV-TR in several aspects. First, DSM-5 combines the symptoms 
in two domains (i.e. 1) impairments in social interaction and communication, 2) repetitive and restricted 
behaviours and activities) instead of three (i.e. 1) social interaction, 3) language / communication, and 3) 
repetitive and restricted behaviours and activities). Impairments in social interaction and communication 
include behaviours such as reduced eye contact, failure to initiate or respond to social interaction, deficits 
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in maintaining social relationships. The second domain includes repetitive and restricted behaviours 
and activities.
Prevalence and comorbidity of ODD, CD, ASD
The community prevalence rates in children and adolescents between five and twenty years of age for 
ODD and CD vary from 4-14%, depending on the criteria used and population studied (Foster & Jones, 
2005; Frick & Dickens, 2006; Frick & White, 2008; Scheepers et al., 2010). The ratio of boys to girls 
with ODD or CD falls between 4:1 and 2:1, but whether this represents a genuine prevalence difference 
across gender or a relative under diagnosis of girls due to a more covert aggression style in girls is 
debatable. 
 The population prevalence of ASD is about 1% (Matson & Shoemaker, 2009). Like ODD/CD, ASD 
is more prevalent in boys than in girls. Large-scale population-based studies have shown that two to three 
times more males than females are affected by ASD (Kim et al., 2011). In clinical ASD samples, male-female 
ratio estimates range up to four till five times more males than females with ASD (Fombonne, Quirke, 
& Hagen, 2009). In children/adolescents with ASD, a wide range of prevalence rates of comorbid ODD 
(4-75%) and CD (2-49%) have been reported (see for an overview van Steensel, Bogels, & de Bruin, 2013).
 Although ODD, CD, and ASD are separate diagnostic categories, these disorders appear to 
frequently co-occur with each other and with other disorders. Research on rates of co-morbid ASD in 
children/adolescents with ODD/CD is hardly available. Far more commonly stated in research, is the 
role of comorbid ADHD which is present in about 50% of children and adolescents with disruptive 
behaviour disorder (Matthys & Lochman, 2010), and 30%-80% of children with ASD have comorbid 
ADHD (Matson, Rieske, & Williams, 2013). In addition, research has found that a number of children 
later diagnosed with ASD, previously had received a diagnosis of ODD/CD (12%) (Mandell, Ittenbach, 
Levy, & Pinto-Martin, 2007), likely due to overlapping difficulties in social interaction, which also 
complicates the correct differential diagnosis of ODD, CD, and ASD. 
 The majority of research on CU traits has been conducted in youths with conduct problems. 
However, little is known about the presence of CU traits in disorders other than CD and about their 
implications for severity of these disorders and functional adaptation (Herpers, Klip, Rommelse, 
Greven, & Buitelaar, 2016). Although prevalence rates will differ by population, one multi-site study 
estimated that 2% to 32% of community youth and 14% to 50% of clinic-referred youth meet the criteria 
for high CU traits, depending on whether or not they are diagnosed with CD and who the informant is 
(Kahn, Frick, Youngstrom, Findling, & Youngstrom, 2012). In community samples, high CU traits were 
associated with more global impairment (Ezpeleta, de la Osa, Granero, Penelo, & Domenech, 2013; 
Pardini, Stepp, Hipwell, Stouthamer-Loeber, & Loeber, 2012; Waschbusch et al., 2004), not only in the 
CD subsample, but in the no CD / high CU subsample as well (Pardini et al., 2012).
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Treatments
Psychological treatments
The Guideline Development Group (2013), a subgroup of the National Institute for Health and 
Care Excellence (NICE), advocates the preferred treatment of disruptive behavioural problems to be 
psychological, with a particular emphasis on working with both parents (if possible) or guardians. 
In addition, other treatment approaches may include cognitive behavioural problem-solving and 
multi-systematic therapy. Evaluation and monitoring of these three different types of treatment 
programmes is important in establishing that such programmes are effective and acceptable to 
the patient population (National Institute for Health and Care Excellence, 2013). Despite evidence 
demonstrating overall low effect sizes of randomised controlled trials in treating aggression in 
children with these interventions, they remain paradoxically the treatment of choice (Bakker, Greven, 
Buitelaar, & Glennon, 2017; Conduct Problems Prevention Research, 1999, 2011; Scotto Rosato et 
al., 2012). However, many meta-analyses thus far have focussed on the treatment of aggression in 
general and are not CD-specific. Hence, in this thesis I will to provide a systematic review and meta-
analysis of nonpharmacological treatments, specifically on outcomes related to CD problems, and 
provide strategies for improving treatment (chapter 2).
Medical interventions
Clinical pharmacological interventions for conduct problems (e.g. aggression) have not been 
extensively developed (Smith & Coghill, 2010), there is no first line medication treatment licensed for 
aggressive symptoms. To date, medication approved for other indications (particularly ADHD) such 
as the psychostimulants (e.g. methylphenidate), alpha-2 agonists (e.g. guanfacine), and atypical 
antipsychotics (e.g. risperidone, aripiprazole, quetiapine) are the drug treatments of choice but 
these remain second-line treatment interventions to psychosocial approaches (Linton, Barr, Honer, 
& Procyshyn, 2013; Smith & Coghill, 2010). Within ASD, only risperidone and aripiprazole are Food 
and Drug Administration approved to treat aggressive behaviour and irritability (LeClerc & Easley, 
2015). In addition, limited clinical data have supported treatment with SSRIs, CNS stimulants, 
NMDA-receptor antagonists, and other agents (LeClerc & Easley, 2015).
Models of aggression
Since Freud’s psychoanalytic theory (i.e. individual behaviours are motivated by sexual and instinctive 
drives and aggression was considered simply as a reaction to the blocking of libidinal impulses), a 
broad range of theories aim to explain the origins and triggers of human aggression. It is believed that a 
combination of 1) genetics, (neuro)endocrinological, and neural dysfunction (i.e. brain level), 2) (neuro)
cognitive level (i.e. cognitive and affective factors), 3) behavioural level, and 4) environmental influences 
may explain the relationships among the various theories of aspects in aggressive individuals (Krol, 
Morton, & De Bruyn, 2004). The multiplicity of factors associated with the emergence, development and 
maintenance of aggressive behaviour suggests that aggression is a complex behaviour involving many 
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different processes and mechanisms. Additionally, these factors may all be associated with each other, 
which makes it even more difficult to reach a full understanding. Identification of the causal mechanisms 
that underlie ODD and CD is important to help inform prevention and treatment modalities. In the 
following sections these four factors will be briefly introduced.
1) Genetic, (neuro)endocrinological and neural dysfunction
Genetic factors play a role in the development or maintenance of aggressive behaviour, and it is 
unlikely to be explained by a few candidate genes (e.g. 5HTTLPR, COMT, and DRD4), but rather 
by a complex interaction between multiple genes (Vassos, Collier, & Fazel, 2014). In addition, the 
X-chromosomal MAOA gene, which encodes the enzyme monoamine oxidase A, responsible for 
the catabolism of dopamine, serotonin, as well as noradrenaline (Bortolato, Chen, & Shih, 2008), 
is believed to play a role in the development and maintenance of aggressive behaviour. The low 
activity variant of the MAOA gene is thought to be associated with reactive aggression particularly 
in those who have grown up in adverse environments (e.g. childhood maltreatment) Buckholtz & 
Meyer-Lindenberg, 2008). Accumulated evidence from quantitative and molecular genetic studies 
(Polderman et al., 2015; Rhee & Waldman, 2002) reveals the influence of genetic factors in the 
aetiology of antisocial behaviour problems. Genome-wide association studies indicate that antisocial 
behaviour may be highly polygenic and has potential heterogeneous genetic associations across 
gender (Tielbeek et al., 2017). Quantitative genetic results are based on research in twin studies and, 
to a lesser extent, adoption studies (Burt, 2009a; Rhee & Waldman, 2002). From twin studies we know 
that concordance rates regarding aggressive behaviour are higher for monozygotic than dizygotic 
twins, suggesting genetic influence on aggressive behaviour. Furthermore, approximately 50% of the 
variance in aggressive behaviour may be explained by genetic risk factors, whereas the remainder 
can be explained by a moderate influence of the non-shared environment and a small to modest 
influence of the shared environments (Burt, 2009a; Polderman et al., 2015; Rhee & Waldman, 2002). 
Also based on twin data, others have reported an association between antisocial behaviour and 
psychiatric traits (e.g. antisocial spectrum disorders and psychopathy), which was partially explained 
by common genetic factors (Gunter, Vaughn, & Philibert, 2010), suggestive of shared biological 
mechanisms between behaviour and traits. In addition, based on both twin and adoption studies, 
shared environmental influences accounted for 10-15%, non-shared environmental influences for 28-
31%, and additive genetic influences for 57-59% of the variance in externalizing disorders (e.g. ODD 
problems and CD problems) (Burt, 2009b). 
 Heritability in ASD has been estimated at > 90% for classical autism (Abrahams & 
Geschwind, 2008; Freitag, 2007), although more recent studies tend to report lower heritability 
estimates (Hallmayer et al., 2011). The genetics of ASD is highly heterogeneous, and, like for ODD/
CD, there are probably thousands of genetic variants that can contribute to a risk of developing ASD. 
Approximately 10% of individuals with ASD have an identifiable genetic aetiology corresponding to 
known chromosomal rearrangements of single gene disorders (e.g. Fragile X), another 7-10% carry 
monogenic forms due to the novo pathogenic mutations or copy number variances, yet the majority 
of ASD cases likely stem from multifactorial underpinnings involving several to many loci and gene-
gene and gene-environment interactions (Abrahams & Geschwind, 2008; Berg & Geschwind, 2012; 
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Devlin & Scherer, 2012; Persico & Napolioni, 2013; Ruggeri, Sarkans, Schumann, & Persico, 2014). 
In this thesis, I will provide a systematic review of genetic studies of aggressive behaviour in both 
humans and animal models, and examine to what degree prior studies have examined phenotypes 
that fit into the RDoC framework (chapter 3).
 In addition to the genetic factors, neural substrates also play a role in the development or 
maintenance of aggressive behaviour. The brain is a complex organ and constitutes a broad range of 
complex mechanisms. Violent and irritable behaviour can be a result of damage to certain regions 
of the brain (e.g. the prefrontal cortex), and damage to brain circuits involved in moral judgments 
(Blair & Lee, 2013). Both, meta-analytic and narrative reviews showed evidence for smaller brain 
structures and lower brain activity in individuals with ODD/CD in mainly executive functional-related 
areas: bilateral amygdala, bilateral insula, right striatum, left medial/superior frontal gyrus, and left 
precuneus (Holz et al., 2017; Noordermeer, Luman, & Oosterlaan, 2016). Executive functioning, 
also seen as cold cognition, refers to goal-directed and problem-solving behaviours, as well as self-
regulation, not involving motivational or affective aspects. 
 Furthermore, (neuro)endocrinological factors such as the hormones oxytocin, cortisol, and 
testosterone have also been implicated in aggressive behaviour. For instance, administration of 
intranasal oxytocin was found to decrease salivary cortisol concentrations during social stress (Linnen, 
Ellenbogen, Cardoso, & Joober, 2012), and dampen amygdala activity to negative stimuli or fear-
inducing visual stimuli (Domes et al., 2007; Kirsch et al., 2005). Furthermore, lower salivary oxytocin 
concentrations predicted high teacher-rated CU traits (Levy et al., 2015). Effects of testosterone, 
cortisol and serotonin in the brain mostly implicate amygdala-prefrontal circuitry (Montoya, 2012). 
For example, gonadal (sex steroid) hormones are thought to have an important influence on the 
connection of the amygdala and the orbitofrontal cortex, influencing regulation of amygdala activity 
by the orbitofrontal cortex (van Wingen et al., 2011). Testosterone has been observed to increase 
amygdala activity (Derntl et al., 2009; Manuck et al., 2010; van Wingen et al., 2009) and to reduce 
orbitofrontal cortex coupling with the amygdala (Hermans et al., 2008; van Wingen et al., 2010), 
which can increase aggression (Mehta and Beer, 2010). Cortisol on the other hand has been shown 
to decrease amygdala activity (Henckens et al., 2010) (see also van Donkelaar, PhD Thesis “Genetic 
and neurobiological mechanisms underlying aggression subtypes”, 2018). 
 In this thesis, I will, for the first time, study three hormones (i.e. oxytocin, cortisol, and 
testosterone) together in one sample consisting of individuals with either ODD/CD, or ASD, 
compared to TDI (chapter 4).
2) Cognitive and affective factors
Cognitive models (e.g. cognitive behaviour therapy) assume that deficits in information processing 
are underlie increased aggression (Fossum, Handegard, Martinussen, & Morch, 2008; Goldstein, 
Glick, Reiner, Zimmerman, & Coultry, 1987). Dysfunctional cognitive processes and misperceptions 
that may lead to aggressive behaviour are described in two models 1) the social learning model 
(SLM) of Bandura (1978), and 2) the social information processing (SIP) model of Dodge & Coie 
(1987). 
According to the model of Bandura (1978), aggression is initially learnt by modelling (e.g. through 
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observation and interaction with other people) and maintained by reinforcement, which encourages 
the further display of aggressive behaviour for personal gain, receiving few or no negative 
consequences. Alongside the SLM model, the SIP model is a circular depiction of the emotional 
and cognitive processes (i.e. deficient encoding, interpretation, preparation, planning and execution 
of response or behaviour) may lead to reduced emotional empathy, impaired decision making, and 
increased threat sensitivity (Crick & Dodge, 1994). At the core of the model is a database of memories, 
acquired social rules, social knowledge and schemata. For example: What do you do if someone 
pushes you? According to the SIP model, it is thought that individuals with aggressive behaviour 
have abnormal cognitive scripts for how to behave in social situations due to modified information 
processing (Crick & Dodge, 1996). These scripts are learnt from parents, media, and experience. The 
SIP consists of six steps from the encoding of social cues to evaluating and selecting responses. The 
processing of social cues can be affected by dysfunctional beliefs, social schemas (Gagnon, McDuff, 
Daelman, & Fournier, 2015), or cognitive biases. In response to the question at the beginning of 
this section, one could think of reasons for the aggressive act (e.g. why did the person push you?), 
but individuals with aggressive behaviour have the tendency to perceive these ambiguous actions 
by others as aggressive. More specific, aggressive individuals have inner biases that make them 
expect others to react aggressively; view ambiguous acts in a hostile manner; assume others act 
purposefully when they hurt or offend them (known as the hostile interpretation bias). This bias is 
considered to be an important cause as well as maintaining factor of aggressive behaviour (Crick & 
Dodge, 1996; Schonenberg & Jusyte, 2014). 
 Within this thesis, I will for the first time set out to investigate and directly compare emotional 
valence detection capacities (chapter 5), and reading faces (chapter 6) within and across clinical 
samples (i.e. ODD, CD, and ASD) and the general population sample. 
3) Behavioural factors
Several clusters of behaviour, such as subtypes (i.e. reactive or proactive) of aggression have been 
found in individuals with severe aggressive behaviour (Blair, Veroude, & Buitelaar, 2016). Reactive 
aggression is known as an emotionally charged response to provocations or frustration and is also 
known as “impulsive”, “hot blooded” or “affective” aggression. Proactive aggression is defined 
as a conscious and planned act, used for personal gain or egocentric motives, also known as 
“premeditated”, “instrumental” or “cold-blooded” aggression (Smeets et al., 2017). These behaviours 
may be a result of frustration-based reactive aggression or threat-based reactive aggression. 
Berkowitz (1989) proposed the frustration-aggression hypothesis, stating that frustration leads to 
anger, and the more anger is generated (by means of unexpected frustration or if seen as unfair) the 
more aggression is generated. However, since we can apply our higher mental processes, such as 
thinking and reasoning, we do not necessarily always respond to frustration with aggression. We may 
do so, however, if our anger is great enough or if, for some reason, we cannot think rationally at that 
moment. CU traits may play a moderating role, and are associated with reductions in specific forms 
of emotional empathy, in particular, responding to the fear, sadness, pain and happiness of others 
(Blair, 2013). 
 In this thesis, I will examine the role of subtypes of aggression in relation to hormonal 
 1
18
concentrations (chapter 4), emotion processing (chapter 5), and reading faces (chapter 6) within 
and across clinical samples (i.e. ODD, CD, and ASD) and general population sample. 
4) Environmental/ cultural factors 
Several environmental risk factors have found to increase the risk for antisocial behaviour. These 
include prenatal factors, traumatic experiences, dysfunctional family life, or the way the child is raised 
and disciplined in the family (e.g. harsh and inconsistent parenting), abuse and neglect, and socially 
disadvantaged subcultures (i.e. deviant peers) (Blair, Leibenluft, & Pine, 2014; Carr, 2006; Humphreys 
& Zeanah, 2015; Hyde et al., 2016; Waller, Gardner, & Hyde, 2013). In addition, research supports 
a role of environmental adversity in particular for CU traits, stating two distinct CU subgroups (i.e. 
primary and secondary), with the secondary variant being specifically characterized by a maltreatment 
history (and high anxiety), compared to the primary variant (Kimonis, Frick, Cauffman, Goldweber, 
& Skeem, 2012; Kimonis, Skeem, Cauffman, & Dmitrieva, 2011). Alongside environmental factors, a 
new model has been proposed recently, the climate aggression and self-control in humans (CLASH) 
model, has been proposed in understanding aggression within and between countries (Van Lange, 
Rinderu, & Bushman, 2016). This model includes fast life strategy, short-term orientation, and poor 
self-control (i.e. no control of temptations and lack of long-term goals) as important determinants 
of aggressive behaviour. Fast life strategy is associated with short-term planning, greater risk taking, 
a focus on immediate gratification for short-term benefits, and more aggression (e.g. Frankenhuis, 
Panchanathan, & Nettle, 2016). Also, violent behaviour in individuals could be based on wounded 
pride, e.g. people think they are better than other people. Another cultural aspect is the role of 
honour: violent response to threats to one’s honour is accepted in some cultures but not others. 
But also humiliation is a primary cause of violence and aggression in cultures of honour. Aggressive 
‘cues’ may trigger aggression (Berkowitz, 1989), e.g. guns, knives, the colour black. Another aspect 
is, although strongly debated, is that violent media exposure tends to be associated with increased 
aggression (Black & Bevan, 1992; Bushman, 2016). Aggressive people view the world as more hostile 
than do non-aggressive people, but situational factors, such as media, may also play a role in this 
view (Bushman, 2016). The influence of genetic factors in interaction with (early) social risk factors 
can be catalyzed by a hostile environment, thus increasing the risk for the development of aggressive 
behaviour (Mendes, Mari Jde, Singer, Barros, & Mello, 2009). Other factors within the family life and 
/ or subculture may be the maternal (mis)use of tobacco (Brennan, Grekin, Mortensen, & Mednick, 
2002; Orlebeke, Knol, & Verhulst, 1997; Ruisch, Dietrich, Glennon, Buitelaar, & Hoekstra, 2017), or 
alcohol during pregnancy (Hawkins, Catalano, & Miller, 1992; Mendes et al., 2009) and malnutrition 
(Liu, Raine, Venables, & Mednick, 2004; Mendes et al., 2009; Ruisch et al., 2017). 
The identification of relevant risk factors for ODD/CD and ASD has been a great challenge given 
their aetiological complexity. This involves both numerous genetic and environmental risk factors, 
as well as the interaction between these factors. For example, apparent environmental influences 
often also have a genetic component (known as the nature of nurture). Clever designs such as twin 
and adoption-at-conception designs (e.g. using a sample of families with children conceived through 
in vitro fertilization) can help disentangle genetic and environmental influences (e.g. Harold et al., 
2013). 
 In this thesis, I will examine some demographic factors in relation to aggressive behaviour within 
and across clinical samples (i.e. ODD, CD, and ASD) and general population sample (chapter 4-6).
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Figure 1. Model of aggression: consisting of a genetic and (neuro)endocrine level, neural dysfunction level, cognitive and 
affective level, behavioural level, and environmental influences. Adjusted and updated from Blair et. al., (2016).
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An integrated perspective of models in aggression
The schematic interpretation as shown in Figure 1, summarizes and integrates the above described 
models including genetic and (neuro)endocrine level, neural dysfunction level, cognitive and affective 
level, and environmental influences in the search of a better understanding of aggressive behaviour. 
 
Study sample
My thesis will focus on some aspects from the above models of aggression, such as broadly defined 
genetic, (neuro)endocrine, (neuro)cognitive, and behavioural underpinnings. This will be studied in 
the “psychopathology and the lack of empathy [CU2]” sample. 
The CU2 project enrolled 132 adolescents (see also Figure 2) with ASD, ODD, or CD diagnosis, who 
were recruited through clinical institutes across the Netherlands, specialized in disruptive behaviour 
problems (Hoenderloo Group, Otto Gerhard Heldring Foundation, and Woodbrookers) or psychiatric 
problems (Karakter Child and Adolescent Psychiatry), and through information leaflets that were 
sent to families via the Dutch federation of Autism (Nederlandse Vereniging voor Autisme). In 
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addition, typically developing individuals (TDI) were recruited via leaflets from a general community 
sample via city councils in the same geographical regions as the clinical groups. All adolescents 
were males and aged between 12 and 19 years old (M = 15.4, SD = 1.9), recruited between February 
2011 and March 2015). The majority of the adolescents were non-Caucasian ethnicity (81%) and the 
mean estimated total IQ was M = 99.3 (SD = 12.2). Participants, parents and teachers were asked to 
complete several questionnaires concerning demographic and behavioural (i.e. CU traits, subtypes 
of aggressive behaviour) details before or during the testing day. In addition, only the adolescents 
were asked to complete a neuropsychological assessment during one or two testing days.  
Measures
Various measurements were employed: self- and parent- rated questionnaires, neurocognitive 
computer tasks, eye-tracking, and saliva collection. Semi-structured interviews were used verify 
diagnosis. Self- and parent-rated questionnaires have been used to assess factors such as aggression 
subtype, and CU traits. The neurocognitive computer tasks focus on emotion valence detection, 
and processing of neutral and emotional faces. Finally, saliva collection was used as non-invasive 
method to collect hormonal concentrations of oxytocin, cortisol, and testosterone. More details on 
the sample and measures are given in Chapter 4-6.
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Figure 2. Recruitment process and drop-out rates.
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Thesis aim and outline
The overall aim of this thesis was to examine proactive and reactive subtypes of aggression, aggression 
with or without CU traits, and their genetic, (neuro)endocrine, (neuro)cognitive, and behavioural 
underpinnings as transdiagnostic markers in a study that compares male adolescents with clinical 
disorders ODD/CD or ASD and typically developing individuals (TDI). These transdiagnostic 
markers between the clinical groups and biological substrate of behaviour are important to clarify 
heterogeneity, comorbidity and inform cross-disorder interventions in the clinical practice. This 
thesis also aimed to provide an overview of the efficacy of psychological treatments.
 In chapter 2, a meta-analysis was conducted to evaluate the efficacy of nonpharmacological 
treatments for CD problems in children and adolescents, based on child, parent and teacher reports; 
articles published between January 1970 and March 2015. Results from this chapter raise questions 
on how to improve current or develop new treatments. In order to do so, better understanding of 
possible biological mechanisms involved in aggressive behaviour is required, which will be further 
explored in chapter 3. In chapter 3, a systematic review is described to examine the evidence for 
genetic underpinnings of aggression and to determine to what degree prior studies have examined 
aggression phenotypes that fit neatly, or at all, into the RDoC framework. This review focuses on 
three types of genetic studies: twin studies, human association studies of aggression, and animal 
model studies published between January 2009 and February 2015. 
 Hormones have been shown to play an important role in influencing reactions to other people, 
including aggression, affiliation and the stress system. In chapter 4, the (neuro)endocrinological 
mechanisms (i.e. hormones such as oxytocin, cortisol, and testosterone) will be examined in the 
possible relation with aggressive behaviour and/or empathy in TDI, and individuals with either ASD, 
or ODD / CD. The role of executive functioning (reflecting the higher order cognitive control of 
thought, action and emotion) are differentially associated with forms of antisocial behaviour and 
patterns of aggressive behaviour (Blair, 2013; Ogilvie, Stewart, Chan, & Shum, 2011). In chapter 
5, emotion processing is investigated during a neuropsychological task (i.e., emotional Go/No-
go) in TDI compared to individuals with either ODD/CD or ASD. Furthermore, whether CU traits 
moderate results in the ODD/CD group as well as the ASD group will be explored. Recognition 
of facial emotional expressions is an important aspect of social communication. Eye-tracking is a 
rather precise method to measure this aspect in empathy. In chapter 6, this method will be used to 
examine common and unique emotional face processing deficits (i.e. the time to first fixation and 
fixation duration) in TDI, compared to individuals with either ODD/ CD or ASD. Furthermore, the 
relationship of CU traits, psychopathic traits and aggressive behaviour with eye-tracking measures 
will be examined. The final chapter of this thesis, chapter 7, provides a summary of the main findings 
of each chapter. Limitations, directions for future research, and clinical implications are discussed.
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Abstract
This meta-analysis evaluates the efﬁcacy of nonpharmacological treatments for conduct disorder 
(CD) problems in children and adolescents, based on child, parent and teacher report. 
PubMed, PsycINFO and EMBASE were searched for peer-reviewed articles published between January 
1970 and March 2015. Main inclusion criteria were nonpharmacological treatment, participants 
younger than 18 years, clinical CD problems/diagnosis, randomized controlled trials and inclusion 
of at least one CD problem-related outcome. Treatment efﬁcacy is expressed in effect sizes (ESs) 
calculated for each rater (parent, teacher, self and blinded observer). 
Of 1,549 articles retrieved, 17 (published between June 2004 and January 2014) describing 19 
interventions met the inclusion criteria. All studies used psychological treatments; only three studies 
included a blinded observer to rate CD problems. Most studies were of very poor to fair quality. 
ESs were signiﬁcant but small for parent-reported outcomes (0.36, 95% CI = 0.27–0.47), teacher-
reported outcomes (0.26, 95% CI = 0.12–0.49) and blinded observer outcomes (0.26, 95% CI = 
0.06–0.47), and they were nonsigniﬁcant for self-reported outcomes (0.01, 95% CI = 0.25 to 0.23). 
Comorbidity, gender, age, number of sessions, duration, intervention type, setting, medication use 
or dropout percentage did not inﬂuence the effect of treatment. 
Psychological treatments have a small effect in reducing parent-, teacher- and observer-rated CD 
problems in children and adolescents with clinical CD problems/diagnosis. There is not enough 
evidence to support one speciﬁc psychological treatment over another. Future studies should 
investigate the inﬂuence of participant characteristics (e.g. age of CD onset), use more homogeneous 
outcome measures and allow better evaluation of study quality. Many reports failed to provide 
detailed information to allow optimization of psychological treatment strategies.
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To date, studies of nonpharmacological treatments for disruptive behaviour have not speciﬁcally 
focused on clinically diagnosed conduct disorder (CD) nor related problem behaviour. Furthermore, 
these studies have often suffered from small sample sizes. The aims of this article are to provide 
an overview of nonpharmacological treatments for children and adolescents with CD and/or CD 
problems in the clinical range [e.g. including disruptive behaviour disorders (DBD) and oppositional 
deﬁant disorder (ODD)], to outline clinical implications for clinical practitioners, and make 
suggestions for future research to optimize clinical outcomes. 
 Conduct disorder is characterized by a repetitive and persistent pattern of antisocial and 
rule-breaking behaviour, categorized into four classes: (a) aggression to people and animals, (b) 
destruction of property, (c) deceitfulness or theft and (d) serious violations of rules (American 
Psychiatric Association, 2013). Aggressive and antisocial behaviour is heterogeneous, and it has 
been suggested that a distinction should be made between covert and overt aggression and between 
reactive or affective aggression and instrumental or proactive aggression (Buitelaar et al., 2013). 
The DSM-5 deﬁnes CD with and without callous-unemotional traits, whereby patients with high 
callous-unemotional traits are more refractory to treatment and have a poorer longterm prognosis 
(e.g. increased risk of criminal activity; American Psychiatric Association, 2013; Frick & White, 2008; 
Loeber & Stouthamer-Loeber, 1998; Scheepers, Buitelaar, & Matthys, 2010). Furthermore, individuals 
presenting with early-onset CD (i.e. before 10 years of age) may have a relatively poorer outcome 
than those with late-onset CD (i.e. onset after 10 years of age; Fairchild, van Goozen, Calder, & 
Goodyer, 2013; Mofﬁtt, 2006; Mofﬁtt, Caspi, Dickson, Silva, & Stanton, 1996) and are at greater 
risk of developing antisocial personality disorder in later life. In many cases, CD is comorbid with 
attention deﬁcit hyperactivity disorder (ADHD) and is preceded by ODD (Loeber, Burke, Lahey, 
Winters, & Zera, 2000). This makes it important to develop effective treatment programmes for 
conduct problems. 
 Treatment for CD problems can be divided into pharmacological and nonpharmacological 
approaches. There is no ﬁrst-line medication licensed for this age group, and all medication is 
primarily used off-label. Medications approved for other indications (particularly ADHD), such as 
stimulants (e.g. methylphenidate), alpha-2 agonists (e.g. guanfacine) and atypical antipsychotics 
(e.g. risperidone, aripiprazole and quetiapine), are currently the medical treatments of choice but are 
secondary to psychosocial interventions (Linton, Barr, Honer, & Procyshyn, 2013; Smith & Coghill, 
2010). Six meta-analyses of psychological treatments for children and adolescents with (but not 
limited to) a CD diagnosis and/or CD problems have been published (Grove, Evans, Pastor, & Mack, 
2008; Lundahl, Risser, & Lovejoy, 2006; McCart, Priester, Davies, & Azen, 2006; National Institute 
for Health and Clinical Excellence, 2013; Weisz et al., 2013; Wilson & Lipsey, 2007), and the aim 
of this article is to investigate the effectiveness of nonpharmacological interventions other than 
psychological ones for the treatment of CD and/or clinical CD problems. 
 The meta-analysis of Wilson and Lipsey (2007) focused on the efﬁcacy of treatment in a 
populationbased sample (e.g. through school-based programmes), and the other meta-analyses 
focused on prevention programmes for children and adolescents with disruptive and delinquent 
behaviour but without a manifest disorder (Grove et al., 2008), programmes for children and 
adolescents with internalizing (e.g. anxiety) and externalizing (e.g. misconduct, ADHD) problems 
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(Weisz et al., 2013), or speciﬁc treatment methods, such as parent training (Lundahl et al., 2006), or 
behavioural parental training and cognitive behavioural therapy (McCart et al., 2006). The National 
Institute for Health and Clinical Excellence (NICE) guidelines, published in 2013, provide a systematic 
review and meta-analysis of psychological treatments and conclude that psychosocial interventions 
have an overall small-to-moderate effect size (ES) compared with care as usual or no treatment in 
reducing antisocial behaviour in youths. The other ﬁve older metaanalyses showed that psychosocial 
treatment was modestly beneﬁcial (overall ESs ranged from 0.17 to 0.42, including beyond the 
end) compared with care as usual or waiting-list control in children and adolescents with DBD/CD 
problems. 
 The present review included 17 studies (11 of which were not included in the NICE review). 
Although the NICE review included 154 studies, the current review extends the NICE guidelines 
in several ways. First, the NICE guidelines do not focus solely on clinical cases of CD/ODD but 
also on population-based samples and use broad deﬁnitions of psychopathy (e.g. the meta-analysis 
included samples in which only a minority had CD/ODD and/or that were not clinically at risk for CD/
ODD). The inclusion of a mixed study population may affect the evaluated efﬁcacy of psychological 
treatment, complicate the interpretation of ﬁndings and limit the generalizability of study outcomes. 
The current review focuses on nonpharmacological treatments in children and adolescents who have 
a clinical CD diagnosis and/or clinical CD problems (including DBD and ODD) and who have an IQ 
of minimally 80 points, compared with the minimally 60 points used as cut-offf in the studies of the 
NICE guideline. Children and adolescents with an IQ lower than 80 have mild intellectual problems 
and may beneﬁt from a different treatment approach from that for individuals with a higher IQ. The 
exclusion of children and adolescents with a lower IQ also increases the homogeneity of our study 
population. Third, the current review includes studies of nonpharmacological treatments involving 
children and adolescents and incorporates data of adolescents between 12 and 18 in contrast to the 
NICE guidelines in which the overall age range was between 7 and 14 years. Fourth, as recommended 
by Rosato et al. (2012), psychological treatments should be age speciﬁc, because developmental 
differences (i.e. in cognitive, behavioural, affective and communicative abilities) affect outcomes. 
Hence, the current review investigates the onset of CD as potential moderator of treatment 
effectiveness in reducing CD problems, an aspect that has not been addressed previously. Fifth, it 
is not always clear whether outcome measures are scored by blinded raters (McCart et al., 2006). 
Last, but not least, in contrast to the six metaanalyses, this review takes into account whether study 
participants are on stable medication during the study. In addition, not all previous metaanalyses 
took the potential role of child and/or environmental factors in treatment efﬁcacy into account. 
 Although evidence for the efﬁcacy of psychological treatments for CD problems is limited, 
these remain the treatment of choice (Conduct Problems Prevention Research Group, 1999, 2011; 
Rosato et al., 2012). The NICE guidelines recommend a psychosocial approach to the treatment of CD 
problems, with emphasis on working with parents (if possible) or guardians. Both the NICE guideline 
(2013) and Eyberg, Nelson, and Boggs (2008) advocate three treatment approaches, depending on 
the age of the affected individual. For children aged 3–11 years, parenting training programmes to 
improve the parenting skills of parents are recommended. These programmes typically consist of 
10–12 parents in a group and involve 10–16 meetings (each lasting 90– 120 min) in which modelling 
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(e.g. imitating the child), rehearsal (e.g. parents rehearse new skills in session) and feedback (e.g. 
therapists discuss and, if necessary, modify parents’ behaviours; Pilling, Gould, Whittington, Taylor, & 
Scott, 2013) are used to improve parenting skills. For children aged 9– 14 years, cognitive behavioural 
approaches are the treatment of choice and consist of 10–18 weekly meetings (lasting 2 hr) during 
which modelling (e.g. imitating peers), rehearsal (e.g. the child rehearses new skills) and feedback 
(e.g. therapists discuss the child’s behaviour, with a view to modifying it; Pilling et al., 2013) are 
used to improve the child’s skills. And for adolescents aged 11–17 years, multimodal programmes 
(e.g. multisystemic therapy) are preferred, consisting of 3–4 meetings a week for 3– 5 months. These 
programmes are based on a social learning model with interventions provided at different levels (i.e. 
individual, family, school, criminal justice and community) and have an explicit and supportive focus 
on the family. They are provided by appropriately trained case managers (Pilling et al., 2013). 
 An up-to-date comparison of nonpharmacological treatments targeting 
speciﬁcally CD or related problems is needed. This systematic review and metaanalysis of 
nonpharmacological treatments for CD, speciﬁcally on outcomes related to CD problems, 
provides strategies for improvement.
Methods 
Inclusion and exclusion criteria
A search of the PubMed, EMBASE and PsycINFO databases for peer-reviewed papers published up 
to March 2015, using the following keywords: (((conduct disorder OR CD OR disruptive behavio* 
AND disorder) OR (disruptive behavio* AND disorders)) NOT (disease)), identiﬁed 1,549 articles. 
The titles and abstracts of the retrieved articles were read by at least two of the authors (MJB and 
JKB), and reference lists and relevant published reviews (i.e. Von Sydow, Retzlaff, Beher, Haun, & 
Schweitzer, 2013; Woolfenden, Williams, & Peat, 2001) were hand-searched to identify additional 
related publications. Books and unpublished articles were not included. Authors were contacted 
to gather further information about details not reported in the selected papers. Then, the following 
inclusion criteria were applied: (a) participants younger than 18 years with CD and/or ODD 
diagnosis, or scores on a dimensional construct of CD problems in the clinical range; (b) at least 
one quantitative measure of CD problem outcome reported (e.g. rating scale or observation scale 
pre- and/or post-measurements, follow-up); (c) study published in a peer-reviewed journal; and (d) 
randomized controlled trial of nonpharmacological intervention versus control (placebo, waiting 
list, no treatment or treatment as usual). Comorbidity and use of medications were not exclusion 
criteria; articles not written in English, case reports and review articles were excluded. In each article, 
all outcome measures relevant to CD problems were selected.
Data extraction and statistics
In total, 1,549 articles were retrieved and an additional 42 were identiﬁed from reference lists. 
Ultimately, 17 articles describing 19 interventions met the inclusion and exclusion criteria (Figure 1). 
These articles were published between June 2004 and January 2014. The following information 
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a
PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses (www.prisma-statement.org). 
b
References 
from identiﬁed articles and relevant published reviews were manually searched to identify additional related publications
was extracted: age range or mean if available, clinical diagnosis and/or diagnostic criteria used, 
sample size, gender distribution, treatment name, treatment duration, setting (e.g. outpatient, 
clinic), outcomes (in terms of CD-related problems), medication use, rater (e.g. parental report, 
teacher report and selfreport) and rater blinding to treatment allocation. All study characteristics 
and participant details of the included studies are summarized in Table 1. Study quality was assessed 
by two authors (MJB and JG), using the standard deﬁnition for randomization; missing data were 
accounted for as described by Jadad et al. (1996), with the following scores for randomized controlled 
trial quality: 5 = excellent, 4 = good, 3 = fair, 2 = poor, 1 = very poor (Crowther, Lim, & Crowther, 
2010; Jadad et al., 1996). Two points were awarded for (appropriate) randomization, two points for 
(appropriate) blinding and one point for reporting the fate of all patients (including dropouts). 
Treatment efﬁcacy is expressed in terms of the ES. Per study, for each instrument and rater, the ES 
was calculated by using the unbiased estimate of ES (dppc2) developed by Morris (2008). 
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) flow diagram on psychological 
treatments. 
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  (M post, T– M pre, T) - (M post, C– M pre, C)
dppc2= Cp
                                SD pre
Within brackets, the Mpost/pre, T and Mpost/pre, C refer to the mean CD problem score, for the 
post- and pre-test for treatment and control group, respectively. SDpre is referred to the standard 
deviation of the pretest and Cp is the sample size bias correction, based on the n in the treatment 
group (Nt) and the n in the control group (Nc; Morris, 2008).
              3
Cp =      1-
   4 (Nt + Nc-2) -1
Cp is deﬁned as the standardized difference between preand post-treatment and was subtracted 
from the standardized mean difference (SMD) of the control condition. Because we were interested 
in a sustained effect of the interventions, we included (where possible) the follow-up outcomes when 
calculating ESs. By using the SMD, we could take into account the use of different instruments to 
monitor CD-related problem behaviours. The SMD and 95% conﬁdence interval were calculated 
using Review Manager 5.3 (‘Review Manager (RevMan)’, 2014). A SMD higher than zero indicates 
that the active treatment is better than the control condition in reducing problem behaviour in 
children and adolescents diagnosed with CD. An overall ES (indicated as ES-all) was calculated per 
rater if multiple outcome measures were used in a study. In addition, as an exploratory step, the data 
obtained with the lowest and the highest scoring instruments were calculated per rater (indicated as 
ES-low and ES-high). One study (McDonald, Dodson, Rosenﬁeld, & Jouriles, 2011) did not provide 
data to enable us to calculate the ES as described above, and so we used an online calculator to 
calculate an ES (Thalheimer & Cook, 2002; see Table 1). In accordance with the literature, an ES 
of 0.2 was considered to be small, 0.5 to be moderate and ≥ 0.8 to be large (Thalheimer & Cook, 
2002). Heterogeneity was calculated using chi-square (v2) and I-squared (I2) tests. If heterogeneity 
was present, metaregression analyses were performed with possible moderators, such as participant 
or treatment characteristics, using Bonferroni correction for multiple testing; the adjusted 
pvalue was .003.
Results 
The 17 studies recruited 1,999 participants (of which 73.4% boys), with a mean age of 7.5 years 
(range 2.8–16.8 years). Nine studies included participants (n = 782) diagnosed according to DSM-
IV or DSM-III with CD and/or ODD; the remaining eight studies included participants at risk of 
conduct problems or with externalizing problems in the clinical range. ADHD was the most common 
comorbidity (n = 6); eight studies did not report comorbidity data. The 17 studies examined the effect 
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of 19 different psychological interventions with a median duration of 14 hr for children/adolescents 
and 21.8 hr for parents. Only half of the studies provided information about the duration of teacher 
involvement. More participants were allocated to the intervention arm than to the control arm (1,225 
and 774, respectively); overall, the median dropout was 17.6%. Interventions were given in a clinical 
setting (52.6%), home, school or a combination of locations. Control conditions were treatment as 
usual (n = 12) or a waiting-list control group (n = 9). Ten studies focused on group interventions and 
seven on individual interventions; four studies used a combination. For nine interventions, pre- and 
post-treatment outcomes were recorded ( x = 16 weeks), and for 10 interventions, pretreatment and 
follow-up outcomes were recorded ( x = 1.2 years). Details on intervention duration are provided in 
Table 1. Two interventions did not have a set duration – Eyberg, Boggs, and Jaccard (2014) continued 
treatment until the parent’s skills reached a preset level, and Sundell et al. (2008) did not regulate 
contact with therapists, who were available 24/7. Two interventions made use of audiovisual material 
(Jones et al., 2014; Scott & O’Connor, 2012). Most interventions (n = 17) made use of parent-reported 
information; seven interventions made use of teacher-reported information, and 10 interventions 
made use of self-reported information [Child Behaviour Check List (CBCL) – Externalizing subscale, 
n = 5, Achenbach, 1991a; Eyberg Child Behaviour Inventory (ECBI) – Intensity and Problem Behaviour 
subscales, n = 8, Robinson, Eyberg, & Ross, 1980]. Two studies collected parent-reported information 
on speciﬁc aggression-related outcomes (e.g. callous-unemotional traits; McDonald et al., 2011; 
Somech & Elizur, 2012) and one study collected similar teacher-reported information (Kolko, Lindhiem, 
Hart, & Bukstein, 2013). None of the parent-scored instruments assessed subtypes of aggression, 
such as reactive and proactive aggression; only one teacher-scored instrument did (van Manen, 
Prins, & Emmelkamp, 2004). The most widely used instrument to score teacher-rated aggression 
was the Teacher Report Form – Externalizing subscale (n = 2; Achenbach, 1991b). A wide range of 
instruments was used for child-rated CD problem outcomes (n = 5). Only two studies included 
blinded observer-rated outcomes (Jouriles et al., 2009; Perrin, Sheldrick, McMenamy, Henson, & 
Carter, 2014). Four of the 19 interventions allowed participants to use medication: in three, ADHD 
medication (not further speciﬁed) was used, and in one, no details were provided (see also Table 
1). Information about whether medication use was stable was not provided in these studies. On the 
basis of the Jadad scale score, most studies were of ‘very poor’ or ‘poor’ quality (n = 12); ﬁve studies 
were of ‘fair’ quality (Table 1).
Effectiveness of psychosocial treatment – parent report
Seventeen interventions made use of parent-reported information (Figure 2). Thirteen interventions 
were focused on parent management skills (e.g. on proactive and nurturing parenting, effective limit 
setting and handling misbehaviour) and psycho-education (Bagner, Sheinkopf, Vohr, & Lester, 2010; 
Boylan, Macpherson, & Fristad, 2013; Drugli & Larsson, 2006; Eyberg et al., 2014; Hanisch et al., 
2010; Jones et al., 2014; Jouriles et al., 2009; Kolko, Campo, Kelleher, & Cheng, 2010; Kolko et al., 
2013; McDonald et al., 2011; Perrin et al., 2014; Somech & Elizur, 2012; Sundell et al., 2008). Some 
interventions focused on additional aspects such as mandated participation of the father (Somech 
& Elizur, 2012), stress of the parent (Boylan et al., 2013; Eyberg et al., 2014), and instrumental 
and emotional support to mothers (Jouriles et al., 2009; McDonald et al., 2011). On the basis of 
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posttreatment/follow-up data, the weighted mean ES-all was 0.37 (95% CI = 0.27–0.47; random 
effect models), indicating that psychosocial treatment had a small but signiﬁcant effect in reducing 
CD problems in children/adolescents with clinical CD problems and/or a CD diagnosis. Because 
the 95% conﬁdence interval did not contain zero, the null hypothesis that dppc2 = 0 was rejected at 
the 0.05 level. In addition, the weighted mean ES based on the lowest parent-reported score in each 
study was 0.30 (95% CI = 0.20–0.40; random effect models) and that based on the highest parent-
reported score was 0.42 (95% CI = 0.33–0.52; random effect models). Heterogeneity was calculated 
in RevMan 5.3 (Review Manager (RevMan), 2014), using the I-squared and chi-square test for the 
lowest and highest ES parentreported scores in each study. If the mean scores of different samples 
differ, then the samples may originate from different populations (heterogeneity). Heterogeneity 
ranged from I2 = 62% (v2 = 40, p = .0005) to I2 = 63% (v2 = 40.13, p = .0004), which shows 
inconsistency of study results (Higgins, Thompson, Deeks, & Altman, 2003). This necessitated the 
use of a random effect model, which corrects for heterogeneity, to test for differences in outcomes in 
the meta-analysis (Borenstein, Hedges, Higgins, & Rothstein, 2010; Ried, 2006). As seen in Table 1, 
the ES reported in the study by Bagner et al. (2010) deviated substantially from that reported in other 
studies. Therefore, this study was excluded from the sensitivity analysis, which showed that speciﬁc 
participant and intervention characteristics did not affect treatment efﬁcacy.
Effectiveness of psychosocial treatment – teacher report
Seven interventions made use of teacher-reported information (Figure 3). Teachers were not always 
directly involved in an intervention other than ﬁlling out some questionnaires. Two parent-focused 
programmes also included teacher report alongside parent report (Hanisch et al., 2010; Kolko et al., 
2010). The follow-up study by Kolko et al. (2013) and
the study by van Manen et al. (2004) included teacher-reported information on the effect of a cognitive 
behavioural intervention. One study involved a multimodal programme (including the child, parents 
and teachers; Owens, Murphy, Richerson, Girio, & Himawan, 2008), and another involved two types 
of interventions, namely, a multimodal programme and a separate parent-focused programme, 
and included teacher-reported ratings (Drugli & Larsson, 2006). On the basis of available teacher-
reported posttreatment/follow-up outcomes, the weighted mean ES-all was 0.26 (95% CI = 0.12–
0.49; random effect models), indicating a small but signiﬁcant effect of the intervention in reducing 
CD problems in children/ adolescents with clinical CD problems and/or a CD diagnosis. In addition, 
the weighted mean ES-low was 0.18 (95% CI = 0.00–0.36; random effect models) and ES-high was 
0.27 (95% CI = 0.08–0.46; random effect models). Heterogeneity ranged from I2 = 32% (v2 = 10.3, 
p = .05) to I2 = 39% (v2 = 11.5, p < .006), which shows inconsistency of study results. Therefore, the 
random effect model was used.
Effectiveness of psychosocial treatment – self-report
Two interventions made use of self-reported information (Figure 4). These were multimodal 
programmes involving children and parents (Sundell et al., 2008) and/or family, school and courts 
(Hendriks, van der Schee, & Blanken, 2012). In these cases, the focus was on the training of speciﬁc 
skills by means of cognitive behavioural therapy (Boylan et al., 2013; Drugli & Larsson, 2006; Kolko 
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Abbreviations studies: ED or H Children with CP and/or ODD subgroup Emotionally Dysregulated or Headstrong; NR Not 
Randomized to Treatment Group; SC Social Cognitive; SS Social Skills      
  [Name study]- All Weighted effect size based on multiple aggression outcomes.    
       [Name study]- High Weighted effect size based on single and highest aggression outcome.
      [Name study]- Low Weighted effect size based on single and lowest aggression outcome. 
 
et al., 2010, 2013) or on improving motivation (Hendriks et al., 2012; van Manen et al., 2004). On the 
basis of self-reported posttreatment/follow-up outcomes, the weighted mean ES-all was0.01 (95% 
CI = 0.25 to 0.23; random effect models), indicating that neither intervention reduced CD problems. 
Only Sundell et al. (2008) included multiple self-report information, which yielded ESs ranging from 
d = 0.12 (95% CI = 0.44 to 0.19; random effect models) to d = 0.01 (95% CI = 0.22 to 0.41; random 
effect models). 
Figure 2. Forest plot conduct disorder problems, comparison of effect sizes per study based on 
parent report. 
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The inclusion of multiple reports resulted in a weighted mean ES-low of 0.00 (95% CI = 0.02 to 
0.21; random effect models) and ES-high of 0.10 (95% CI = 0.11 to 0.31; random effect models). 
Heterogeneity was I2 = 0% (v2 = 1.72, p = .63), which shows consistency of study results. Nevertheless, 
the random effect model was used to correct for the different outcome measures used in the 
metaanalysis.
Effectiveness of psychosocial treatment – observer report
Three interventions also made use of blinded observers (not further speciﬁed) to score the children/ 
adolescents’ CD problems (Jouriles et al., 2009; Perrin et al., 2014) (Figure 5). The weighted mean 
ES-all was 0.26 (95% CI = 0.06–0.47; random effect models), indicating a moderate but signiﬁcant 
effect in reducing CD problems. As both studies reported only one observer-rated outcome, it was 
not appropriate to calculate the weighted mean ES-low and ES-high. In these two studies, the mean 
weighted ES-all based on parent-reported information was higher than that based on observer-
reported information (d = 0.41, 95% CI = 0.21–0.62).
Figure 3. Forest plot CD problems, comparison of effect sizes per study based on teacher report.
Abbreviations studies: PT or PT+CT Parent Training, Parent Training and Child Training; SC or SS Social Cognitive subgroup, Social Skills 
subgroup
    [Name study]- All Weighted effect size based on multiple aggression outcomes.   
      [Name study]- High Weighted effect size based on single and highest aggression outcome.   
      [Name study]- Low Weighted effect size based on single and lowest aggression outcome. 
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Moderators of treatment effect
In order to explain the heterogeneity in outcomes, we investigated whether ESs (per ES level and per 
rater) were moderated by speciﬁc participant and intervention characteristics. However, analyses 
revealed no effect of comorbidity, gender, age, type of control (i.e. waiting-list control, treatment 
as usual or active control group), number of sessions, duration (hours), intervention type (i.e. 
parent-focused, child-focused or multimodal programmes), group size (i.e. group, individual or 
combination), setting (i.e. school, clinic, home or combination) or dropout percentage (all p-values 
were at least >.07). Individual studies, in particular of children aged 10 years or older, did not report 
whether their participants had early- or late-onset CD, with the exception of Kolko et al. (2010, 2013). 
However, we found a trend towards smaller ESs in studies involving children aged 10 years or older 
compared with those of studies involving children younger than 10 years (i.e. average treatment 
efﬁcacy based on all parentreported information was 0.21 and 0.52, respectively). A similar trend was 
seen with teacherreported information (average ES = 0.32 in children aged <10 years and average ES 
= 0.11 in children aged >10 years). It was not possible to compare treatment efﬁcacy in the two age 
groups 
based on self-reported and observer-reported information because of the limited data available. 
Treatment efﬁcacy appeared not to be inﬂuenced by whether CD had been formally diagnosed or 
by early- versus lateonset CD. Moreover, timing of assessment (posttreatment or follow-up) did not 
inﬂuence results: ES ranged from 0.06 to 1.46 for interventions with posttreatment assessment (n = 
9) and from 0.01 to 0.76 for interventions with a follow-up assessment (n = 10). This was the case for 
Figure 4. Forest plot CD problems, comparison of effect sizes per study based on self -report.
Abbreviations studies: NR Not Randomized to Treatment Group
     [Name study]- High Weighted effect size based on single and highest aggression outcome.   
      [Name study]- Low Weighted effect size based on single and lowest aggression outcome
       [Name study]- All Weighted effect size based on multiple aggression outcomes. 
 2
44
parent-, teacher-, selfand observer-rated outcomes. As most studies (n = 15) did not provide details  
about the medication used, it was not possible to perform sensitivity analyses for medication use. 
Lastly, trials with high Jadad ratings did not necessarily yield large ESs, although the statistical power 
to identify such effects was relatively low, as reported in another study (Field & Gillett, 2010).
Discussion 
We carried out this systematic review and metaanalysis to investigate the effect of nonpharmacological 
interventions for CD problems and to provide recommendations for future research, with a view to 
optimizing clinical outcomes in children/adolescents with CD. Although we speciﬁcally searched 
databases for nonpharmacological treatments other than psychological treatments, all identiﬁed 
studies used psychological treatments. Overall, we found that CD is more common among males 
than females and that based on information provided by teachers, parents and blinded observers, 
psychosocial treatments have a small but signiﬁcant effect in reducing CD problems in children/
adolescents. However, based on the children/adolescents’ ratings, these interventions were not 
effective. Within the same rater and between raters, different instruments evaluating the same 
construct of CD problems yielded widely different ESs. Treatment effects remained signiﬁcant 
when we focused on the instrument with the lowest ES, to account for this variability. While our 
ﬁndings support the use of psychological treatments for CD, there is a lack of evidence about what 
the best treatment is. While gender, age, number of sessions, duration, intervention type, setting, 
medication use or dropout percentage did not inﬂuence treatment efﬁcacy, our ﬁndings suggested 
ⴀ ⴀ
Figure 5. Forest plot CD problems, comparison of effect sizes per study based on blinded rater report.
  [Name study]- All Weighted effect size based on multiple aggression outcomes. 
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that treatment was less effective in older children (>10 years) than in younger children (<10 years), 
based on parent-rated outcomes. It is possible that the diminished efﬁcacy of treatment in older 
children is because treatment is often delayed in children with early-onset CD and/or CD problems. 
An alternative explanation is that different interventions are used at different ages. For example, 
systematic treatment of children older than 10 years might be more effective if accompanied by 
parent training. 
 Our ﬁndings regarding the efﬁcacy of psychological treatment for CD-related problems 
are partly in line with the current literature, in which small-tomoderate effects have been reported 
(Excellence, 2013; Grove et al., 2008; Lundahl et al., 2006; McCart et al., 2006; Weisz et al., 2013; 
Wilson & Lipsey, 2007). The studies included in this analysis made use of different raters (teacher, 
parent, children and blinded observers) and different assessment instruments. We noted that parents 
tended to consider treatment more effective than did teachers or blinded observers. This might be 
because, unlike blinded observers, parents expect treatment to be effective (Sonuga-Barke et al., 
2013). That teachers considered treatment to be less effective than parents did, might be because 
children are slower to implement acquired skills in the classroom than at home or because peer-
pressure at school prevents them from doing so. Therefore, psychological treatment should not only 
impart skills but also take into account the school environment, so that children are encouraged 
to use these skills (Berryhill & Prinz, 2003). Interventions may be more effective if they also target 
teachers (e.g. helping teachers adapt their behaviour so that negative interactions with children are 
reduced) or peers. 
 In contrast, on the basis of self-report information provided by the children/adolescents, we 
did not ﬁnd psychological interventions to have a signiﬁcant effect. This might be because children/
adolescents are usually less inclined to report on their externalizing behaviour (Smith, Pelham, 
Gnagy, Molina, & Evans, 2000). The self-report measures of CD problems used in the two studies 
that included selfreported data (Hendriks et al., 2012; Sundell et al., 2008) have been shown to 
have a high internal consistency and re-test validity. The review by Grove et al. (2008) suggested 
that children who have completed psychological treatment are better at avoiding being caught by 
parents, teachers and schools than before participation. Therefore, children might continue to exhibit 
antisocial behaviour at the same rate and intensity as before treatment but they are not caught doing 
so; however, they continue to report exhibiting this behaviour. 
 Conduct disorder behaviour may be exhibited in different ways (e.g. covert vs. overt aggression) 
and in different contexts (e.g. home vs. school). In the studies included in this review, CD problem 
outcomes were mainly scored with the CBCL and the ECBI questionnaires. In the CBCL, information 
about misconduct behaviour (both aggression and delinquency) is represented in the Externalizing 
scale, and in the ECBI, the Intensity scale represents misconduct behaviour. Unfortunately, the two 
scales are not comparable at the level of individual items. Furthermore, the ECBI lacks information 
about how children or adolescents act at home and at school, whereas the CBCL lacks information 
on the frequency of misconduct behaviour. Thus, while the two questionnaires are complementary 
in observing and rating CD problem behaviour, they may miss important information about function 
(e.g. covert vs. overt; Olson et al., 2013) and subtypes of aggression (e.g. proactive vs. reactive; 
Raine et al., 2006). The predominant subtype of aggression may inﬂuence the focus of treatment 
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focus, which in turn may lead to better outcomes. For example, in the case of predominant reactive 
aggression, treatment could be focused on improving cognitive control and improving strategies 
for controlling negative emotions of distress, frustration and anger. In the case of predominant 
proactive aggression, the focus of treatment could be on improving sensitivity to moral issues and 
moral reasoning and on increasing emotional empathy (Blair, 2013). 
 Although we did not ﬁnd the dropout rate to inﬂuence treatment efﬁcacy, the dropout varied 
considerably in the different studies. Unfortunately, the studies did not provide information about the 
characteristics of the dropouts, so we could not analyse whether dropout is related to the subtype of 
aggression.  Interventions  for  young  children (aged < 10 years) have the beneﬁt that the involvement 
of parents and/or guardians means that they can make sure the child attends treatment sessions. 
This is in contrast to interventions for older children (>10 years), where treatment compliance is less 
likely to be under parent and/or guardian control. For this reason, the dropout rate might be higher 
among older children.
 We did not ﬁnd treatment duration to inﬂuence treatment efﬁcacy. Thus, while one could 
infer that shorter treatments are as effective as longer treatments, this would need to be conﬁrmed 
in a cost– beneﬁt analysis that includes the actual cost of treatment over time and the individual’s 
involvement in different systems.
Limitations
This review overcame some of the shortcomings of previous studies by including randomized 
controlled trials with a speciﬁc target group and incorporating sensitivity analyses to take possible 
moderators (e.g. study quality) into account. However, we could not control for other potential 
modifying factors because of a lack of information or a small number of studies, such as those 
involving an active control intervention (e.g. treatment as usual). For instance, we were unable to 
control for the following aspects: (a) potential effects of psychiatric medication used by participants, 
(b) potential gender effects primarily due to the small sample sizes of the CD cohorts in general 
and of females in particular, (c) blinded versus unblinded raters, because only two primary studies 
used blinded observer report, (d) the inﬂuence of callous-unemotional traits and/or subtypes of CD 
problems (e.g. covert), and (e) onset of CD (i.e. early or late onset), which was reported in only one 
individual study. Surprisingly, nearly half of the included studies did not report data on comorbidity, 
not even on ADHD, which is the most common comorbidity in cases with CD. 
Another limitation is that our standardized quality assessment (Jadad scale) reﬂects the information 
provided in individual study reports and may not fairly represent the trials themselves (Jadad et al., 
1996). For example, there is some debate about the use of the Jadad scale, which includes double 
blinding, because the design of many psychological trials makes it difﬁcult to blind patients or use 
blinded raters.
Recommendations for future research
The small ES of psychological interventions may lead to two conclusions that are not necessarily 
opposing, namely that CD problems are persistent and rather refractory to treatment and that 
psychological interventions for CD problems could be improved, to make them more effective. Future 
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studies should address a number of shortcomings identiﬁed in our review. First, we found evidence 
for rater effects so that future studies should integrate information from multiple informants (e.g. 
parents, teachers and blinded observers) and assess CD problems in more than one environment 
(e.g. home and school situations). Second, we need to understand whether treatments are more 
effective in certain subgroups, classiﬁed by the time of onset, the presence and severity of callous-
unemotional symptoms and the subtype of aggression. Third, future randomized controlled trials 
should be more precise in reporting their methods of randomization and blinding, the fate of all 
patients (including dropouts) within the trial and the medication used by participants, all of which 
might inﬂuence the effect of treatment on CD outcomes. Fourth, more randomized controlled trials 
with large samples are needed because there have been relatively few such studies, which limits the 
generalizability of ﬁndings and makes it difﬁcult to evaluate possible moderators and mechanisms 
of change. Larger, possibly multisite, studies are needed to optimize psychological treatment 
efﬁcacy and maintenance. Fifth, as the nonpharmacological interventions in the current meta-
analysis were behavioural/psychosocial treatments, there is a need to investigate the effectiveness 
of other psychological interventions, such as dietary interventions and cognitive training. One study 
suggested that food intolerance (based on primarily ADHD and/or CD) and deﬁcient intake of either 
micronutrients (e.g. vitamins) or fatty acids (e.g. omega-3) may predispose imprisoned delinquents 
to aggressive behaviour (Benton, 2007). Finally, while we found that intervention duration (in hours) 
did not moderate study outcomes, few studies explicitly investigated this and future studies should 
establish whether there is an optimal treatment duration. To the best of our knowledge, guidelines are 
not consistent about the duration of treatment, and so we would suggest a standardized treatment 
duration of 3 months, in order to allow interstudy comparison of treatment efﬁcacy.
Implications for healthcare policy and clinical practice
This review suggests that psychological treatments have modest efﬁcacy in reducing problems in 
children/adolescents with diagnosed CD or with clinical CD problems and that treatments appear 
to be more effective in younger children (<10 years) than in older children (>10 years). The limited 
evidence based on parent-reported information suggests that, regardless of group- or individual-
focused sessions, the following treatment programmes may be especially effective in reducing 
CD problems: (a) the parent–child-based intervention: ‘Parent–Child Interaction Therapy’, and 
the multicomponent intervention ‘Incredible Years Program plus Child Literacy Program’ [in an 
emotionally dysregulated (e.g. angry and resentful) subgroup as opposed to a headstrong (e.g. 
arguing with adults) subgroup]; and (b) two speciﬁc parent-focused interventions: ‘ParentTraining 
Hitkashrut’ and ‘Project Support’. In addition, teacher-reported information suggested that a 
multicomponent group-focused treatment programme such as ‘Parent Training plus Child Training’ 
is also effective in reducing CD problems. However, as to date only single trials of speciﬁc types 
of treatment for children/adolescents with particular clinical CD diagnoses and/or CD problems 
in the clinical range have been performed, there is a need for further research. The ﬁnding that 
psychological interventions had a modest effect not only on CD symptoms but also on CD-related 
problems, such as academic performance, in both the home and school environments is promising 
and shows that such interventions are broadly beneﬁcial.
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Conclusion 
The current review demonstrates that psychological treatments for children/adolescents with CD 
and CD-related problems are modestly effective, as rated by parents, teachers and blinded observers, 
but not by children; however, the ES varied according to the instrument used. There is not enough 
evidence to support one type of psychological treatment over another. We could not compare 
treatment efﬁcacy between children/adolescents based on self-report and blinded observer report 
because of the limited data available. In addition, too few studies examined the possible moderating 
role of participant and study characteristics, and so more research is needed in this area. The overall 
quality of the studies was poor, and many studies failed to provide important details, such as on 
subtypes of aggression and presence of callous-unemotional traits, information that is needed to 
further optimize psychological treatment strategies. Future studies of CD should pay close attention 
to these details, be of high quality and be adequately powered.
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Key Points
Practitioner message
Psychological treatments appear to be effective in reducing conduct disorder (CD) problems in 
children and adolescents with clinically elevated CD problems and/or CD diagnosis.
Effect sizes (ESs) are small, but signiﬁcant, based on parent report (effect size, ES = 0.36), 
teacher report (ES = 0.21) and blinded observer report (ES = 0.26). This suggests that these 
treatments are effective in reducing CD problems across different raters and situations (e.g. 
home and school environments). However, this is not the case when children/adolescents rated 
their CD problems; then psychological treatments appear not to be effective. 
Effects are not limited to CD symptoms, but include to a range of CD problems including 
frequency of misconduct behaviour, academic problems, and how children/adolescents behave 
at home and at school. Nevertheless, ESs varied within the same rater and between raters, when 
different instruments measuring the same construct of CD problems were used. 
Comorbidity, gender, age, number of sessions, duration, intervention type, setting, medication 
use or dropout percentage do not appear to inﬂuence the effect of treatment. 
There is tentative evidence that treatment may be more effective in children younger than 10 
years.
In the light of current evidence, psychological treatment is recommended for children/adolescents 
with CD problems. Future studies should address a number of key shortcomings to further 
bolster this recommendation.
Areas for future research
There is not enough evidence to support one speciﬁc psychological treatment over another. 
More research is needed comparing speciﬁc interventions. 
Studies included in this meta-analysis used a range of different outcome measures for CD 
problems. While this allows generalization of treatment effects across a range of CD problems, 
future studies should use a more homogeneous set of outcome measures to improve 
comparability across studies. 
To allow better evaluation of the quality of studies, future randomized controlled trials should 
provide detailed information on their methods of randomization and blinding and on the fate of 
all trial participants (including dropouts). 
In order to improve treatment efﬁcacy, future studies should pay greater attention to the role of 
participant characteristics, such as CD onset, presence of and severity of callous-unemotional 
traits, subtype of aggression (e.g. proactive vs. reactive aggression) and severity of aggression. 
The nonpharmacological interventions included in the meta-analysis were psychosocial 
treatments. More research is needed into the effectiveness of other intervention types, such as 
diet and cognitive training.
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Abstract
The Research Domain Criteria (RDoC) address three types of aggression: frustrative non-reward, 
defensive aggression, and offensive/proactive aggression. This review sought to present the 
evidence for genetic underpinnings of aggression and to determine to what degree prior studies 
have examined phenotypes that fit into the RDoC framework. Although the constructs of defensive 
and offensive aggression have been widely used in the animal genetics literature, the human 
literature is mostly agnostic with regard to all the RDoC constructs. We know from twin studies that 
about half the variance in behaviour may be explained by genetic risk factors. This is true for both 
dimensional, trait-like, measures of aggression and categorical definitions of psychopathology. The 
non-shared environment seems to have a moderate influence with the effects of shared environment 
being unclear. Human moleculair genetic studies of aggression are in an early stage. The most 
promising candidates are in the dopamergic and serotonergic systems along with hormonal 
regulators. Genome-wide association studies have not yest achieved genome-wide significance, 
but current samples are too small to detect variants having the small effects one would expect for 
a complex disorder. The strongest molecular evidence for a genetic basis for aggression comes 
from animal models comparing aggressive and non-aggressive strains or documenting the effects 
of gene knockouts. Although we have learned much from these prior studies, future studies should 
improve the measurement of aggression by using a systematic method of measurement such as that 
proposed by the RDoC initiative.
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During the early stages of human evolution, aggression was probably an adaptive trait, as it is for 
many animals in the wild today. seems logical that during this period of time people who had the
variants of genes that promoted aggression were more likely to survive than other people. These 
variants have persisted in the human genome and partly explain why some people exhibit aggressive 
behaviours. 
 Although the word “irascibilem” comes from the Latin “irascibilem”, meaning “to  attack,” 
in current language aggression means much more. In the genetics literature aggression has been It 
operationalized in many ways. As a categorical disorder it has been studied as conduct disorder (CD), 
oppositional defiant disorder (ODD) and antisocial personality disorder (APD). These categories are 
convenient for diagnosticians because other work suggests aggression to be a quantitative trait that 
is better operationalized on dimensions of externalizing behaviour, rule breaking, psychopathy and 
violence. 
 A dimensional view of aggression is consistent with the approach taken by the NIMH 
Research Domain Criteria (RDoC) Initiative [Sanislow et al., 2010]. RDoC seeks to focus researchers 
on the fundamental mechanisms underlying psychopathology. In doing so, it has been creating a 
dimensional taxonomy of behaviour that, hopefully, corresponds better to underlying mechanisms 
than does a system of discrete diagnoses. 
 In the RDoC nomenclature, aggression is categorized into three areas: frustrative non-
reward, defensive aggression and offensive (or proactive) aggression. Frustrative non-reward refers 
to behaviours that correspond to the withdrawal or prevention of reward. This derives from human 
and animal studies showing that aggression occurs after repeated, failed attempts to obtain rewards 
even after sustained efforts. Defensive aggression refers to behaviours caused by the perception 
of an immediate threat, which have the goal of eliminating the threat. Offensive (or proactive) 
aggressive behaviours are instrumental behaviours aimed at achieving a positive goal, often in the 
face of competition or in the context of social hierarchies. 
 The long-term goal of RDoC is to map RDoC phenotypes to underlying mechanisms. In this 
review, we sought to present the evidence for genetic underpinnings of aggression and to determine 
to what degree prior studies have examined phenotypes that fit neatly, or at all, into the RDoC 
framework. We focus the review on three types of genetic studies: twin studies, human association 
studies of aggression and animal model studies. 
Twin studies of aggression
This section outlines recent findings from twin studies on aggression and related psychopathology, 
i.e. ODD, CD and APD. Studies using the classical twin design estimate heritability by comparing the 
covariation between monozygotic (MZ; identical) and dizygotic (DZ; fraternal) twins [Plomin et al., 
1994; Boomsma et al., 2002]. MZ twins are assumed to share 100% of their genetic material while 
DZ twins share 50% of their genetic material, and both types of twins share a common environment 
[Posthuma et al., 2003]. Under an ACE model [Neale and Cardon, 1992], the correlation (r) between 
phenotypes of MZ twin pairs encompasses additive genetic factors (a2 or h2 ; heritability) plus 
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common environmental factors (c2 ), that is rMZ = h2 + c2. For DZ twin pairs who share 50% of their 
segregating genetic material, rDZ = 0.5 * h2 + c2. This gives the following formula to calculate the 
fraction of phenotypic variance accounted for by genetic factors: h2 = 2(rMZ – rDZ). The influence 
of the common environment c2 can be derived as follows: rMZ – h2 (or 2 * rDZ – rMZ). Genetic 
influences can also be non-additive (d2 ), but these effects cannot be estimated simultaneously with 
c2 if only using data from twin pairs who are raised together. Accordingly, variance within twin pairs 
that is not explained by genetic factors or the common environment, is attributed to influence of the 
non-shared environment, e2 = 1 – rMZ, which also includes measurement error [Holzinger, 1929; 
Falconer, 1960]. It is important to note here that the non-shared (unique) environment includes all 
experiences that contribute to differences between children in the same family, i.e. a common event 
(for example parents’ divorce) can affect siblings differently. 
 Twin studies have investigated aggression from different perspectives, e.g. as a personality 
trait [Miles and Carey, 1997], as antisocial behaviour [Rhee and Waldman, 2002] or as a symptom of 
childhood and adolescent psychopathology. Previous reviews of twin studies and adoption studies 
on aggression have estimated heritability up to 0.50, with an additional large role for non-shared 
environmental influences and a small influence of the shared environment [Viding et al., 2008; 
Tuvblad and Baker, 2011]. Genetic effects seem to predominantly account for phenotypic correlations 
between different forms of aggression, such as reactive (defensive) and proactive (offensive) 
aggression, although few studies have examined this [Rhee and Waldman, 2011]. To update these 
prior reviews, we conducted a systematic search for studies in the period January 2009 until February 
2015. PubMed and PsycINFO were searched for peer-reviewed papers to identify studies of twins 
with characteristics of externalizing behaviour and psychopathy, regardless of age. We used the 
following search strategy: aggress OR antisocial behav OR aggressive trait OR behaviour problem 
OR behaviour problem OR problem behavi OR CD OR conduct disorder OR conduct problem  
OR crime OR criminal OR delinquen OR disruptive behav OR ODD OR oppositional defiant disorder 
OR antisocial personality OR psychopathy OR sociopathy AND heritabilit . 
 A total of 254 records were retrieved. Neither books nor unpublished articles were retrieved 
from the references. Titles and abstracts were read by at least two of the authors (MJB and KV); 
article selection is summarized in Figure 1. Articles were retained if they: 1) included constructs 
related to aggression, i.e. aggressive traits, externalizing/impulsive-antisocial behaviour and violent 
criminality/offences/delinquency or diagnostic categories ODD/CD/APD 2) reported univariate 
heritability estimates 3) had been published in peer–reviewed journals from January 2009 onwards. 
Reference lists from the identified articles were manually searched for relevant publications. Articles 
were excluded if they were not written in English, were a case-report, were review articles, reported 
only multivariate analyses, or were not specifically focused on aggression, e.g. publications about 
substance abuse, victimization, or sexual risk behaviour. 
 From the literature search, which generated 254 hits, 80 articles were identified of which 40 
articles were eligible for review according to the above guidelines. All included studies were published 
as articles in scientific journals. Online publication dates ranged from January 2009 to November 
2014. The following information was extracted from the articles: sample size, age range (or mean if 
unavailable), clinical diagnostic criteria used, instruments used to measure the construct of  ggression 
and key findings. A portion of the studies used interviews or reports to assess diagnoses of ODD, 
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Figure 1. Selection of publications for twin studies review.
CD or APD based on the Diagnostic and Statistical Manual of Mental Disorders (DSM; APA, 2001) 
while other studies employed questionnaires and rating scales to assess aggressive symptoms on 
a continuum. All characteristics and details of the included studies are summarized in Table 1. We 
discuss the findings below, starting with research on aggression as a dimensional measure followed 
by research on diagnostic categories. Within these subsections, results are ordered (where possible) 
on the basis of age.
Twin Studies of Aggression as a Dimension of Behaviour 
Aggression in children and adolescents. 
Researchers have explored the etiology of aggressive behavior in children as young as two years of 
age [Gagne et al., 2011]. The authors reported that more than half of the variance of externalizing 
behavior problems could be explained by genetic factors, and around one quarter by shared 
environmental influences. A genetic correlation between externalizing behavior and inhibitory control 
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was also observed, pointing to deficient inhibitory control as a risk factor for aggressive traits. At age 
4, somewhat lower heritability estimates for externalizing behavior have been found (0.39, 95% CI 
=0.25–0.54; Tucker-Drob and Harden, 2013). The influence of the non-shared environment was of 
equal size as the genetic influences. Interestingly, the amount of variance accounted for by shared 
environmental factors changed with age depending on preschool enrollment. For 5-year-old children 
that attended preschool, there was no contribution of shared environment while heritability estimates 
increased. For children who did not attend preschool, the influence of the shared environment was 
more than 50% and the influence of additive genetic factors decreased. Another study in 4-year-olds 
from the same cohort found a gene- environment interaction [Boutwell et al., 2012]. In the context of 
maternaldisengagement, genetic risk factors had a strong effect on externalizing behavior problems. 
Genetic risk did not play a role in behavior problems when maternal disengagement was low, i.e. 
when children were securely attached. Remarkably, other researchers showed that genetic effects 
explained the correlation between negative parenting and conduct problems around age 6, but only 
for low levels of negative parenting [Fujisawa et al., 2012]. For high levels of negative parenting, 
there was a larger non-shared environmental correlation between negative parenting and conduct 
problems. To summarize, the reviewed twin studies in children between age 2 and 6 have focused 
on externalizing and conduct problems in a broad sense. Heritability estimates ranged from 0.39 to 
0.60 with variation contingent upon the school and home environment. 
 From about the time when children start primary school, aggression can be operationalized 
more specifically. Self-report, parent-report or teacher ratings have been used to assess externalizing 
and aggressive behavior, with different measures leading to slightly different findings. Both the Twins 
Early Development Study (TEDS) from the UK and the Netherlands Twin Register (NTR) included twin 
pair ratings by the same teacher as well as by different teachers. Same teacher ratings provided larger 
heritability estimates (0.69, 95% CI = 0.57–0.76 – 0.82, 95% CI = 0.79–0.85) than different teacher 
ratings (0.40, 95% CI = 0.20–0.52 – 0.47, 95% CI = 0.38–0.55; Barker et al., 2009; Lamb et al., 2012). 
Also, heritability estimates of conduct problems based on parent-report were higher compared to 
estimates from self-report [Trzaskowski et al., 2013]. Several studies focused on callous-unemotional 
(CU) traits, which are considered a genetic risk for antisocial behavior [Viding and McCrory, 2012; 
Blair, 2013]. Distinct developmental trajectories have been found in 7 to 12 year olds, with the largest 
heritability for boys who have stable high CU traits (0.78, 95% CI = 0.42–0.88; Fontaine et al., 2010). 
Composite scores across ages confirmed high heritability of CU traits, while heritability estimates 
were close to zero in a Genome-Wide Complex Trait Analysis [GCTA; Viding et al., 2013]. Contrary to 
Fontaine et al. [2010], Ficks et al. [2014] observed no sex differences in genetic and environmental 
influences on CU traits, although nonshared environmental influences on impulsivity were larger 
in boys. For parent ratings of conduct problems, the Child Behavior Checklist [CBCL; Achenbach 
and Rescorla, 2001] is often employed. Scores are taken from the DSM-Oriented Scale (DOS) for 
conduct problems [Spatola et al., 2010; Bertoletti et al., 2014] or the externalizing scale of the CBCL 
encompassing the aggression and rule-breaking subscales [Burt and Klump, 2012; Robbers et 
al.,2012; Nikolas et al., 2013]. Meta-analyses have shown a distinction between aggression and rule-
breaking, with the former primarily influenced by genetics and the latter by the shared environment 
[Burt, 2009, 2013]. In summary for children between 6 to 14 years old, the heritability of parental 
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reports of aggression-related phenotypes ranged from 0.46 to 0.60. The estimates for non-shared 
environmental influences were between 0.18 and 0.48. 
 Some twin studies collected longitudinal data to examine stability and change in the etiology 
of behavior over time. In the Risk Factors for Antisocial Behavior twin study, children age 9–10 were 
followed into adolescence. Separate genetic and non-shared environmental influences were found 
on aggression versus rule breaking during childhood, in addition to joint influences on a latent 
common factor of antisocial behavior [Niv et al., 2013]. At age 14–15, novel genetic influences on 
the latent factor of general antisocial behavior were observed. In the same project, a link between 
adolescent aggression and brain functioning at age 9– 10 was demonstrated [Niv et al., 2015]. The 
power of alpha waves, brain oscillations of 8–13 Hz measurable by electroencephalography (EEG), is 
a biomarker of low arousal. This intermediate phenotype was explored based on theories stating that 
low arousal evokes externalizing behavior to reach a higher, optimal level of arousal. Indeed, alpha 
power recorded over the frontal cortex at age 9–10 predicted aggression at age 14–15. The correlation 
could be explained by genetic factors and was shown in males but not females, and for aggressive 
behavior but not for rule-breaking. 
 In Swedish twins, followed from age 8 to 20, a latent factor representing persistent antisocial 
behavior was found as well as novel shared environmental influences on aggression and delinquency 
at age 13–14 [Tuvblad et al., 2011]. Within the same twin registry, self-reports of antisocial behavior 
and related traits at age 16–17 reflected shared environmental risk for criminality [Kendler et al., 2013]. 
Analyzing parent-reports in addition to self-reports revealed genetic continuity but also novel genetic 
influences at age 13–14 and 16–17, plus novel unique environmental influences for early adolescents 
[Wichers et al., 2013]. Data from the Add Health project suggested that for young adults (age 18 to 
26), genetic influences on criminal behavior were smaller than those on selfreported delinquency 
in adolescence [Vaske et al., 2012]. An analysis combining CBCL data from 1022 Swedish twin pairs 
aged 7–9 years and 501 British twin pairs aged 8–16 years concluded that the etiologies of aggressive 
and nonaggressive antisocial behavior differ for males and females [Eley et al., 1999]. 
 Interestingly, a meta-analysis reported an age-related increase in heritability estimates of 
externalizing behaviors [Bergen et al., 2007]. It has been suggested that this increase may be specific 
to rule-breaking and delinquency, while the magnitude of genetic and environmental influences on 
aggression only is stable across adolescence [Burt and Klump, 2009; Burt and Neiderhiser, 2009]. 
However, Tuvblad and colleagues probed reactive (impulsive; defensive) and proactive (instrumental; 
offensive) aggression and found larger heritability estimates in early adolescence than in childhood 
for both subtypes of aggression [Tuvblad et al., 2009a]. Altogether, aggression is heritable across 
development (range 0.38–0.88) but the magnitude of genetic and environmental influences varies 
according to age and assessment method. 
Aggression in adults
A few extant twin studies focused specifically on aggressive traits in adults, some of which have 
used retrospective measures. With conviction of violent crime as a ichotomous variable, heritability 
estimates were comparable to previous heritability findings of self-reported anti-social behavior [Frisell 
et al., 2012]. Estimates for this outcome in the classic twin design were similar in a sibling model 
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but for adoptees, genetic and shared environmental influences appeared smaller. Using the Lifetime 
History of Aggression Questionnaire [LHA; Coccara et al., 1997], two factors were distinguished [Yeh 
et al., 2010]; general aggression (temper tantrums, verbal and indirect aggression) plus physical 
aggression (fighting and physical assault). Genetic influences were larger for general aggression 
while non-shared environmental influences were larger for physical aggression, pointing to the 
importance of subtyping aggressive behavior. Two studies in adult twins have used questionnaires 
to measure the construct of psychopathy. Brook and colleagues administered the Multidimensional 
Personality Questionnaire [MPQ; Tellegen, 1982] to middle-aged males. On the impulsiveantisocial 
dimension, heritability was 0.32 (95% CI = 0.18–0.45), and a strong influence of the non-shared 
environment was reported with no effect of the shared environment [Brook et al., 2010]. Non-shared 
environmental factors also explained the correlation between the impulsive-antisocial dimension 
and the fearless-dominant dimension of psychopathy. On the Self-Report Psychopathy scale [SRP; 
Hare, 1985], heritability was 0.34 (95% CI = 0.10–0.69) and genetic plus non-shared environmental 
factors explained the phenotypic correlation of psychopathy with risktaking, among other variables 
[Veselka et al., 2011]. 
 Overall, in adult twin studies based on a dimensional approach to aggression, as in studies 
with children, various definitions and measures have been used. It is therefore difficult to compare 
results and to make a link with the RDoC classification [Sanislow et al., 2010]. In the next section, we 
will describe research that focused on diagnostic categories related to DSM criteria [APA, 2000]. 
Aggressive Psychopathology 
Oppositional defiant disorder (ODD) and conduct disorder (CD) in children and adolescents. 
Several studies of twin children and adolescents (N = 12, age range: 4–23 years) have focused on 
aggression expressed in childhood and adolescent psychopathology (e.g. CD or ODD). All these 
studies were characterized by a wide age range, encompassing both childhood and adolescence. 
For example, Singh and Waldman [2010] focused on an age range from 4 to 17 years in a sample 
characterized by symptoms of ODD and CD rated by the parent [Singh andWaldman, 2010]. Based 
on a univariate standard ACDE model (95% CI’s not provided), both disorders showed a different 
model of best fit, in which heritability was roughly the same. An AE model was the best fit for ODD, in 
which two thirds of variance was accounted for by genetic effects. While an ADE model was a best fit 
for CD: nearly half of the variance was explained by additive genetic factors, followed by non-additive 
genetic and non-shared environment effects. In the Tennessee Twin Study, high heritabilities were 
reported for CD 0.70 (95% CI = 0.44–1.00; Waldman et al., 2011) and confirmed by Lahey et al. [2011]. 
In addition, for ODD symptoms heritability was 0.69 (95% CI’s not provided; Lahey et al., 2011). 
However, selfreports showed a reduction in variance explained by genetic influences 0.39 (95% CI = 
0.16–0.72) and a small to moderate role for the common 0.14 (95% CI = 0.004–0.47) and non-shared 
environment 0.47 (95% CI = 0.38–0.57) effects [Waldman et al., 2011]. In contrast, Lahey et al. [2011] 
reported strong genetic influences and moderate non-shared environmental influences for both CD 
and ODD based on combined adult caretaker- and youthreports. In addition, a multivariate model 
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based on a global factor for internalizing and externalizing disorders showed moderate genetic and 
non-shared environmental effects of the externalizing factor in both CD and ODD. The non-shared 
environment effect was moderate in ODD and small in CD. 
 As these few studies mentioned above show, there are mixed results for CD and ODD; some 
studies favor an ACE/ADE model and others an AE model. Another example of an ACE model is a study 
(N = 605 twin pairs) of Tuvblad et al. [2009a,b]. Both CD and ODD symptoms were assessed with the 
DISC-IV structured interview. The authors found unique genetic and environmental influences for 
each set of symptoms, which suggests unique influences of the two disorders. Moreover, the relative 
effects of genetic, shared, and non-shared environmental factors were similar between CD and ODD. 
Furthermore, it has been suggested that both the genetic (95% CI
f
 = 0.17–0.74, 95% CI
m
 = 0.12–0.70) 
and nonshared environmental (95% CI
f
 = 0.23–0.39, 95% CI
m
 = 0.22–0.37) influences on CD are 
slighter higher in girls (f) than boys (m) and slighter lower for shared environment (95% CI
f 
= 0.00–
0.50, 95% CI
m
 = 0.03–0.56). Furthermore, common influences have been reported based on a latent 
externalizing behaviour factor, indicating high genetic and moderate non-shared environmental 
influences. Anckarster et al. [2011] reported that both CD and ODD are more influenced by genetic 
(95% CI
f 
= 0.13–0.36, 95% CI
m
 = 0.61–0.67) factors in boys (m) than in girls (f). In contrast, the 
influence of shared environment was negligible (95% CI
f
 = 0.17–0.35, 95% CI
m
 = 0.00–0.02), the one 
exception being conduct problems in girls. 
 Bornovalova et al. [2010] studied a large sample of twin pairs (aged 11 years) in which an 
ACE model was the best fit. A higher heritability of 0.73 (95% CI = 0.59–0.79) and nonshared 
environmental influences of 0.24 (95% CI = 0.21–0.26) was found for ODD compared with CD, 
in which heritability was 0.51 (95% CI = 0.39–0.63) and common environment was 0.30 (95% CI = 
0.18–0.41). In addition, common environment was significant for CD only. In the longitudinal study 
of Young et al. [2009], twin pairs were assessed at 12 and 17 years of age on both childhood and 
adolescent psychopathology and aggressive traits (CBCL and TRF- externalizing behaviour). They 
reported smaller genetic 0.49 (95% CI = 0.25–0.76) and nonshared environmental 0.25 (95% CI 
= 0.20–0.32) influences at age 17 compared with age 12 (a2 = 0.70, 95% CI = 0.46–0.85; e2 = 0.19, 
95% CI = 0.15–0.24). This AE model was linked to structural stability of behavioural and response 
disinhibition across adolescence, and this relationship was primarily genetic in origin. 
 To conclude this section on developmental psychopathology in childhood and adolescence, 
one large study in adolescents reported an AE model with moderate genetic effects in conduct 
problems [Schulz-Heik et al., 2010]. 
Aggressive psychopathology in older adolescents and adults. 
Among the studies of CD or ODD, two also reported on Adult Antisocial Behaviour (AAB) [Hicks et 
al., 2009, 2013]. For AAB, Hicks et al. [2009] reported strong genetic influences (95% CI = 0.65–0.79) 
and moderate non-shared environment influences (95% CI = 0.21–0.26). Across six environmental 
risk factors (low academic achievement and engagement, antisocial peers, lack of prosocial peers, 
mother-child relationship problems, father-child relationship problems, stressful life events), genetic 
variance in externalizing disorders increased in the context of greater environmental adversity. This 
indicates that as environmental stress increases genetic differences among young adults become 
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more important in the etiology of externalizing disorders. Three studies focused on adults with CD 
and AAB [Meier et al., 2011; Hicks et al., 2013] and cluster B personality antisocial personality disorder 
[Torgersen et al., 2012]. Hicks et al. [2013] focused on both biological twins and non-biological siblings. 
They reported for both CD and AAB moderate genetic (95% CI = 0.35–0.52), shared (95% CI = 0.11–
0.25) and non-shared environmental influences (95% CI = 0.34–0.42). Meier et al. [2011] reported 
approximately two thirds of the variance explained by nonshared environmental influences (95% CI = 
0.63–0.74), followed by genetic effects (95% CI = 0.26–0.37) in CD regardless of gender. No gender 
differences were reported for AAB for which the non-shared environment explained two thirds of 
the variance followed by genetic influences. However, males showed greater stability in antisocial 
behaviour from childhood to adulthood. As for the study on cluster B personality [Torgersen et al., 
2012], one-third of the variance was explained by genetic influences and two thirds by non- shared 
environment based on interview measures of personality disorders. These findings were method 
specific, since the magnitude of the genetic component varied by type of interview compared to self-
reported questionnaires. Thus, differences in twin studies on AAB and APD may be due to gender or 
to differences in measurement methods. 
 Overall, the non-shared environmental effects are less strong compared to genetic effects. 
Furthermore, a risk of bias arises in the cited studies, given that the power to detect shared 
environmental influences is often low in biometric analyses of twin data and these studies assume 
that the environmental effects are free of influence by genetic effects [Burt, 2013]. Therefore, results 
should be interpreted with caution. 
Summary: Twin Studies of Aggressive Behaviour and Psychopathology 
Recent publications about twin data on aggression-related problems suggest that around 50% of the 
variance in aggressive behaviour may be explained by genetic influences. The non-shared environment 
seems to have a moderate influence. With regard to the shared environment, findings are mixed: 
About half of the reviewed studies report no influence while other studies indicate estimates between 
0.15 and 0.35. The former is in line with a previous review that showed the presence of only non-
shared environmental and genetic influences of 0.50 each [Tuvblad and Baker, 2011]. Although a 
meta-analysis demonstrated increased heritability estimates for externalizing with age [Bergen et 
al., 2007], this pattern was not evident in the current review. However, most of the included articles 
examined children and adolescents, and only a few articles focused specifically on adults. An effect 
of gender has occasionally been observed [Tuvblad et al., 2009b; 2011; Meier et al., 2011; Lamb et 
al., 2012; Robbers et al., 2012] but, for most studies, similar models for boys and girls were suitable. 
Hence, heritability estimates may be comparable between males and females despite the finding that 
aggression occurs more often in males, particularly direct, overt aggression as opposed to relational 
aggression [Ligthart et al., 2005]. Of note, genetic influences on aggressive behaviour might depend 
on the environment, as gene-environment interaction appears to play an important role. 
 The operationalization of the construct aggression differed widely across the reviewed articles. 
Some researchers investigated aggression as a trait in the general population while others focused on 
DSM-based psychopathology, i.e. ODD, CD and AAB/APD. Both the dimensional and the categorical 
approaches yielded heritability estimates ranging from approximately 0.30 to 0.80. Several studies 
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found a latent factor of externalizing/antisocial behaviour with unique genetic or environmental 
influences on specific forms of aggression [Bornovalova et al., 2010; Yeh et al., 2010; Lahey et al., 
2011; Tuvblad et al., 2011; Niv et al., 2013]. Thus, a limitation of the current state of the field is that 
researchers do not use common definitions with regard to aggression, which makes it difficult to 
compare studies. Future studies may improve the measurement of aggression by using dimensional 
constructs from the RdoC framework, i.e. defensive aggression, offensive aggression and frustrative 
non-reward (http://www.nimh.nih.gov/researchpriorities/rdoc/negative-valence-systems-workshop-
proceedings. shtml). These constructs are defined and will be continuously refined based on multiple 
units of analysis, such as genes, brain circuits and behaviour, to better integrate clinical findings with 
neuroscience [Sanislow et al., 2010; Cuthbert and Insel, 2013]. Discovering genes that are related to 
various aggression dimensions is one step towards advanced understanding of psychopathology. 
Human association studies of aggression
Based on previous searches performed by Vassos et al. [2014] and Gunter et al. [2010] we searched 
articles on PubMed using the terms “(aggression OR aggressivity OR aggressive OR anger 
OR hostility OR irritability OR violence OR convict  OR crimin  OR offend  OR externalizing OR 
conduct OR antisocial OR impulsive aggression OR psychopathy OR ODD OR oppositional defiant 
OR callous unemotional) AND (genetics OR gene OR polymorphism OR genotype OR allele OR 
genome OR haplotype)” to update their searches from December 2009 until February 2015, with 
an output of 7,202 articles. Subsequently, we filtered works written in English language, performed 
in humans, including sample characteristics and performing genetic association studies that had 
been published as articles in scientific journals. We selected 268 potential articles within this 
range of dates and some additional 263 articles from a previous review [Gunter et al., 2010] and a 
meta-analysis [Vassos et al., 2014]. From these 531 articles we selected those studies that included 
traits related to aggression (aggressiveness, anger, externalizing behaviour, impulsive aggression, 
criminality, violence or delinquency), or diagnostic categories of ODD, CD, antisocial behaviour 
or ASPD, callous unemotional or psychopathy. Also, we excluded studies assessing aggressive or 
antisocial traits in drug use or dependence cohorts, or samples of other psychiatric disorders (e.g. 
schizophrenia, bipolar disorder, major depression). A total of 277 articles were finally considered for 
this review. Our selection process is described in Figure 2. 
 Most association studies exploring the genetic susceptibility to aggression have focused on 
candidate genes (candidate gene association studies, CGAS), especially those related to serotonergic 
and dopaminergic neurotransmission. Additionally, a few genomewide association studies (GWAS) 
have been performed and will also be reviewed. These studies have used either trait measures of 
aggression (Table II) or measures of aggression psychopathology (Tables 3 and 4). Candidate gene 
association studies have often rendered conflicting results, since in several cases associations were 
identified with different alleles of the same variation or could not be replicated in the same phenotype. 
In addition, many of the CGAS were performed in small samples that often lead to false positive or 
false negative findings due to lack of statistical power. Finally, GWAS of aggression phenotypes 
have not identified genome-wide significant associations so far. In consequence, results obtained in 
previous association studies, either CGAS or GWAS, must be taken with caution. 
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Figure 2. Selection of publications for association studies review.
Candidate Genes Studied Across the Lifespan 
The MAOA and 5HTT genes have been studied quite extensively in aggressive traits in children, 
adolescents and adults (Table 2), and also in diagnostic categories of aggression in children (Table 
III) and adults (Table 4). MAOA encodes the enzyme monoamine oxidase A, responsible for the 
catabolism of dopamine, serotonin and other neurotransmitters. An upstream polymorphism 
consisting of a variable number of tandem repeats (uVNTR) located in the promoter region of the gene, 
with an effect on transcription, has been extensively studied. In children, several studies identified 
the uVNTR variants determining low gene expression levels associated with aggression, anger, 
externalizing behaviour and delinquency, especially in high risk environments (maltreatment or low 
maternal sensitivity) [Weder et al., 2009; Edwards et al., 2010; Pickles et al., 2013]. In adolescents and 
young adults, low activity variants were found associated with increased aggressive reactions, violent 
delinquency and even the use of weapons, stabbing and shooting [Guo et al., 2008; Kuepper et al., 
2013; Beaver et al., 2010a,b, 2014). In adults, many studies have associated the low activity variants 
with aggression, impulsivity, hostility and violent criminal and delinquent behaviours [Manuck et 
al., 2000, 2002; Eisenberger et al., 2007; Frazzetto et al., 2007; Reif et al., 2007; Gallardo-Pujol et 
al., 2013; Armstrong et al., 2014; Gorodetsky et al., 2014; Tiihonen et al., 2014]. Only a few studies 
have failed to replicate these results or have identified high activity variants as risk alleles for these 
phenotypes [Huizinga et al., 2006; Yang et al., 2007; van der Vegt et al., 2009; Perroud et al., 2010; 
Verhoeven et al., 2012]. Thus, the bulk of the evidence indicates that low activity alleles of the MAOA-
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uVNTR are probably associated with aggressive traits. Interestingly, the MAOA gene has not been 
associated with CD or ODD in children. Indeed, it has only been associated with CD in the presence 
of an adverse childhood environment [Caspi et al., 2002; Foley et al., 2004; Haberstick et al., 2005; 
Kim-Cohen et al., 2006; Young et al., 2006; Prom-Wormley et al., 2009; Qian et al., 2009; Wakschlag 
et al., 2010; Kieling et al., 2013]. Many studies assessing MAOA in adults identified associations 
with antisocial behaviour, conduct problems and psychopathy in the presence of adverse childhood 
environment, most of them identifying the shorter variant of the uVNTR as the risk allele [Lu et al., 
2003; Widom and Brzustowicz, 2006; Prichard et al., 2007; Flowler et al., 2009; Williams et al., 
2009; Beach et al., 2010; Derringer et al., 2010; Fergusson et al., 2011, 2012; Philibert et al., 2011; Reti 
et al., 2011; McGrath et al., 2012; Sadeh et al., 2013; Byrd and Manuck, 2014; Ficks and Waldman, 
2014; Haberstick et al., 2014]. 
 Studies of the MAOA-uVNTR and aggression have usually been restricted to males; since this 
is an X-linked gene. Because information on the inactivation of the locus is not available, association 
results are difficult to interpret in females. Other MAOA variants, such as the single nucleotide 
polymorphisms (SNPs) rs5906957, rs909525, rs6323, and rs2064070, have been associated with 
physical aggression in boys or anger in male adults [Antypa et al., 2013; Pingault et al., 2013]. Also, 
another VNTR (10 bp) in this gene was found associated with ASPD [Philibert et al., 2011]. 
 The SLC6A4 or 5HTT gene, which encodes the serotonin transporter, has been associated 
with several aggressive phenotypes. A functional polymorphism in the promoter, called 5HTTLPR for 
5HTT-Linked Polymorphic Region, has been associated in children and adolescents with aggression, 
violence, delinquency and externalizing behaviour, although with contradictory results regarding 
the identity of the risk variant and the associated genotypes [Zalsman et al., 2001; Cadoret et al., 
2003; Gerra et al., 2005; Beitchman et al., 2006; Haberstick et al., 2006; Hohmann et al., 2009; 
Zimmermann et al., 2009; Aslund et al., 2013]. In contrast, many studies of adults have found the 
short variant (S) of 5HTTLPR to drive lower transcription levels of the gene and to be associated with 
aggression, anger, hostility, neuroticism, violence and criminality [Greenberg et al., 2000; Liao et al., 
2004; Retz et al., 2004; Verona et al., 2006; Reif et al., 2007; Gonda et al., 2009; Sysoeva et al., 2009; 
Conway et al., 2012; Gyurak et al., 2013; LopezCastroman et al., 2014].  
 The shorter variant of 5HTTLPR has been associated with conduct problems and CD [Sakai et 
al., 2006, 2007, 2010; Brody et al., 2011]. The 5HTTLPR has been associated with psychopathy and 
antisocial behaviour, although with conflicting results [Flowler et al., 2009; Garcia et al., 2010; Sadeh 
et al., 2013; Ficks and Waldman, 2014]. 
 SNP rs25531 modifies the transcription of 5HTTLPR: The long 5HTTLPR allele with a G (Lg) 
at rs25531 drives low transcription levels, similar to the short allele (S), whereas the La allele at 
rs25531determines higher transcription levels. This could explain contradictory association results. 
Beitchman et al., [2006] considered this SNP when analyzing 5HTTLPR genotypes, identifying 
association between lower transcription genotypes (S/S, S/Lg and Lg/Lg) and childhood aggression 
[Beitchman et al., 2006]. 
 Several meta-analyses have evaluated the contribution of the MAOA-uVNTR and 5HTTLPR 
to aggressive behaviour. Vassos et al. [2014] assessed these two variants, among others, in a total of 
31 genes, and did not observe any significant contribution to the phenotype for any of the variants 
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Table 2. Genes Associated with Aggression Trait Measures.
Gene symbol Gene name Phenotype Study References
Children and 
adolescents
AVP arginine vasopressin Aggression CGAS (Malik et al., 2014)
AVPR1A arginine vasopressin receptor 1A Aggression CGAS (Malik et al., 2014)
AVPR1B arginine vasopressin receptor 1A Aggression CGAS (Luppino et al., 2014; 
Zai et al., 2012b)
BDNF brain-derived neurotrophic factor Aggressive behavior CGAS (Kang et al., 2008; Kretschmer
CHRM2 cholinergic receptor, muscarinic 2 Externalizing behavior CGAS (Dick et al., 2011; 
Latendresse et al., 2011)
CYP19 Externalizing behavior CGAS (Miodovnik et al., 2012)
DRD2 dopamine receptor D4 Aggressive behavior and 
violent delinquency
CGAS (Guo et al., 2007; Zai et al., 2012a)
DRD4 dopamine receptor D4 Aggression, externalizing 
behavior and delinquency 
CGAS (Buchmann et al., 2014; Dmitrieva 
et al., 2011; Farbiash et al., 2014; 
Hohmann et al., 2009; Nobile et 
al., 2007; Schlomer et al., 2015)
MAOA monoamine oxidase A Aggression, anger, externalizing 
behavior, delinquency 
and use of weapons
CGAS (Beaver et al., 2014; Edwards 
et al., 2010; Guo et al., 2008; 
Pickles et al., 2013; Pingault et 
al., 2013; van der Vegt et al., 
2009; Weder et al., 2009)
ESR1 estrogen receptor 1 Anger CGAS (Vermeersch et al., 2013)
LRRC7 leucine rich repeat containing 7 Aggressive behavior GWAS (Mick et al., 2011)
OXTR oxytocin receptor Aggression CGAS (Malik et al., 2012; 
Malik et al., 2014)
SLC6A4 
(5HTT)
solute carrier family 
6 (neurotrans
mitter transporter), member 
4  (serotonin transporter)
Aggression, violence, delinquency 
and externalizing behavior
CGAS (Aslund et al., 2013; Beitchman 
et al., 2006; Cadoret et al., 2003; 
Gerra et al., 2005; Haberstick 
et al., 2006; Hohmann et al., 
2009; Zalsman et al., 2001; 
Zimmermann et al., 2009)
SLC6A3 
(DAT1)
solute carrier family 
6 (neurotransmitter 
transporter), member 3 
(dopamine transporter)
Externalizing behavior, 
pathological violence, serious 
delinquency and criminal conduct
CGAS (Beaver et al., 2008; Chen et 
al., 2005; Guo et al., 2007; 
Young et al., 2002)
SLIT2 slit homolog 2 (Drosophila) Anger CGAS (Sokolowski et al., 2010)
STIP1 stress-induced phosphoprotein 1 Aggressive behavior GWAS (Mick et al., 2011)
TMEM132D transmembrane protein 132D Aggressive behavior GWAS (Mick et al., 2011)
Adults
AR androgen receptor Violent criminal behavior, 
aggression, impusivity 
and neuroticism
CGAS (Aluja et al., 2011; Cheng 
et al., 2006; Jonsson et al., 
2001; Rajender et al., 2008; 
Westberg et al., 2009)
ABCG1 ATP-binding cassette, sub-family 
G (WHITE), member 1
Aggression and anger CGAS (Gietl et al., 2007)
AKAP5 A kinase (PRKA) anchor protein 5 Anger CGAS (Richter et al., 2011)
ANK3 ankyrin 3, node of Ranvier (ankyrin 
G)
Externalizing behavior CGAS (Logue et al., 2013)
CDH13 cadherin 13 Violent behavior CGAS (Tiihonen et al., 2014)
CHRM2 cholinergic receptor, muscarinic 2 Externalizing behavior CGAS (Dick et al., 2008)
COMT catechol-O-methyltransferase Aggression, externalizing and 
anger
CGAS (Kulikova et al., 2008; Perroud 
et al., 2010; Shehzad et al., 2012; 
Wagner et al., 2010)
CRHR1 corticotropin releasing hormone 
receptor 1
Aggressive behavior CGAS (Chen et al., 2014)
CYP2D6 CYP2D6 Aggression CGAS (Gonzalez et al., 2008)
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DARPP32 protein phosphatase 1, regulatory 
(inhibitor) subunit 1B
Anger CGAS (Reuter et al., 2009)
DBH dopamine beta-hydroxylase 
(dopamine beta-monooxygenase)
Aggressive hostility, 
impulsivity and neuroticism
CGAS (Hess et al., 2009) 
FYN FYN proto-oncogene, Src 
family tyrosine kinase
Anger GWAS (Mick et al., 2014)
HTR1B 5-hydroxytryptamine (serotonin) 
receptor 1B, G protein-coupled
Aggressive behavior, 
anger and hostility
CGAS (Conner et al., 2010; Hakulinen 
et al., 2013; Zouk et al., 2007)
HTR2A 5-hydroxytryptamine (serotonin) 
receptor 2A, G protein-coupled
Aggression, anger, hostility 
and criminality
CGAS (Banlaki et al., 2015; Berggard 
et al., 2003; Dijkstra et al., 
2013; Giegling et al., 2006; 
Keltikangas-Jarvinen et al., 2008)
MAOA monoamine oxidase A aggression, impulsivity, 
hostility, use of weapons 
and violent criminal and 
delinquent behaviors
CGAS (Antypa et al., 2013; Armstrong 
et al., 2014; Beaver et al., 2010a; 
Beaver et al., 2010b; Eisenberger 
et al., 2007; Frazzetto et al., 
2007; Gallardo-Pujol et al., 2013; 
Gorodetsky et al., 2014; Huang 
et al., 2004; Kinnally et al., 2009; 
Kuepper et al., 2013; Manuck et 
al., 2000; Manuck et al., 2002; 
Reif et al., 2007; Tiihonen et al., 
2014; Verhoeven et al., 2012)
NOS1 nitric oxide synthase 1 (neuronal) Impulsive aggressivity 
and aggression
CGAS (Reif et al., 2009; Retz et al., 
2010; Rujescu et al., 2008)
NOS3 nitric oxide synthase 3 
(endothelial cell)
Aggressive behavior CGAS (Rujescu et al., 2008)
SLC6A4 
(5HTT)
solute carrier family 
6 (neurotransmitter 
transporter), member 4  
(serotonin transporter)
Aggression, anger, hostility, 
neuroticism, violence 
and criminality
CGAS (Conway et al., 2012; Gonda et 
al., 2009; Greenberg et al., 2000; 
Gyurak et al., 2013; Liao et al., 
2004; Lopez-Castroman et al., 
2014; Reif et al., 2007; Retz et al., 
2004; Silva et al., 2007; Sysoeva 
et al., 2009; Verona et al., 2006)
TBX19 T-box 19 Angry hostility CGAS (Wasserman et al., 2007)
TH tyrosine hydroxylase Angry hostility and neuroticism CGAS (Persson et al., 2000) 
TPH1 tryptophan hydroxylase 1 Aggression, aggressive 
behavior, anger and violence
CGAS (Evans et al., 2000; Hennig et 
al., 2005; Manuck et al., 1999; 
Reuter and Hennig, 2005; 
Rotondo et al., 1999; Rujescu 
et al., 2002; Yang et al., 2010)
TPH2 tryptophan hydroxylase 2 Anger CGAS (Ke et al., 2006; Mann et al., 2008; 
Yang et al., 2010; Yoon et al., 2012)
CGAS: candidate gene association study; GWAS: genome-wide association study
Gene symbol Gene name Phenotype Study References
Table 2. Genes Associated with Aggression Trait Measures. (continued)
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Table 3. Genes associated with Aggression Psychopathology Measures in Children and Adolescents.
 
Gene symbol Gene name Phenotype Study References
 RBFOX1 
(A2BP1)
RNA binding protein, fox-
1 homolog (C. elegans) 1
Conduct problems 
and CD
GWAS (Anney et al., 2008; Sonuga-
Barke et al., 2008)
ADH1C alcohol dehydrogenase 1C (class 
I), gamma polypeptide
CD GWAS (Sonuga-Barke et al., 2008)
BDNF brain-derived neurotrophic factor ODD and CU CGAS (Willoughby et al., 2013)
MYRFL 
(C12orf28)
myelin regulatory factor-like Conduct problems GWAS (Anney et al., 2008)
COMT catechol-O-methyltransferase CD CGAS (Caspi et al., 2008; DeYoung 
et al., 2010; Qian et al., 2009)
DRD4 dopamine receptor D4 CD, ODD and CU CGAS (Kirley et al., 2004; 
Nikitopoulos et al., 2014; 
Zohsel et al., 2014)
KIAA2012 
(FLJ39061)
KIAA2012 Conduct problems GWAS (Anney et al., 2008)
HTR1B 5-hydroxytryptamine (serotonin) 
receptor 1B, G protein-coupled
CD and CU CGAS 
GWAS
(Jensen et al., 2009; Moul et 
al., 2013; Viding et al., 2010)
HTR2A 5-hydroxytryptamine (serotonin) 
receptor 2A, G protein-coupled
CU CGAS (Jensen et al., 2009; 
Moul et al., 2013)
KIRREL kin of IRRE like (Drosophila) Conduct problems GWAS (Anney et al., 2008)
RPS24P4 
(LOC729257)
ribosomal protein S24 pseudogene 4 Conduct problems GWAS (Anney et al., 2008)
MAOA monoamine oxidase A CD and ODD with 
adverse childhood 
environment
CGAS (Caspi et al., 2002; Foley et 
al., 2004; Haberstick et al., 
2005; Kieling et al., 2013; Kim-
Cohen et al., 2006; Prom-
Wormley et al., 2009; Qian 
et al., 2009; Wakschlag et al., 
2010; Young et al., 2006)
MFHAS1 malignant fibrous histiocytoma 
amplified sequence 1
CD GWAS (Sonuga-Barke et al., 2008)
OXTR oxytocin receptor CD and CU CGAS (Beitchman et al., 2012)
PAWR PRKC, apoptosis, WT1, regulator Conduct problems GWAS (Anney et al., 2008) 
PKD1L2 polycystic kidney disease 1-like 
2 (gene/pseudogene)
Conduct problems GWAS (Anney et al., 2008)
PKD1L3 polycystic kidney disease 1-like 3 Conduct problems GWAS (Anney et al., 2008)
RGL1 ral guanine nucleotide dissociation 
stimulator-like 1
Conduct problems GWAS (Anney et al., 2008)
RIT1 Ras-like without CAAX 1 CD GWAS (Sonuga-Barke et al., 2008)
ROBO2 roundabout, axon guidance receptor, 
homolog 2 (Drosophila)
CU GWAS (Viding et al, 2010)
SLC6A1 
(GAT1)
solute carrier family (neurotransmitter 
transporter, member 1 (GABA transporter)
CD GWAS (Sonuga-Barke et al., 2008)
SLC6A4 
(5HTT)
solute carrier family 6 (neurotrans
mitter transporter), member 
4  (serotonin transporter)
CD and conduct 
problems
CGAS (Brody et al., 2011; Sakai 
et al., 2010; Sakai et al., 
2007; Sakai et al., 2006)
SLC6A3 
(DAT1)
solute carrier family 6 (neurotransmitter 
transporter), member 3 
(dopamine transporter)
ODD and conduct 
problems
CGAS (Burt and Mikolajewski, 2008: 
Lee, 2007 #276; Todd et al., 
2005; Young et al., 2002)
CGAS: candidate gene association study; GWAS: genome-wide association study; CD: conduct disorder; ODD: oppositional deﬁant disorder; 
CU: callous-unemotional
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Table 4. Genes Associated with Aggression Psychopathology Measures in Adults.
Gene symbol Gene name Phenotype Study References
AR androgen receptor Antisocial behavior CGAS (Prichard et al., 2007)
BDNF brain-derived neurotrophic factor psychopathy CGAS (Kourmouli et al., 2013)
DYRK1A dual-specificity tyrosine-(Y)-
phosphorylation regulated kinase 1A
Antisocial behavior GWAS (Tielbeek et al., 2012)
ESR1 estrogen receptor 1 Antisocial behavior, neuroticism 
and psychoticism
CGAS (Prichard et al., 2007; 
Westberg et al., 2003)
HTR2A 5-hydroxytryptamine (serotonin) 
receptor 2A, G protein-coupled
Antisocial behavior CGAS (Burt and Mikolajewski, 
2008)
MAOA monoamine oxidase A Antisocial behavior, conduct 
problems and psychopathy
CGAS (Beach et al., 2010; Byrd and 
Manuck, 2014; Derringer 
et al., 2010; Fergusson et 
al., 2012; Fergusson et al., 
2011; Fowler et al., 2009; 
McGrath et al., 2012; 
Philibert et al., 2011; Reti et 
al., 2011; Sadeh et al., 2013; 
Williams et al., 2009)
NR4A2 nuclear receptor subfamily 
4, group A, member 2
Antisocial behavior CGAS (Prichard et al., 2007)
SLC6A4 
(5HTT)
solute carrier family 6 
(neurotransmitter transporter), 
member 4  (serotonin transporter)
Psychopathy and 
antisocial behavior
CGAS (Ficks and Waldman, 2014; 
Fowler et al., 2009; Garcia et 
al., 2010; Sadeh et al., 2013)
SNAP25 synaptosomal-associated 
protein, 25kDa
Antisocial personality disorder CGAS (Basoglu et al., 2011)
TFAP2B transcription factor AP-2 
beta (activating enhancer 
binding protein 2 beta)
Antisocial behavior CGAS (Prichard et al., 2007)
CGAS: candidate gene association study; GWAS: genome-wide association study
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assessed. Heterogeneity (I2 ) for the uVNTR and LPR was higher than 50% (P < 0.01). In contrast, the 
meta-analysis of Ficks and Waldman [2014] identified an association between aggressive behaviours 
and the low activity alleles of the MAOA-uVNTR (OR = 1.14; P = 1.37e-06) and the short allele of 
the 5HTTLPR (OR = 1.52; P = 7.59e-11). Also, Byrd and Manuck [2014] found the low activity alleles 
of the MAOA-uVNTR to be associated with aggressive behaviours in the presence of childhood 
maltreatment (P = 8e-07). 
Candidate Genes Studied in Children and Adolescents 
Association studies assessing aggressive traits in children and adolescents have also considered 
other candidate genes (Table 2). Thus, a 48-bp VNTR polymorphism in intron 3 of DRD4, encoding 
the dopamine receptor D4, has been studied. Carriers of the 7-repeat (7R) allele showed higher 
levels of aggression, externalizing behaviour and delinquency [Nobile et al., 2007; Hohmann et al., 
2009; Dmitrieva et al., 2011; Buchmann et al., 2014; Farbiash et al., 2014; Schlomer et al., 2015]. 
Interestingly, an epistatic effect of this allele and the S allele of 5HTTLPR has been reported for 
aggressive and delinquent behaviour [Hohmann et al., 2009]. Also, polymorphic variants within 
the dopamine transporter gene (SLC6A3 or DAT) and the dopamine receptor 2 gene (DRD2) have 
also been associated with aggressive behaviour, externalizing behaviour, violence, criminal conduct 
and violent delinquency in children and adolescents [Young et al., 2002; Chen et al., 2005; Guo et 
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al., 2007; Beaver et al., 2008; Zai et al., 2012a]. The genes for vasopressin and for the oxytocin and 
vasopressin receptors (AVP, OXTR, AVPR1A and AVPR1B) have been associated with aggression in 
children [Malik et al., 2012, 2014; Zai et al., 2012b; Luppino et al., 2014]. Oxytocin and vasopressin 
encode neurohypophysial hormones with primary roles in sexual reproduction and in water 
retention, respectively, but they have also been related with different behavioural traits. Associations 
with other less studied genes were identified in children and adolescent samples, such as BDNF 
with aggressive behaviour [Kretschmer et al., 2014; Musci et al., 2014], CHRM2 and CYP19 with 
externalizing behaviour [Dick et al., 2011; Latendresse et al., 2011; Miodovnik et al., 2012] or SLIT2 
and ESR1 with anger [Sokolowski et al., 2010; Vermeersch et al., 2013]. 
Candidate gene association studies evaluating CD and ODD in children and adolescents have 
also considered other genes related to serotonergic and dopaminergic neurotransmission (Table 
III). The COMT Val/Val genotype of the p.Val158Met polymorphism was found associated with CD 
[Caspi et al., 2008; Qian et al., 2009; DeYoung et al., 2010]. COMT encodes the enzyme cathecol-
omethyltransferase, involved in the degradation of dopamine, epinephrine and norepinephrine. 
Also, the DRD4-7R allele was found associated with ODD, CD and callous unemotional (CU) traits 
[Kirley et al., 2004; Nikitopoulos et al., 2014; Zohsel et al., 2014]. DAT has been associated with ODD 
and conduct problems [Lee et al., 2007; Burt and Mikolajewski, 2008]. The genes for the serotonergic 
receptors HTR1B and HTR2A have been associated with CD and CU [Jensen et al., 2009; Moul et 
al., 2013]. Several variants within the OXTR gene have been associated with CD and CU [Beitchman 
et al., 2012; Malik et al., 2012; Sakai et al., 2012; Dadds et al., 2014; Smearman et al., 2015]. Also, 
associations have been described for BDNF with ODD and CU [Willoughby et al., 2013]. 
Candidate Genes Studied in Adults 
Association studies with aggression traits in adults are summarized in Table 2. The Val/Val genotype 
of the p.Val158Met (rs4680G>A) polymorphism in the COMT gene has been associated with 
aggression, externalizing behaviour and anger. It has also been found to moderate the influence of 
childhood sexual abuse in these traits [Kulikova et al., 2008; Perroud et al., 2010; Shehzad et al., 2012]. 
However, other studies did not replicate these results [Flory et al., 2007; Kang et al., 2008; Albaugh 
et al., 2010]. Several associations have been reported for the serotonin receptor genes HTR1B and 
HTR2A in adult samples. [Berggard et al., 2003; Giegling et al., 2006; Zouk et al., 2007; Keltikangas-
Jarvinen et al., 2008; Conner et al., 2010; Dijkstra et al., 2013; Hakulinen et al., 2013; Banlaki et al., 
2015], but no significant associations were identified for HTR1A or HTR2C [Serretti et al., 2007; 
Keltikangas-Jarvinen et al., 2008; Perroud et al., 2010]. No consistent results were obtained for TPH1 
and TPH2 genes in the susceptibility to aggressive behaviours [Manuck et al., 1999; Rotondo et al., 
1999; Evans et al., 2000; Rujescu et al., 2002; Hennig et al., 2005; Reuter and Hennig, 2005; Mann 
et al., 2008; Yang et al., 2010; Yoon et al., 2012]. Associations with the nitric oxide synthase genes 
NOS1 and NOS3 have been reported for aggressive behaviours [Rujescu et al., 2008; Reif et al., 
2009; Retz et al., 2010]. An androgen receptor (AR) haplotype has been associated with aggression, 
impulsivity, violent criminal behaviour and neuroticism, mostly in adult males [Jonsson et al., 2001; 
Cheng et al., 2006; Rajender et al., 2008; Westberg et al., 2009; Aluja et al., 2011]. Other less studied 
genes in adult samples are: ABCG1, AKAP5, ANK3, CDH13, CHRM2, CRHR1, CYP2D6, DARPP32, 
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DBH, TBX19, and TH. These have been associated with aggressive behaviours in one or a few studies 
[Persson et al., 2000; Gietl et al., 2007; Wasserman et al., 2007; Dick et al., 2008; Gonzalez et al., 
2008; Hess et al., 2009; Reuter et al., 2009; Richter et al., 2011; Logue et al., 2013; Chen et al., 2014; 
Tiihonen et al., 2014]. 
Only a few association studies have been performed for antisocial behaviour and psychopathy (Table 
IV). Studies in which antisocial behaviour was assessed in alcoholic individuals or as an outcome 
of drug use are not considered here. Other less studied genes showed association with antisocial 
behaviour, conduct problems or psychopathy in adults are the ones encoding the androgen receptor 
(AR) and the estrogen receptor 1 (ESR1), and also BDNF, HTR2A, NR4A2, SNAP25 and TFAP2B 
[Westberg et al., 2003; Prichard et al., 2007; Burt and Mikolajewski, 2008; Basoglu et al., 2011; 
Kourmouli et al., 2013]. 
Genome-Wide Association Studies (GWAS) 
GWAS studies of aggression have highlighted genes involved in synaptic plasticity, which had 
previously not been assessed by any candidate gene association study (Tables 2–4). None of the 
association signals reached genome-wide significance, but suggestive associations at P = 1e-05 will 
be discussed. Two GWAS have been performed on aggressive traits (Table 2). Mick et al. identified 
several genes that were nominally associated with aggressive behaviour scores in children, such as 
LRRC7 and STIP1. These genes are involved in neuronal excitability and astrocyte differentiation, 
respectively [Mick et al., 2011]. Another GWAS was performed in adults and identified 11 nominal 
association signals with anger (P ≤ 1e-05). The most significant association was found with the 
FYN gene, involved in calcium influx and release in the postsynaptic density and also in long-term 
potentiation [Mick et al., 2014]. The long-term potentiation pathway could play a role in aggressive 
behaviours both in children and in adults, since FYN, LRRC7 and STIP1, as well as other nominally 
associated genes in the children GWAS, such as BDNF, NTRK2, and CAMK2A, are mediators in 
this pathway [Mick et al., 2011, 2014]. Another study assessed hostility in adolescents and in adult 
males and identified several SNPs that showed nominal associations with anger, some of them in 
the PURG and SHISA6 genes. However, little is known about the function of these genes [Merjonen 
et al., 2011]. 
GWAS studies in children have been performed for CD and CU traits (Table 3). Anney et al. 
performed a family-based genomewide study and identified nine genes that were associated with 
conduct problems: A2BP1, c12orf28, FLJ39061, KIRREL3, LOC729257, PAWR, PKD1L2, PKD1L3, and 
RGL1 [Anney et al., 2008]. A2BP1 and KIRREL3 encode proteins involved in neuron development 
and synaptic plasticity, respectively, and PAWR participates in the regulation of dopamine receptor 
D2 signaling. However, little is known about the function of the other genes in the brain. Another 
GWAS studied the interaction between genes and environmental risk factors (GxE). It found nominal 
associations between CD and mother’s warmth interacting with several variants in five genes: 
RIT1, ADH1C, SLC6A1, A2BP1, and MFHAS1 [Sonuga-Barke et al., 2008]. SLC6A1 codes for a GABA 
transporter, and the proteins encoded by RIT1 and A2BP1 are involved in neuronal development 
and regeneration. Interestingly, the latter also shows suggestive associations with CD the GWAS 
discussed above [Anney et al., 2008]. Hamshere et al. performed a meta-analysis of ADHD GWAS 
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data and observed that polygenic risk for ADHD was higher in ADHD with CD, and that was mainly 
associated with aggression [Hamshere et al., 2013]. Regarding CU, Viding et al. performed a two-
stage GWAS, identifying several suggestive associations. Some SNPs that were associated with 
psychopathic traits in the discovery sample (all of them showing 01e-05 < P < 0.05) and that were 
nominally replicated were located in neurodevelopmental genes, such as ROBO2 [Viding et al., 
2010]. One of the genes within the top-30 list is close to the serotonin receptor HTR1B, which had 
previously been found associated with CU traits, CD, childhood aggressive behaviour, impulsive 
aggression, anger and hostility [Zouk et al., 2007; Jensen et al., 2009; Conner et al., 2010; Hakulinen 
et al., 2013; Moul et al., 2013]. Finally, a GWAS that assessed antisocial behaviour in adults (Table 
4) identified association with DYRK1A, which encodes a kinase with a role in synaptic plasticity and 
brain development [Tielbeek et al., 2012]. 
Summary: Genetic Association Studies of Aggression 
Both CGAS and GWAS approaches have identified potential susceptibility genes for aggressive 
behaviours. Candidate gene studies have focused mainly in dopaminergic and serotonergic genes 
and have identified several associations in these (MAOA, 5HTT, HTR1B, HTR2A, DAT, DRD2, DRD4, 
etc.) and other systems (e.g., hormone-related genes like ESR1, AR, AVP or OXTR). However, most of 
these associations showed contradictory results or were identified in underpowered samples. Thus 
these results should be interpreted with caution. On the other hand, genome-wide studies, although 
not reaching genome-wide significance, have highlighted genes involved in neurodevelopmental 
processes and synaptic plasticity, not previously considered in candidate gene studies. This may 
indicate that aggressive behaviour does not only involve neurotransmitters or hormonal functions, 
but also molecules involved in establishing neuronal circuits, neuron-to-neuron connectivity and 
brain plasticity. 
The lack of genome-wide significant findings in the GWAS and the variable results obtained from 
many of the GCAS is likely due to the small sample sizes of these studies and also to clinical 
and etiological heterogeneity of the patient groups studied. When assessing aggression-related 
phenotypes it may be relevant to separate the different phenotypes into more homogeneous groups 
(e.g., reactive versus proactive aggression) rather than considering them as a whole, since variability 
in the causes of each type of aggressive behaviour may dilute genetic susceptibility effects. In this 
review we have considered only those data obtained from studies in which aggressive behaviours 
could not be attributed to other psychiatric conditions, such as drug dependence, bipolar disorder 
or schizophrenia. For instance, a recent meta-analysis of violent or aggressive behaviours considered 
277 associations in 31 genes and did not find any significant result, although GxE interactions were 
not considered. However, this meta-analysis included data from studies with very different phenotypic 
traits, psychiatric and neurological disorders, and probably that may have prevented from identifying 
significant associations [Vassos et al., 2014]. On the other hand, other meta-analyses identified 
associated the MAOA-uVNTR and 5HTTLPR polymorphisms [Byrd and Manuck, 2014; Ficks and 
Waldman, 2014]. 
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Animal model studies of aggression
Aggression is an evolutionarily conserved behaviour that has been studied in many non-human 
species. This section of the review focuses on four species of animal models that have helped 
tremendously to shape the basis of our current understanding of neurobiological and molecular 
mechanisms underlying aggression: avian models, zebrafish, rodents and drosophila models. We 
particularly emphasize the utilities and potential of these animal model organisms for future genetic 
studies of aggression. 
Avian Models of Aggression 
As one of the earliest species used to study the biological basis of aggression, songbirds, demonstrate 
rich social behaviours such as territoriality, flock hierarchies and male dominance, as well as breeding 
and parenting behaviours. Most studies focused on offensive behaviour associated with territoriality. 
Defensive behaviours have been studied using intruders or subordinate birds. Study of songbirds 
behaviour and their hormonal and neuronal correlates have shaped our basic understanding of 
aggressive behaviour including, for example, the roles of plasma testosterones and hypothalamo-
pituitary-gonadal (HPG) axis (see reviews [AdkinsRegan, 2005; Maney and Goodson, 2011]), and the 
serotonin and dopamine systems. In contrast to the large amount of behavioural, neurochemical and 
endocrine studies of songbirds over the last several decades, dissecting the genetic underpinnings 
of aggression has been scarce. 
 A naturally occurred segregation of high vs. low aggression with a plumage polymorphism in 
white-throated sparrow offers a unique opportunity for identifying causal genetic factors responsible 
for aggressive songbird phenotypes [Thorneycroft, 1966; Ficken et al., 1978]. Half of white-throated 
sparrows are heterozygous carriers of a rearranged chromosome 2 (ZAL2m); they have a white stripe 
in the crown and show high aggressive and poor parenting behaviours. Another half are homozygous 
for wild-type chromosomes (ZAL2); they are less aggressive, show normal parenting and have a tan 
stripe in the crown. Heterozygotes almost always mate with wild-type birds, which maintains the 
population structure. Horton et al reported a behavioural characterization of a homozygote female, 
demonstrating extremely aggressive and dominating behaviour and supporting the causal role of 
rearranged chromosome 2 in increased aggression [Horton et al., 2013]. However, it has taken nearly 
30 years after the discovery of this phenotype to describe causal genes and variants in the affected 
regions [Davis et al., 2011; Huynh et al., 2011]. Among them a prime candidate gene is estrogen 
receptor 1(ESR1), in which promoter polymorphisms linked with the rearranged chromosome were 
shown to regulate brain region-specific expression of ESR1 which was correlated with aggressive 
behaviour [Horton et al., 2014]. 
Rodent Models of Aggression 
Rodents, including mouse, rat, hamster and prairie vole, are wellstudied models for aggressive 
behaviour due to controlled breeding, and their rich repertoire of species-specific social behaviours. 
Similar to many birds, rodents are also territorial. Adult male mice or rats will establish a territory 
when given sufficient living space and attack unfamiliar males intruding in their home cage. The 
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intruders will show defensive behaviours in response to the offensive attacks by the resident. In this 
classic resident-intruder test setting, both offensive aggression (resident) and defensive behaviour 
(intruder) can be studied [Mineur and Crusio, 2002]. Usually, the latency to initiate the first attack 
from the resident from the first sniff of the opponent is indicative of the aggressiveness of the 
resident. 
 Variations of the resident-intruder test are often used to evaluate the factors influencing 
aggressive behaviour. For example, social isolation (individual housing from days to weeks) can 
increase offensive aggression of male mice towards group-housed strangers [DaVanzo et al., 1986]. 
However isolation can also induce timidity in a small but considerable percentage of mice, which 
show alert and defensive postures, and behaviours such as running away, nonagonistic social 
interactions rather than delivering attack bites [Krsiak, 1975; DaVanzo et al., 1986]. The difference 
in social isolation induced abnormal aggressive behaviour in mice provides a model to study 
underlying genetic, hormonal and environmental factors. For example, cannabinoid CB1 receptor 
(CB1r) knockout mice showed lack of isolation-induced aggression, which was associated with 
higher expression of 5HT1Br, COMT and MAO-A in amygdala [Rodriguez-Arias et al., 2013]. Social 
isolation also disrupts immune function and enhances agonistic behaviour in prairie voles [Scotti et 
al., 2015]. Social-isolated rats show hyper- aroused behaviour during aggressive contacts, respond 
inappropriately to species-typical social cues and attack more aggressively by aiming at vulnerable 
body parts such as head, throat and belly. The enhanced abnormal aggressive behaviour was 
associated with significantly increased activation of brain regions that are known to regulate inter-
male aggression in rats [Toth et al., 2012]. 
 For female mice or rats, a well-studied aggressive behaviour is maternal aggression. Female 
mice show enhanced aggression during the first two weeks of the post-partum period. The lactating 
female will attack male and female intruders to protect her litter. The attack bites of dominant 
females are usually directed towards the head and snout of opponents [Miczek et al., 2001]. These 
offensive attacks are usually fast and rarely preceded by anogenital investigation or threats; although 
sniffing the intruder’s genital area after an attack is also considered offensive aggressive behaviour. 
Sometimes, highly aggressive females will attack this vulnerable part. Maternal aggressive behaviour 
can also be defensive, for example piloerection and an upright posture in front of the intruder, boxing 
and holding down the intruder with her front legs, etc [Bosch and Meddle, 2005]. Neural manipulation 
studies showed that disrupting offensive attacks may not affect defensive expressions and vice versa, 
suggesting that the two categories of maternal aggressive behaviour are neurobiologically dissociable 
domains. However, some argued that all maternal aggression can be collectively categorized as 
defensive because the ultimate goal of such behaviour was to defend and protect the litter [Lonstein 
and Gammie, 2002]. Lonstein et al. thoroughly reviewed the neural circuitry underlying the maternal 
aggression and the sensory, hormonal and neurochemical control of the behaviour [Lonstein and 
Gammie, 2002]. A large number of studies have evaluated the roles of neuropeptides such as 
oxytocin, vasopressin and opioid, neurotransmitter systems such as dopamine, serotonin, GABA, 
as well as corticotrophin releasing hormone and nitric oxide in contributing to the presentation of 
maternal aggression in rodents (reviewed [Lonstein and Gammie, 2002]. 
 Noxious and painful stimuli (for example electric shock) have been used to induce aggressive 
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bites in rodents, even in nonaggressive strains. However, the validity of such approaches is questioned 
in regard to human aggression. The tube dominance test is another standardized laboratory test that 
is commonly used to measure aggression and social dominance in rodents [Lindzey et al., 1961]. The 
test employs a transparent tube that allows two animals (mice or rats) to enter from opposite ends 
face to face and to interact in the center. Dominant animals will force the opponent to completely 
retreat from the tube. The numbers of winning vs. losing interactions are indicative of the dominance 
status. Defensive burying refers to a stereotypical response in rodents to a noxious stimuli (such as 
an electric shock-probe), demonstrated by shoving bedding material to bury the threats. Behaviours 
observed in a standardized shock-probe/defensive bury test such as burying, freezing, rearing, 
grooming and exploration are often used to measure anxiety levels and different coping strategies 
that are correlated with aggression phenotypes. 
 Strain differences in rodents (particularly mice) have clearly shown that aggressive phenotypes 
are inherited. Several genetic tools have been developed for rodent models to study the molecular 
and biological mechanisms underlying aggressive behaviour. The earliest one was artificial breeding. 
Using standardized behavioural testing paradigms, artificial selective breeding was carried out to 
produce contrasting inbred strains with high vs. low aggression scores. These inbred strains include 
the Finland Turku aggressive (TA) and non-aggressive (TNS) strains [Sandnabba, 1996], the North 
Carolina NC900 and NC100 strains [Caramaschi et al., 2007], and the Netherlands short attack 
latency (SAL) and long attack latency (LAL) mice [van Oortmerssen and Bakker, 1981]. Cross-fostering 
and the post-natal environment do not alter the development of aggression in these mouse lines, 
further supporting the genomic etiology of their aggression. The TA and TNS lines demonstrated 
Mendelian segregation and autosomal inheritance [Sandnabba, 1996]. The Y chromosome was 
found to play a role in the difference of attack latencies between the SAL and LAL lines [Sluyter et al., 
1995; Sluyter et al., 1997]. Several naturally developed inbred lines with different levels of aggression 
were also recognized as useful models for studying the genetics of aggression. For example, the 
FVB/NtacfBR male shows more aggression toward females when compared with C57BL/6J males 
[Canastar and Maxson, 2003]; the NZB/B1NJ strain shows extremely high inter-male aggression, 
whereas A/J mice rarely show any aggressive behaviour [Roubertoux and Guillot, 2005]. A useful 
summary of commonly used inbred mouse lines was provided by Crawley et al. who compared a 
wide variety of behavioural traits including aggression, anxiety and parental behaviours based on an 
extensive literature review [Crawley et al., 1997]. 
 Like the studies of songbirds, studies of these inbred strains in the past three decades have 
helped our understanding of neural circuitry, hormonal and neurochemical correlates for different 
domains of aggressive behaviour. See reviews [Miczek et al., 2001]. However, identification of causal 
genetic determinants has not been fruitful. A few attempts have been made to identify quantitative 
trait loci (QTLs) underlying differences in aggressive phenotypes between inbred lines. QTL analysis 
showed that aggressive attacks measured in different testing conditions, for example the inter-male 
aggression and isolation induced aggression, have overlapping, yet different genetic contributions 
[Roubertoux and Guillot, 2005]. This observation supports the distinction of different domain/
categories of aggressive behaviour and highlights the complexity of underlying genetic causality. 
However, we are still far away from pinpointing the causal genes within these QTL regions which 
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often contain hundreds of genes. New analytic methodologies have recently been used to uncover 
such complex genetic causes of aggression. Malki et al. [2014] used a weighted gene co-expression 
network analysis (WGCNA) method to examine transcriptome-wide differences between the three 
inbred mouse lines with high vs. low aggression levels. They uncovered two important pathways 
involving NF-kB and MAPKs. The study also yielded 14 differentially expressed genes from the two 
significant pathways as plausible candidates and some of them, such as Adrbk2, had previously 
been implicated in aggressive behaviour. Since gene expression is an unbiased approach, identifying 
previously implicated candidate genes con- firms the biological relevance of those co-expression 
networks in mouse aggressive phenotypes. Although we still have not pinpointed the genetic 
determinants underlying the differences in aggression between those inbred models, we are one step 
closer towards understanding the complex genetic networks that are underlying the phenotypes. 
 Another useful genetic approach is single gene manipulation, i.e., transgenic and gene 
knockout or mutations, particularly in mice. A detailed review of earlier genetic knockout studies has 
been provided elsewhere [Takahashi and Miczek, 2014]. We performed an updated PubMed search 
using keywords of “Knockout AND (Mice OR Mouse) AND (aggressive behaviour) OR aggression)” 
and retrieved 265 articles on non-human animals. After filtering through title, abstract and full texts, 
we summarized 85 genes that altered one or more subtypes of aggressive behaviour in knockout 
mice (or were silenced by siRNA, see Table 5). Many of these genes regulate sensory, hormonal and 
neurochemical/ neurotransmitter systems and neurodevelopmental processes. KO mice phenotype 
information can also easily searched through databases such as Mouse Phenome Database at The 
Jackson Laboratory and currently 50 strains of mutant mice with abnormal aggressive behaviour are 
available from the Jackson Laboratory inventory. 
 In this section, we give some classical examples and highlight the advantages and limitations 
of the single gene approach. For example, gene knockouts of 5-HT neuron-specific transcription 
factor Pet-1 or tryptophan hydroxylases 2 (TPH2) lead to enhanced offensive aggression in resident-
intruder tests accompanied by reduced 5-HT content or 5-HT neural activities [Hendricks et al., 
2003; Alenina and Kikic, 2009; Angoa-Perez et al., 2012; Mosienko et al., 2012]. Knockout of alpha-
calcium-calmodulin– dependent kinase II (a-CaMKII) induced a decreased fear response and an 
increase in defensive aggression accompanied by reduced serotonin release in dorsal raphe neurons 
[Chen et al., 1994]. In contrast, knockout of the monoamine oxidase A (MAOA) gene increased 
brain 5-HT content. In humans, deficiency of MAOA causes Brunner syndrome characterized by 
impulsive aggressiveness [Brunner and Nelen, 1993]. MAOA knockout mice also display enhanced 
aggression toward intruder mice [Scott et al., 2008], but reduced defensive behaviour in the presence 
of predatorrelated cues [Godar et al., 2011]. These examples show the complexity of the genetic 
mechanisms underlying different aggression domains and also highlight the limitations of the single 
gene approach. 
 Manipulation of a single gene produces a cascade of expression and biochemical changes 
during development, which interact with environmental factors and other genetic factors. For 
example MAOA knockout mice showed enhanced expression of NMDA receptor subunit 2A and 
2B expression in the prefrontal cortex and their abnormal aggressive behaviour can be selectively 
countered by administration of NMDAR antagonists [Bortolato and Godar, 2012]. This showed a 
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critical role of NMDA receptor in the pathogenesis of escalated aggression among MAOA knockout 
mice. Consistent with this, an NR1 subunit deficient mouse line shows reduced social investigation 
and lack of species-typical aggressive behaviour in a resident-intruder paradigm [Mohn et al., 1999; 
Duncan et al., 2004]. Therefore, interpretation of single gene knockout studies needs to be cautious 
and take into consideration downstream and compensatory changes in the context of the whole 
organism. 
 Two species of voles distinct in their social behaviours exist as a perfect model to study 
genes and aggression. Prairie and pine voles are highly social and monogamous, whereas meadow 
and montane voles are asocial and promiscuous [Insel and Shapiro, 1992; Young and Wang, 2004]. 
Prairie voles develop pair bonds between mates. Males display intense aggression toward female or 
male conspecific strangers in the resident-intruder paradigm but they maintain a high level of social 
affiliation with their familiar female partners [Aragona and Liu, 2006; Gobrogge et al., 2007]. Although 
similar in nonsocial behaviours, nonmonogamous vole species do not show partner preference or 
increased aggression towards stranger conspecifics [Insel et al., 1995]. Species comparisons show 
that polymorphisms in the arginine vasopressin (AVP) receptor gene, V1aR, were associated with 
distinct patterns of gene expression in the brain associated with differences in pair bonding and 
selective aggression of voles [Lim et al., 2004; Hammock et al., 2005; Ophir et al., 2008]. Genetic 
variations of V1aR and plasma levels of AVP were also associated with human social behaviours 
including aggression and partner relationships [Walum et al., 2008; Gouin et al., 2012; Luppino et 
al., 2014]. 
Drosophila Models of Aggression 
Aggressive behaviour in the fruit fly, Drosophila melanogaster, has been observed since 1915 when 
first reported by Sturtevant [Sturtevant, 1915]. Males spread their wings and engage in antagonistic 
encounters when competing for mating females. Both offensive and defensive behaviours have been 
observed. Drosophila’s nervous system is simple but recapitulates a range of cellular and network 
properties relevant to humans. With modern genetic tools for drosophila, this model system has made 
significant contributions to our genetic understanding of aggressive behaviour. Similar approaches 
that we described for rodent models, such as artificial selection, QTL mapping and single gene 
manipulation, have been used in drosophila research. A detailed summary of these studies and the 
genetic, pheromonal regulation, neurobiological and genetic regulation of aggressive behaviour has 
been reviewed elsewhere [Dahanukar and Ray, 2011; Zwarts et al., 2012; Fernandez and Kravitz, 2013]. 
In this section we highlight several recent significant contributions. 
 Edwards et al. compared the transcriptomes of high vs. low aggression drosophila lines. 
They identified 1593 probe sets that were differentially regulated in these lines [Edwards et al., 2006]. 
Remarkably, out of 19 genes selected for behavioural validation using genomic manipulation in an 
isogenic background, 15 showed significant effects in altering aggressive behaviours after Bonferonni 
corrections. These genes are involved in diverse biological processes, including electron transport, 
catabolism, nervous system development and G-protein coupled receptor signaling. Seven were 
computationally predicted genes and none had been previously implicated in aggressive behaviour. 
Dierick and Greenspan also examined the gene expression between the high aggression and neutral 
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lines [Dierick and Greenspan, 2006]. Among the significantly, differentially expressed genes, a 
cytochrome gene, Cyp6a20 that might be involved in pheromone degradation, was confirmed to 
directly regulate aggressive behaviour by using a mutant line and an odor- binding protein. Obp56a, 
showed the most robust reduction in expression in the aggressive line [Dierick and Greenspan, 
2006]. 
 High-throughput and automated behavioural assays were developed to measure drosophila 
social behaviour including aggression, enabling larger scale genetic correlations with the behaviour 
[Hoyer et al., 2008; Dankert et al., 2009]. Forty inbred lines were quantified for aggressive behaviour 
and genome-wide association screens for quantitative trait transcripts were performed on these 
lines [Edwards et al., 2006]. Two hundred sixty-six novel candidate genes associated with aggressive 
behaviour were identified. Nine genes were confirmed to show altered aggression from behavioural 
evaluation of 12 selected candidate genes [Edwards et al., 2006]. Furthermore, a network based co-
expression analysis revealed functional modules of correlated transcripts that were associated with 
variations of aggressive behaviour. Table VI, lists the candidate genes for aggression implicated 
by drosophila studies. We also included the genes that were identified through the above describe 
expression analysis and were confirmed by behaviour changes on the mutant lines. Of note, none 
of these genes have been implicated in human aggression. More recently, collective efforts were 
made to generate 192 genome-sequenced inbred lines derived from a single Raleigh population. The 
drosophila melanogaster Genetic Reference Panel (DGRP) was constructed to share these inbred 
lines and their genetic data [Mackay et al., 2012]. DGRP provides powerful resources for mapping 
genetype- phenotype relationships. Taking the advantage of the DGRP resources and standardized 
quantitative behavioural assays, a GWAS study for aggressive behaviour was conducted. 74 common 
variants in 39 genes were reported as significant association candidates and one SNP in the intron 
of CG14869 (AdamTS-A) met the genome-wide significance threshold (2.61 x 10-8) [Shorter et al., 
2015]. Only one significant candidate gene association, 5-HT1A, had been previously implicated in 
aggression. Additionally, 22 genes harboring rare variants were significantly associated with aggressive 
behaviours and 10 passed Bonferroni corrections. None of these genes had been implicated in 
aggression previously [Shorter et al., 2015]. The same paper also described an extreme QTL GWA 
study of the advanced intercross populations (AIPs) derived from the most and least aggressive 
DGRP lines. This approach identified 746 SNPs in or near 355 genes with significant association, of 
which 22 passed Bonferroni corrections. The top genes included some in the serotonin, dopamine 
and glutamate pathways, consistent with the well-known roles of these genes in aggression. Due to 
the large number of genes with significant associations, these are not included in Table VI. See the 
original reference for the complete list of genes and variants [Shorter et al., 2015]. Surprisingly, this 
list of genes has almost no overlap with the GWA results from the original DGRP lines. Despite this 
non-overlap in genes and variants, two results were mapped and enriched onto a genetic interaction 
network inferred from an analysis of pairwise epistasis in the DGRP lines [Shorter et al., 2015]. This 
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Gene Names Human 
Homolog
Aggression phenotype/domain Studied for aggression 
in humans
Hormonal Regulations
AVP receptor V1aR (Avpr1a) AVPR1A Social aggression was unaffected in KO 
mice(Wersinger, Caldwell et al. 2007)
Yes (Table 2)
vasopressin 1b receptor (Avpr1b) AVPR1B Avp1b gene knockout affected social 
memory, reduced inter-male aggression 
and maternal aggression(Toth, Tulogdi et 
al. 2012, Scotti, Carlton et al. 2015)
Yes (Table 2)
corticotropin-releasing 
factor receptor 1(Crfr1)
CRHR1 Gene deficiency reduces maternal 
aggression(Gammie, Bethea et al. 2007)
Yes (Table 2)
Corticotropin-releasing factor 
receptor type 2(Crfr2)
CRHR2 KO mice showed increased aggression (Coste, 
Heard et al. 2006) and reduced maternal 
aggression(Gammie, Hasen et al. 2005)
No human studies
corticotropin releasing hormone 
binding protein(Crhbp)
CRHBP Gene Knockout specifically impaired maternal 
aggression(Gammie, Seasholtz et al. 2008)
No human studies
Aromatase P450 (CYP19) CYP19 KO male exhibited a complete loss of aggressive 
behavior (Toda, Saibara et al. 2001)
Yes (Table 2)
estrogen receptor-α (ERα) ESR1 Reduction of ERα expression in preoptic 
neurons significantly increased aggression 
toward both sexual partners and male 
intruder(Ribeiro, Musatov et al. 2012)
Yes (Tables 2 and 4)
Estrogen receptor-beta(Esr2) ESR2 Gene disruption elevated aggression 
levels(Nomura, Andersson et al. 2006)
No human studies
growth hormone releasing 
hormone(Ghrh)
GHRH Gene knockout reduces aggressiveness(Sagazio, 
Shohreh et al. 2011)
No human studies
melanocortin-5 receptor (MC5R) MC5R MC5R deficiency disinhibits an 
aggression-suppressing pheromonal 
signal(Morgan, Thomas et al. 2004)
No human studies
Steroidogenic factor 1 (SF1), or 
Nuclear Receptor Subfamily 5, 
Group A, Member 1(Nr5a1)
NR5A1 KO mice were significantly more aggressive 
(Grgurevic, Budefeld et al. 2008)
No human studies
oxytocin (OT) OT KO mice showed reduced aggression and 
increased social investigation(Lazzari, Becker 
et al. 2013); enhanced offensive aggression 
and infanticidal behavior were observed in 
KO mice(Ragnauth, Devidze et al. 2005)
OT reduces 
reactive aggression 
in state anxious 
women(Campbell and 
Hausmann 2013)
Oxytocin receptor (Oxtr) OXTR Male Oxtr-/- mice had elevated levels of 
aggression(Dhakar, Rich et al. 2012)
Yes (Tables 2 and 4)
Granulin(Grn), progranulin(Pgrn) PGRN Pgrn-deficient mice showed 
enhanced aggressiveness to intruders 
(Kayasuga, Chiba et al. 2007)
A missense mutation 
in PGRN gene was 
found in a patient 
of frontotemporal 
dementia with 
aggressiveness and 
abnormal sexual 
behavior(Rainero, 
Rubino et al. 2011)
Melanin-concentrating 
hormone (MCH)
PMCH Mch Ko mice showed abnormal olfactory 
behaviors and male showed increased 
aggression(Adams, Domouzoglou et al. 2011)
No human studies
prostaglandin E receptor 
subtype EP1 (Ptger1)
PTGER1 KO mice showed impulsive aggression 
(Matsuoka, Furuyashiki et al. 2005)
No human studies
steroid-5-alpha-reductase, 
alpha polypeptide 1(Srda1)
SRD5A1 KO mice is lack of testosterone induced 
aggression(Frye, Rhodes et al. 2002) 
No human studies
Thyroid Stimulating 
Hormone Receptor(Tshr)
TSHR TSHR KO mice show ADHD phenotype with 
increased aggression (Mouri, Hoshino et al. 2014)
No human studies
Urocortin 2(Ucn2) UCN2 Male UCN2 null mice showed reduced 
aggressiveness(Breu, Touma et al. 2012)
No human studies.
Table 5. Genes implicated in aggressive phenotype in knockout mice studies.
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Gene Names Human 
Homolog
Aggression phenotype/domain Studied for aggression 
in humans
Neurochemical and 
Neurotransmitter systems
Acetylcholinesterase (AChE) ACHE AChE KO mice were lack of aggressive 
behavior (Duysen, Stribley et al. 2002)
No human studies
adenosine receptor A1 (Adora1) ADORA1 Mice lacking the adenosine A1 receptor 
are anxious and aggressive(Gimenez-
Llort, Fernandez-Teruel et al. 2002)
No human studies
adenosine A2a receptor ADORA2A KO male showed enhanced aggression towards 
intruder(Ledent, Vaugeois et al. 1997)
No human studies
adrenoceptor alpha 2C(Adra2c) ADRA2C KO mice showed increased 
aggression(Scheinin, Sallinen et al. 2001)
No human studies
cannabinoid CB1 receptors (Cnr1) CNR1  KO mice housed in groups showed higher levels 
of offensive aggression, and lack of isolation 
induced enhance in aggression(Rodriguez-
Arias, Navarrete et al. 2013)
No human studies
dopamine beta-hydroxylase 
knockout (Dbh)
DBH DBH KO mice showed absence of resident-intruder 
aggression(Marino, Bourdelat-Parks et al. 2005)
Yes (Table 2)
Dopamine D2 receptor (Drd2) DRD2 DRD2 long isoform KO mice showed reduced 
aggression(Vukhac, Sankoorikal et al. 2001)
Yes (Table 2)
glutamic acid decarboxylase 
(GAD65)
GAD2 KO mice showed reduced intermale 
aggression(Stork, Ji et al. 2000)
No human studies
glutamate receptor, 
ionotropic, AMPA 3(Gria3)
GRIA3 GluA3-deficient mice showed an 
increase in isolation-induced male 
aggression(Adamczyk, Mejias et al. 2012)
No human studies
glutamate delta-1 receptor(Grid1) GRID1 KO mice showed robust aggression in the 
resident-intruder test(Yadav, Gupta et al. 2012).
No human studies
5-hydroxytryptamine (serotonin) 
receptor 1B (Htr1b)
HTR1B KO mice showed increased aggression towards 
intruder(Bouwknecht, Hijzen et al. 2001)
Yes (Tables 2 and 3)
monoamine oxidase A(Maoa) MAOA KO mice display enhanced aggression toward 
intruder mice(Scott, Bortolato et al. 2008), but 
showed reduction of defensive and fear-related 
behaviours(Godar, Bortolato et al. 2011).
Yes (Tables 2,3 and 4)
membrane metallo-
endopeptidase (Mme)
MME KO mice showed enhanced aggression to 
intruder (Fischer, Zernig et al. 2000)
No human studies
NPY1R  neuropeptide Y 
receptor Y1 (Npy1r)
NPY1R Receptor deletion resulted in increase in 
territorial aggression (Karl, Lin et al. 2004)
No human studies
Enkephalins(Enk), 
Proenkephalin (Penk)
PENK ENK KO mice showed increased offensive 
aggression(Konig, Zimmer et al. 1996)
No human studies
Solute Carrier Family 6 
(Neurotransmitter Transporter), 
Member 1(Slc6a1)
SLC6A1 GABA transporter 1 KO mice showed 
reduced aggression(Liu, Liu et al. 2007)
Yes (Table 3)
solute carrier family 
6 (neurotransmitter 
transporter), member 3 
(dopamine transporter)
(Slc6a3, Dat1)
SLC6A3/
DAT1
DAT1 KO mice exhibited increased 
aggression(Rodriguiz, Chu et al. 2004)
Yes (Tables 2 and 3)
solute carrier family 6 (5-HT 
transporter), member 4, Slc6a4
SLC6A4/5-
HTT
5-HT transporter (5-HTT) knockout 
mice showed reduced maternal 
aggression(Heiming, Monning et al. 2013)
Yes (Tables 2, 3 and 4)
tryptophan hydroxylase 2 (Tph2) TPH2 Mice lacking Tph2 (and brain 5HT) show intense 
compulsive and impulsive behaviors to include 
extreme aggression(Angoa-Perez, Kane et al. 2012)
Yes (Table2)
Nerve System Development
brain-derived neurotrophic 
factor (Bdnf)
BDNF KO mice exhibited elevated conspecific aggression 
and social dominance(Ito, Chehab et al. 2011)
Yes (Tables 2, 3 and 4)
alpha-calcium/calmodulin-
dependent protein 
kinase II (Camk2a)
CAMK2A
Camk2a overexpression increases offensive 
aggression(Hasegawa, Furuichi et al. 2009)
No human studies
calcium channel, voltage-
dependent, N type, 
alpha 1B(Cacna1b)
CACNA1B Gene KO enhanced aggressive behavior 
to the intruder(Kim, Jeon et al. 2009)
No human studies
Table 5. Genes implicated in aggressive phenotype in knockout mice studies. (continued)
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Gene Names Human 
Homolog
Aggression phenotype/domain Studied for aggression 
in humans
calcium channel, voltage-
dependent, beta 3 
subunit(Cacnb3)
CACNB3 Null mice showed increase aggression 
(Murakami, Nakagawasai et al. 2007)
No human studies
cell adhesion molecule 1(Cadm1) CADM1 KO mice showed excessive aggression 
and anxiety(Tanabe, Fujita et al. 2013)
No human studies
CREB-regulated transcription 
coactivator 1 (Ctrc1)
CRTC1 Crtc1(-/-) mice exhibit impulsive 
aggressiveness and many other behavioral 
abnormalities(Breuillaud, Rossetti et al. 2012)
No human studies
ENGRAILED 2 (EN2) EN2 KO mice displayed reduced 
aggression(Cheh, Millonig et al. 2006)
No human studies
v-erb-b2 avian erythroblastic 
leukemia viral oncogene 
homolog 4(Erbb4) and 2(Erbb2)
ERBB2 and 
ERBB4
ErbB2/B4-deficient mice show increased 
aggression(Barros, Calabrese et al. 2009)
No human studies
protein FEV (Fev) or 
plasmacytoma-expressed 
transcript 1(Pet1)
FEV (or 
PET1)
Pet-1 plays a critical role in 5-HT neuron development 
and is required for normal anxiety-like and aggressive 
behavior(Hendricks, Fyodorov et al. 2003)
No human studies
GDP Dissociation 
Inhibitor 1(Gdi1)
GDI1 Gdi1-deficient mice show lowered 
aggression(D’Adamo, Welzl et al. 2002)
No human studies
Neuronal Immediate Early 
Gene, 1 (Homer1)
HOMER1 Heterozygous mice showed increased 
aggression(Jaubert, Golub et al. 2007)
No human studies
Densin-180, leucine rich 
repeat containing 7(LRRC7)
LRRC7 KO male showed enhanced 
aggression(Carlisle, Luong et al. 2011)
Yes (Table 2)
limbic system-associated 
membrane protein(Lsamp)
LSAMP KO mice showed reduced aggressiveness and 
reduced dominance(Innos, Philips et al. 2011)
No human studies
neural cell adhesion 
molecule (Ncam)
NCAM NCAM deletion increased inter-male aggression 
and altered emotionality(Kohl, Riccio et al. 2013)
No human studies
methyl-CpG binding 
protein 2 (Mecp2)
MECP2 Mecp2 conditional knockout (CKO) 
mice were aggressive, hyperphagic, and 
obese(Fyffe, Neul et al. 2008).
A patient with 
Rett syndrome 
demonstrated episodes 
of uncontrolled 
aggression(Huppke, 
Maier et al. 2006)
neuregulin-1 (Nrg1) NRG1 Mutant animals demonstrated increased aggressive 
following(O’Tuathaigh, O’Connor et al. 2008).
No human studies
Neuronal nitric oxide 
synthase (nNOS, Nos1)
NOS1 nNOS knockout mice were significantly 
more aggressive than wild type(Trainor, 
Workman et al. 2007)
Yes (Table 2)
Tailless, nuclear receptor 
subfamily 2, group E, 
member 1 (Nr2e1)
NR2E1 Deletion of Tailless gene produded highly aggressive 
phenotype(Juarez, Valdovinos et al. 2013)
NR2E1 showed 
forebrain-specific 
expression and may 
be associated with 
bipolar disorder, 
schizophrenia, 
or aggressive 
disorders(Kumar, 
McGhee et al. 2008)
neurexin 1α (Nrxn1α) NRXN1 Knockout increased intermale 
aggression(Grayton, Missler et al. 2013)
Gene mutations 
were found in autism 
and intellectual 
disabilities(Yangngam, 
Plong-On et al. 2014).
neuronal PAS domain 
protein 4 (Npas4)
NPAS4 Ko mice spend more time avoiding an 
unfamiliar male during a first encounter, 
showed higher social dominance than their WT 
littermates(Coutellier, Beraki et al. 2012)
No human studies
p21-activated kinase( 
Pak4, Pak5, and Pak6)
PAK4, PAK5, 
and PAK6
All the knockout genotypes were found to be 
less aggressive(Furnari, Jobes et al. 2013)
No human studies
ST8 Alpha-N-Acetyl-
Neuraminide Alpha-2,8-
Sialyltransferase 2 (St8sia2)
ST8SIA2 KO mice displayed both a decreased social 
motivation and an increased aggressive 
behavior(Calandreau, Marquez et al. 2010)
No human studies
Table 5. Genes implicated in aggressive phenotype in knockout mice studies. (continued)
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Table 5. Genes implicated in aggressive phenotype in knockout mice studies. (continued)
Gene Names Human 
Homolog
Aggression phenotype/domain Studied for aggression 
in humans
Olfactory and other 
sensory systems
alpha-1,3 galactosyltransferase 
gene (Ggta1)
A3GALT2 Increased aggression in KO 
mice(Sorensen, Dahl et al. 2008)
No human studies
acid-sensing ion 
channel 3 (Asic3)
ASIC3 Gene KO reduced aggressiveness(Wu, 
Lin et al. 2010)
No human studies
beta2-microglobulin (B2m) B2M B2M deficient mice show specific defect in inter-
male aggression(Loconto, Papes et al. 2003)
No human studies
transient receptor potential 
cation channel, subfamily 
C, member 2 (Trpc2)
N/A Trpc2 knockout mice is lack of male-
male aggression(Miller 2014)
N/A
cyclic nucleotide-gated 
channel alpha2 (Cnga2)
CNGA2 Knockout mice failed mate or 
fight(Mandiyan, Coats et al. 2005)
No human studies
mitogen-activated protein 
kinase 7(Mapk7)
MAPK7 Conditional deletion of the Mapk7 gene in 
neural stem cells impairs several pheromone-
mediated behaviors including aggression and 
mating in male mice(Zou, Storm et al. 2013)
No human studies
 guanine nucleotide 
binding protein (G protein), 
alpha activating activity 
polypeptide O(Gnao1)
GNAO1 G protein G(alpha)o is essential for vomeronasal 
function and aggressive behavior in mice.
(Chamero, Katsoulidou et al. 2011)
No human studies
olfactory G-protein 
-subunit G8 (Gng8)
GNG8 Gene knockout reduced pheromone-mediated 
aggressiveness in both males and females, 
with other socio-sexual behaviours remaining 
unaltered(Montani, Tonelli et al. 2013)
No human studies
kin of IRRE like 3 (Kirrel3) KIRREL3 Kirrel3(-/-) mice display a loss of male-male 
aggression(Prince, Brignall et al. 2013)
No human studies
prepronociceptin PNOC Group housed KO mice showed 
enhanced aggression under competitive 
conditions(Ouagazzal, Moreau et al. 2003)
No human studies
pituitary adenylate cyclase-
activating polypeptide (Pacap)
PACAP Social isolation induced aggressive behavior in KO 
mice but not in WT mice(Ishihama, Ago et al. 2010)
No human studies
pituitary adenylate cyclase-
activating polypeptide (PACAP) 
type 1 receptor (PAC1)
PAC1 PAC1-deficient males displayed reduced 
aggression and increased mounting 
towards males(Nicot, Otto et al. 2004)
No human studies.
potassium intermediate/
small conductance calcium-
activated channel, subfamily 
N, member 3,(Kcnn3)
KCNN3 KO mice showed deficits in mating and 
aggressive behaviors(Kim, Ma et al. 2012)
No human studies
potassium inwardly-
rectifying channel, subfamily 
J, member 3 (Kcnj3)
KCNJ3 KO mice showed deficits in mating and 
aggressive behaviors(Kim, Ma et al. 2012)
No human studies.
Vomeronasal Type-1 
Receptor 1 (Vn1r1)
VN1R1 Mice with deletion of a cluster of V1r genes 
display abnormal inter-male and maternal 
aggression(Del Punta, Leinders-Zufall et al. 2002)
No human studies
Other unspecified genes
early growth response 3(Egr3) EGR3 Gene KO increased offensive aggression towards 
the intruder(Gallitano-Mendel, Wozniak et al. 2008)
No human studies
Glycogen synthase 
kinase-3 alpha (Gsk3a)
GSK3A Mutant mice showed reduced 
aggression(Kaidanovich-Beilin, Lipina et al. 2009)
No human studies
TNF receptor type 1  and type 
2 (Tnfrsf1a and Tnfrsf1b)
TNFRSF1A 
and 
TNFRSF1B
Combined deletion of two receptors resulted in a 
lack of aggressive behavior(Patel, Siegel et al. 2010)
No human studies.
Heat shock factor 1 (Hsf1) HSF1 HSF1 deficiency increased 
aggression(Uchida, Hara et al. 2011)
No human studies.
maternally imprinted/paternally 
expressed gene, Peg3
PEG3 KO animal showed higher maternal 
aggression(Champagne, Curley et al. 2009)
No human studies.
Prion protein (Prnp) PRNP Prnp knockout showed enhanced offensive 
aggression(Budefeld, Majer et al. 2014)
3’UTR polymorphism 
was associated 
with increased 
risk for delusions, 
anxiety, agitation/
aggression(Flirski, 
Sieruta et al. 2012)
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observation supports the multifactorial nature of the genetic underpinnings for aggression and 
suggests that different aggression genes may converge on the same interconnected networks or 
pathways.
Frustrative Non-Reward Reactions 
Frustrative non-reward aggression has been less well studied in animal models. Discontinuation or 
omission of scheduled reinforcement can effectively induce escalated levels of aggressive behaviour 
in fish [Vindas et al., 2012, 2014], birds [Azrin and Hutchinson, 1966; Cherek and Pickens, 1970], 
rodents [Stanford and Salmon, 1989; Miczek et al., 2001], pigs [Melotti et al., 2013], monkeys and 
humans [Barzman and Eliassen, 2014]. An operant procedure has been implemented in mice using 
sucrose as a reinforcer to examine extinction induced aggressive confrontation to intruder mice 
[Miczek et al., 2001]. Similar paradigms have been used to induce aggressive responses in other 
species. Studies have examined the roles of the nonadrenergic system [Stanford and Salmon, 1989], 
the 5-HT1B receptor [de Almeida and Miczek, 2002], neurosteroids and GABAA receptors [Miczek et 
al., 2003] in frustrative non-reward induced reactions in rodents and fish. Barzman et al found that 
the expression of TNF-related inflammatory cytokine genes was positively correlated with frustrative 
non-reward and aggressive behaviours in pediatric patients with bipolar disorder [Barzman and 
Eliassen, 2014]. However, no studies have examined the genes underlying frustrative nonreward 
aggression in animals. 
Summary of Animal Models of Aggression 
The face, construct and predictive validities for aggression models of various species have been 
extensively evaluated. Although evolutionarily conserved, many aggressive measurements in animal 
models are species-specific and should be cautiously translated to human behaviour. Nevertheless, 
animal models have facilitated our understanding of the neurobiological and molecular underpinning 
of normal and pathological aggressive behaviours. Although many classical pathways such as 
hormonal and neurotransmitter pathways have been largely replicated and confirmed in various 
animal and human studies, recent advances in genetic tools and network based analysis have 
suggested novel genetic mechanisms. This is not surprising, since previous candidate gene centered 
studies had already suggested a multifactorial genetic contribution with small and pleiotropic effects 
and complex epistatic relationships. Future directions are 1) to focus on developing network based 
analytic approaches to identify of causal genes and networks and to clarify the relationship of genes 
and networks with aggressive behaviour; and 2) to further delineate the speciesspecific and non-
specific domains of aggressive behaviour as well as escalated/abnormal aggression, and to clarify the 
overlapping yet distinct causal genes and networks underlying these separable domains, particularly 
overlooked domains such as frustrative non-reward.
Summary and conclusions 
In planning this review, we had set out to learn about the genetic underpinnings of the RDoC 
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constructs associated with aggression: frustrative non- reward, defensive aggression and offensive 
(or proactive) aggression. Although the constructs of defensive and offensive aggression have been 
widely used in the animal genetics literature, the human literature is mostly agnostic with regard 
to all the RDoC constructs. That said, many aggression phenotypes have been studied in human 
genetic paradigms and the insights from these studies are likely relevant to the RDoC constructs. 
 We know from twin studies that about half the variance in behaviour may be explained 
by genetic risk factors. This is true for both dimensional, trait- like, measures of aggression and 
categorical definitions of psychopathology. The non-shared environment seems to have a moderate 
influence with the effects of shared environment being unclear. Gene-environment interaction 
appears to play an important role but the details need to be worked out. 
 Human molecular genetic studies of aggression are in an early stage. The most promising 
candidates are in the dopaminergic and serotonergic systems along with hormonal regulators. 
Genome-wide association studies have not yet achieved genomewide significance, but current 
samples are too small to detect variants having the small effects one would expect for a complex 
disorder. These studies have implicated genes involved in neurodevelopmental processes and 
synaptic plasticity, not previously considered in candidate gene studies. This may indicate that 
aggressive behaviour does not only involve neurotransmitters or hormonal functions, but also 
molecules involved in establishing neuronal circuits, neuron-to-neuron connectivity and brain 
plasticity. 
 Future studies should improve the measurement of aggression by using a systematic method 
of measurement such as that proposed by the RDoC initiative, which differentiates defensive 
aggression, offensive aggression and frustrative non-reward [Sanislow et al., 2010]. Although the 
RDoC matrix provides some guidance about the measurement of frustrative non-reward in humans, 
it does not provide guidance for the measurement of offensive and defensive aggression, although 
relevant measures are well-developed in the animal literature. These measurement gaps suggest a 
role for the creation of reliable and valid measures of RDoC constructs for use in human aggression 
studies. Replication has been difficult for the field of psychiatric and behavioural genetics. Such 
problems will only be magnified for aggression if the field cannot come to a consensus about how 
aggression phenotypes should be measured.
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Abstract
The aim of the current study was to compare levels of oxytocin, cortisol, and testosterone in 
adolescents with either autism spectrum disorder (ASD), or oppositional defiant disorder (ODD)/
conduct disorder (CD), and in typically developing individuals (TDI), and relate hormone levels to 
severity and subtype of aggression and callous-unemotional (CU) traits. Saliva concentrations of 
oxytocin, cortisol, and testosterone were assessed in 114 male participants (N=49 ASD, N=37 ODD/
CD, N=28 TDI,) aged 12-19 years (M = 15.4 years, SD = 1.9). The ASD and the ODD/CD groups had 
significantly lower levels of oxytocin than the TDI group, and the ODD/CD group had significantly 
higher levels of testosterone than the ASD group. There were no group effects on cortisol levels. 
Group differences remained for oxytocin after correcting for the influence of CU traits, but were 
not significant after controlling for aggression. Results for testosterone became non-significant 
after correction for either CU traits or aggression. Across groups, higher levels of CU traits were 
related to higher levels of cortisol and testosterone, however, proactive and reactive aggression 
were unrelated to all three hormonal levels. The current findings show that, regardless of cognitive 
ability or comorbid disorders, the diagnostic groups (ASD, ODD/CD) differ from each other by their 
hormonal levels, with the ASD group characterized by relative low level of oxytocin, and the ODD/
CD group by a relative low level of oxytocin and high level of testosterone. These group effects were 
partly driven by differences in CU traits between the groups.
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Hormones play an important role in influencing reactions to our social and non-social environment 
(Heinrichs, Baumgartner, Kirschbaum, & Ehlert, 2003; Jaeggi, Trumble, Kaplan, & Gurven, 2015; van 
Anders, Goldey, & Kuo, 2011). Three important hormones in this context are oxytocin, cortisol and 
testosterone. These hormones constitute active regulators of complex social cognition and affiliative 
behaviour (oxytocin) (Bakermans-Kranenburg & van, 2013; Meyer-Lindenberg, Domes, Kirsch, & 
Heinrichs, 2011; Ooi, Weng, Kossowsky, Gerger, & Sung, 2016), arousal and the stress system (cortisol) 
(Northover, Thapar, Langley, Fairchild, & van Goozen, 2016; Schechter, Brennan, Cunningham, Foster, 
& Whitmore, 2012), and arousal and aggression (testosterone) (Duke, Balzer, & Steinbeck, 2014). 
Here, we assess the level of these three hormones in individuals with either autism spectrum disorder 
(ASD) or oppositional defiant disorder (ODD)/conduct disorder (CD) and in typically developing 
individuals (TDI) during adolescence. ASD are early onset neurodevelopmental disorders defined by 
core impairments in social interaction and verbal and nonverbal communication, stereotyped and 
restricted patterns of interest and activity and abnormal sensory processing according to DSM-5 
criteria (American Psychiatric Association., 2013). ODD is characterized by angry and irritable mood, 
and argumentative, defiant and disobedient behavioral patterns. CD, is characterized by a pattern of 
aggressive, destructive, and/or deceitful behaviors that violate the rights of others according to the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria (APA, 2013). In this paper 
we will combine ODD and CD into one diagnostic group since both disorders are closely linked 
neurodevelopmental disorders of which ODD is either prodromal to CD or a subsyndromal form of 
CD (Biederman et al. 1996). Our interest for comparing these hormones in ASD and ODD/CD as 
two distinct disorders stems from the fact that both involve social/communication problems and 
deficits in empathy (Herpers, Klip, Rommelse, Greven, & Buitelaar, 2016). In individuals with ODD/
CD these problems are associated with increased levels of aggression. Individuals with ASD also 
have elevated levels of aggressive behaviour when compared to TDI (Hill et al., 2014), although the 
aggressive behaviour is not a core symptom of ASD and is typically less severe in ASD than ODD/
CD (APA, 2013). 
 Aggression is a heterogeneous and multifaceted construct, and a common way to subtype 
aggression is into reactive and proactive aggression (Smeets et al., 2017). Reactive aggression 
is known as an emotionally charged response to provocations or frustration and is also known 
as “impulsive”, “hot blooded” or “affective” aggression. Proactive aggression is defined as a 
conscious, goal-directed and planned act, used for personal gain or egocentric motives, also 
known as “premeditated”, “instrumental” or “cold-blooded” aggression (Smeets et al., 2017). 
Callous-unemotional (CU) traits are a category of interpersonal, affective, lifestyle and antisocial 
behaviours that are part of the broader clinical construct of psychopathy, marked by lack of remorse 
or guilt, callous-lack of empathy, lack of concern over performance, and shallow or deficient affect 
(Frick, Ray, Thornton, & Kahn, 2014). CU traits have been further proposed as personality traits 
that qualify the antisocial and aggressive behaviours of individuals with CD. CD with high CU 
traits has been in particular associated with reductions in specific forms of empathy, in particular 
responding to the fear, sadness, pain and happiness of others (Blair, 2013) and a worse outcome 
(Frick et al. 2014). As reviewed elsewhere, high CU traits are not unique to individuals with CD 
but may also observed in the general population and in individuals with other disorders as ASD 
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or Attention-deficit Hyperactivity Disorder (ADHD); they may be conceptualized as cross-disorder 
traits (Herpers et al. 2012) that affect quality of life in ASD and other disorders (Herpers et al. 2016). 
 Below we aim to provide a brief overview of the current literature on the three hormones: 
oxytocin, cortisol, and testosterone in ASD, ODD/CD, and typically developing individuals, and also 
in relation to empathy, aggression subtypes and CU traits.
  
Oxytocin 
In TDI, higher basal oxytocin levels have been associated with lower generosity (i.e. less risk seeking 
behaviour) in preschool boys, regardless of whether the target of generosity was an in- or outgroup 
member (Fujii et al., 2016). This association was observed only under social conditions and thus 
may be reduced in completely anonymous situations. Intranasal oxytocin in adult TDI can improve 
empathy for victims of aggression by improving face recognition of neutral and angry, but not happy 
faces (Savaskan, Ehrhardt, Schulz, Walter, & Schachinger, 2008). Core deficits of ASD such as 
impairments in social interaction have also been associated with to low oxytocin levels (Fieldman, 
Golan, Hirschler-Guttenberg, Ostfield-Etzion, & Zagoory-Sharon, 2014; Parker et al., 2014), given 
the results of intranasal administered oxytocin and/or measuring plasma oxytocin levels, but not 
on basal saliva levels. Whether oxytocin deficits are linked with aggressive behaviour in ASD is still 
unclear. Within ODD/CD some studies have linked lower oxytocin levels to aggressive behaviours 
(Fetissov et al., 2006; R. Lee, Ferris, Van de Kar, & Coccaro, 2009), suggesting that hypo-oxytocinergic 
function may account for aggressive behaviour (Fetissov et al., 2006). Also, molecular genetic 
studies reported significant associations between variants of oxytocin genes (i.e. single nucleotide 
polymorphisms rs6770632, rs1042778) and extreme persistent and pervasive aggressive behaviour 
in males (Beitchman et al., 2012; Malik, Zai, Abu, Nowrouzi, & Beitchman, 2012), and between the 
oxytocin rs237885 and rs2268493 A allele genotype and CU traits (Beitchman et al. 2012). A strong 
association has been observed between low basal saliva oxytocin levels and high levels of CU traits 
among male adolescents with conduct problems (Levy et al., 2015). The present study examines 
whether basal saliva oxytocin levels differ between individuals with either ASD or ODD/CD and TDI, 
and are associated with aggressive subtypes and CU traits.  
Cortisol
A recent review reported diverse findings on basal cortisol levels in TDI compared to ASD individuals 
(Taylor & Corbett, 2014). For ODD/CD – but not ASD - higher basal cortisol levels were associated 
with aggression in preschoolers, lower levels in elementary school-aged children, and associations 
were non-significant in adolescents (Alink et al., 2008). With respect to ODD/CD, most studies 
found that specifically reactive aggression was related to higher levels of cortisol (Lopez, Vazquez, 
& Olson, 2004; van Bokhoven et al., 2005). Several studies demonstrated that CU traits were linked 
to lower basal cortisol levels (Loney, Butler, Lima, Counts, & Eckel, 2006; von Polier et al., 2013), but 
others found no significant association (e.g. Northover et al., 2016). In the current study, basal saliva 
cortisol level will be compared in individuals with either ASD or ODD/CD and related to aggression 
subtypes and CU traits.
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Testosterone
Basal testosterone levels have been studied less frequently in relation to ASD and ODD/CD, in 
contrast to the relationship with aggression which is studied comprehensively. High levels of 
testosterone are thought to be related to aggressive behaviour in clinical samples (Gao, Glenn, 
Schug, Yang, & Raine, 2009). Recent individual studies and critical reviews focused on both TDI and 
clinical samples, report conflicting and equivocal (longitudinal) effects of endogenous testosterone 
levels in male adolescents (Archer, Graham-Kevan, & Davies, 2005; Bitsika et al., 2017; Duke et al., 
2014). Studies reported diverse results on the so-called extreme-male-brain model (Baron-Cohen, 
2002) in ASD, which suggests that core deficits of ASD can be attributed to being exposed to high 
prenatal testosterone levels. An explanation for the absence of aggression in some people with ASD 
and elevated levels of testosterone, is that they have a sufficient level of emotional empathy to inhibit 
any such tendencies (Wen & Wen, 2014), and as such testosterone may mediate social approach 
or avoidance behaviour (Kaldewaij, Koch, Volman, Toni, & Roelofs, 2017). Moreover, there is also 
evidence for a cortisol and testosterone interaction (Carre & Mehta, 2011). In delinquent males 
during resting conditions, high levels of testosterone have been related to aggressive behaviour, 
provided that cortisol levels are low (i.e. basal saliva levels 1 SD below the mean) (Popma et al., 
2007; Terburg, Morgan, & van Honk, 2009). This was observed in covert (i.e. feeling angry without 
expressing openly) aggression only, suggesting a specific relation between hormones and types of 
aggression. Taken together, literature suggests limited relationships between higher testosterone 
levels and increased aggression in clinical samples only. In the current study, the role of basal salivary 
testosterone and the testosterone-cortisol (T/C) ratio is compared between individuals with either 
ASD or ODD/CD and TDI, and examined as a possible biological marker for type of aggression and/
or CU traits. 
To conclude, this is the first study designed to examine whether 1) individuals with either ASD or 
ODD/CD could be differentiated from TDI and each other by hormonal levels (i.e. oxytocin, cortisol, 
testosterone), 2) associations exist between hormone levels and type (i.e. reactive or proactive) of 
aggression, and 3) associations exist between hormone levels and self- or parent-rated CU traits. 
In both ASD and ODD/CD, attention deficit/hyperactivity disorder (ADHD) frequently co-occur 
(Matson, Rieske, & Williams, 2013; Matthys & Lochman, 2010), therefore we control for comorbid 
ADHD in our study. Both ASD and ODD/CD have been associated with impairments in various 
cognitive functions (Erskine et al., 2013; H. Lee, Kang, Kim, Kim, & Chung, 2011), therefore we control 
for cognitive ability in our study. 
Experimental Procedures
Recruitment
Adolescents with ASD or ODD/CD were recruited through clinical institutes across the Netherlands, 
specialized in severe disruptive behaviour problems (Hoenderloo Group, Otto Gerhard Heldring 
Foundation, and Woodbrookers) or severe psychiatric problems (Karakter Child and Adolescent 
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Psychiatry) and through information leaflets that were sent to families via the Dutch federation 
of Autism (NVA). All participants who were recruited from clinical institutes, obtained a clinical 
ASD or ODD/CD diagnosis prior to study participation. Clinical diagnoses (ASD or ODD/CD) 
were established according to DSM-5 (APA, 2000) criteria by a multidisciplinary team based on 
information on developmental history and presenting clinical symptoms gathered by a certified child 
psychiatrist and/or child psychologist, and review of clinical and prior records (if available), including 
information available from school or other professional institutions involved with the child. Thus, a 
consensus diagnosis was assigned, which is seen as more reliable compared to structured interviews 
for assessing diagnostic categories (Leckman, Sholomkas, Thompson, Belanger, & Weissman, 1982). 
The TDI group was recruited via leaflets from a general community sample via city councils in the 
same geographical regions as the clinical groups. 
Inclusion
All participants (TDI, ASD, ODD/CD) were recruited between April 2011 and March 2015 as part of 
a larger study on empathy (CU2-study). Both adolescents (if 12 years and older) and their legally 
appointed guardian provided written informed consent. Adolescents with a clinical ASD or ODD/CD 
diagnosis according to the criteria of the DSM-5 (American Psychiatric Association, 2013) and a total 
IQ ≥ 80, were included in this study. Adolescents were excluded if they fulfilled one or more of the 
following exclusion criteria (a) combined diagnosis of ASD and ODD/CD, (b) an estimated total IQ 
< 80); and/or (c) suffering from a condition which may affect neurological or cognitive functioning, 
such as schizophrenia, bipolar disorder, alcohol and/or drugs dependency, presence of tics, language 
disorders (e.g. dyslexia) and epilepsy. In- and exclusion criteria for TDI group were similar to the ASD 
and ODD/CD group, except for having a clinical psychiatric diagnosis. The use of non-psychotropic 
(5.5%) and antidepressant medication (2.3%) was allowed. If possible, psychotropic medication (i.e., 
stimulants, 21.8%; antipsychotics, 9.3%; atomoxetine, 2.3%) was stopped prior to testing. Stimulants 
were discontinued for at least 24 hours. Antipsychotics were discontinued for at least 72 hours. 
However, when discontinuation was thought to have severe deteriorating effects, medication was 
continued (ASD: n = 10, ODD/CD: n = 12). This study was approved by the Dutch Central Committee 
on Research involving Human Subjects, protocol number NL26773.000.09 (Centrale Commissie 
Mensgebonden Onderzoek; CCMO).
Pre-screening
The participants and their guardian were requested to complete pencil-and-paper questionnaires 
separately from each other at home or at the test location (a quiet room deprived of stimuli). In 
addition, all three groups were similarly screened for ASD using the parent Social Communication 
Questionnaire ([SCQ] Rutter, Bailey, & Lords, 2003). This is a 40-item parent-report questionnaire that 
asks about characteristic autistic behaviour on a binary scale (yes/ no). The first item is a language 
screening question that is not included in the total score. Nineteen items rate current behaviour 
and 20 items rate behaviour when the child was 4-5 years old (Rutter et al., 2003). 81% Of the ASD 
group and 35% of the ODD/CD group had a SCQ score above 12. Typically developing adolescents 
were required to obtain non-clinical scores on the parent SCQ (i.e. raw scores of <12) in order to 
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be accepted in the current study. Based on English versions of the SCQ, sensitivity ranged between 
.85-.88 and specificity between .72 and .78 (Berument, Rutter, Lord, Pickles, & Bailey, 1999; Chandler 
et al., 2007; Charman et al., 2007). Cronbach’s Alpha for the total SCQ was .75 in the current study.
  
Participants
Initially, 432 subjects were approached to participate within the Netherlands, of whom n = 304 refused 
to participate, n = 6 ran away from home/ institute, n = 18 did not meet inclusion criteria, and for n = 
2 we were unable to obtain consent of legally appointed guardian. This resulted in a total of 114 male 
adolescents (n = 28 TDI,  n = 49 with ASD, and n = 37 with either ODD or CD), aged between 12 and 
19 years (M = 15.4 years, SD = 1.9), 81% of non-European origin, 100% boys. Main participant and 
demographic characteristics are summarized in Table 1.
Measures
DISC-IV: Adolescents and legal guardians who gave informed consent, were administered screening 
questionnaires and the DISC-IV interview to confirm the clinical diagnosis with a research diagnosis 
across all three groups (TDI, ASD, and ODD/CD). This information was used to classify the 
adolescents into the TDI, ASD, and ODD/CD groups. For all three groups, caretakers were asked to 
fill out a digital version of the National Institute of Mental Health Diagnostic Interview Schedule for 
Children (DISC-IV; (Shaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000), which is focused on the 
presence of axis-I disorders in terms of the DSM-IV-TR (APA, 2000). To assess relevant psychiatric 
comorbidities, parents were asked to fill out the following sections of the DISC-IV: ADHD, ODD, CD, 
Tic Disorder, misuse of Alcohol, Marihuana, and Other Drugs. In the TDI group, the absence of a 
clinical psychiatric diagnosis was assessed based on a DISC-IV parent interview.
 WISC-III. Adolescents were required to have a minimum average estimated total full-scale 
intelligence quotient (FSIQ) IQ of ≥ 80. FSIQ was estimated using four subtests of the Dutch version 
Wechsler Intelligence Scale for Children (WISC-III): Picture Completion, Vocabulary, Similarities and 
Block Design (Wechsler, 1991). These selected WISC-III subtests are known to correlate between .90-
.95 with the Full-scale IQ (Groth-Marnat, 1997). For adolescents older than 16 years, the Wechsler 
Adult Intelligence Scale (WAIS-III) was administered (Wechsler, 1997). When intelligence was 
assessed within a year prior to the inclusion, and either the WISC or WAIS was applied, we used the 
scores of that assessment. In case of a disharmonic intelligence profile, adolescents with a verbal 
intelligence scale ≥ 80 were included. 
 The Reactive Proactive aggression Questionnaire (RPQ) assesses the level of proactive and 
reactive aggression in adolescents (Raine et al., 2006). In the current study, the Dutch translation 
of the RPQ was used (Cima, Raine, Meesters, & Popma, 2013). This questionnaire consists of 
23 propositions placed on a three-point scale ranging from 0 (‘never’) to 2 (‘often’). Proactive 
aggression is reported on 12 items (e.g., How many times have you bullied or threaten someone?’), 
while reactive aggression is reported on 11 items (e.g., ‘How many times have you hit someone to 
defend yourself?’). Total scores are calculated by prorated summary scores of the 12 items related to 
proactive aggression, and the 11 items related to reactive aggression. Cronbach’s alpha was .91. 
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The Inventory of Callous-Unemotional traits (ICU) assesses CU traits in adolescents, divided into 
three subscales: uncaring (8 items), callousness (11 items) and unemotional (5 items) (Frick, Cornell, 
Barry, Bodin, & Dane, 2003). The ICU exists of 12 positively worded and 12 negatively worded items, 
rated on a four-point scale ranging from 0 (‘not at all true’) to 3 (‘definitely true‘). An example of 
an item measuring the uncaring scale is ‘I am concerned about the feelings of others’. The item ‘I 
seem very cold and uncaring to others’, measures for example the callousness scale. An item which 
measures the unemotional scale is, for example, ‘I do not show my emotions to others’. Subscale 
scores are calculated by prorated summary scores of the item ratings. Subsequently, the total score 
can be calculated by summing the subscale scores. A higher score reflects higher levels of CU traits. 
The ICU was reported by both adolescents and their legal guardian. Cronbach’s alpha of the self-
report was .78, compared to a Cronbach’s alpha .89 based on legal guardian/ parent report.
Hormone measures – oxytocin, cortisol, and testosterone
Hormones. Levels of oxytocin, cortisol, and testosterone were assessed in saliva without using oral 
stimulants for saliva production. Saliva collection is a reliable, simple, stress-free method, and is 
better suited to assessing hormone concentrations in adolescents than other methods, such as 
using plasma (Kirschbaum & Hellhammer, 1994; Daughters et al. 2015). Participants once sampled 
6 ml saliva in a plastic clear test tubes provided by the lab. They were instructed to complete 
sampling at least one hour after eating, drinking, brushing their teeth or smoking. The saliva 
samples were directly stored at -20 degrees Celsius and subsequently assessed at the department 
of Laboratory Medicine, Radboud UMC, Nijmegen. The level of oxytocin was measured in saliva 
by a radio immuno assay (RIA) after solid phase extraction, as previously described (Althaus et al., 
2016). Cortisol and testosterone were measured in saliva samples by an in-house developed RIA 
after a chromatochrafic paper separation and extraction (with correction for losses), as previously 
described (MacKenzie, Hoefnagels, Jansen, Benraad, & Kloppenborg, 1990; Swinkels, van Hoof, 
Ross, Smals, & Benraad, 1991). Cortisol is measured with an intra- and interprecision of 4,4% and 
6,3% respectively. Testosterone is measured with an intra- and interprecision of 6,9% and 5,4% 
respectively. All assay concentrations were within the range of the standard linear concentration curve 
Table 2. Distribution of participants across the batches and basal saliva hormone levels after correction for age.
B1 
N
B2 
N
B3 
N
B4 
N
Level of oxytocin Level of cortisol Level of testosterone
TDIA 8 15 5 0 1=2=3 1=2=3 B3>B1&B2
ASD 14 24 1 10 1=2=3=4 B2<B1 B1>B3
ODD/ CD 14 1 12 10 1=2=3=4 1=2=3=4 1=2=3=4
TDI: Typical Developing Individuals; ASD: Autism Spectrum Disorder; ODD/ CD: Oppositional Deﬁant Disorder / Conduct 
Disorder; B1: Batch 1 analyzed on 30-08-2013; B2: Batch 2 analyzed on 17-12-2013; B3:Batch 3 analyzed on 10-05-2014; 
B4: Batch 4 analyzed on 21-10-2014. A For the TDI group only: since batch 4 contains no samples, batches 1-3 are compared 
among the hormones.
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used for the calibration of each hormone. Oxytocin is measured with an intra- and interprecision of 
6,4% and 7,0% respectively. Since cortisol inhibits testosterone, the T/C ratio was taken into account 
in the analyses. The ratio between testosterone and cortisol was calculated by dividing testosterone 
concentrations (nmol/L) by cortisol concentrations (nmol/L) so that higher values reflected higher 
testosterone to cortisol ratios. All participants (n=114) sampled saliva between 9 a.m. and 10 a.m. 
(average sample duration M = 9.33, SD = .83 minutes), except for a subgroup of adolescents due to 
practical reasons. Here saliva was sampled between 6:45 and 8:45 a.m. (n = 11), or between 10:00 
and 12:30 a.m. (n = 11). From this subgroup the cortisol (M = 6.59, SD = 4.35), testosterone (M = .29, 
SD = .16) and oxytocin levels (M = 1.77, SD = 1.08) differed less than two standard deviations from 
the mean sample levels (cortisol: M = 4.18, SD = 2.19, testosterone: M = .19, SD = .13, oxytocin: M 
= 1.71, SD = .68). Their saliva samples were included in this study and sensitivity analyses were run 
with and without this subgroup. Few saliva samples (n = 6) could not be assessed due to technical 
problems. Hormones were assessed over four batches within one year (see Table 2). 
Statistical Analyses
The hormonal measures were subjected to a Van der Waerden transformation to normalize the 
skewed measures (SPSS version 24) and measures were transformed into the same scale (z-scores). 
ANOVAS were conducted to examine whether hormonal values differed between the three groups, 
using group (TDI, ASD, and ODD/CD) as between-subject factor, and hormones (for oxytocin, 
cortisol, and testosterone) as the dependent variables. To examine whether hormonal values were 
related to aggression subtypes and CU traits across disorder, correlations were calculated between 
hormonal values (i.e. oxytocin, cortisol, and testosterone) and aggression subtypes assessed by the 
RPQ, and self- or parent-rated CU traits for the whole sample. Partial correlations were calculated 
corrected for IQ. For the TDI group some variables are a constant (i.e. medication use and ADHD 
comorbidity), therefore it was examined whether general medication use (yes/no discontinuation 
during test day) and ADHD comorbidity (yes/no) were related to hormonal levels in the clinical 
groups only. Furthermore, analyses were run without saliva sampled outside the 9-10 a.m. timeframe 
as between subject factors. As we conducted three ANOVAS (for the three hormones), a false 
discovery rate (FDR) multiple testing correction was used. 
Results
Descriptives
See Table 1 for sample characteristics. All participants were male and the majority of the ODD/CD 
group was diagnosed having ODD (81.1%; see Table 1 for sample characteristics). Comorbid ADHD 
was found in ASD (44.2%) and ODD/CD group (66.7%). The ASD group had the highest percentage 
of medication use (63.5%), compared to the ODD/CD group (47.6%) and the TDI group (0%). 
Within both ASD and ODD/CD groups the most prescribed medication was stimulants (32.7% and 
27% respectively) followed by antipsychotics (14.3% and 5.4% respectively). The three groups did not 
differ in age but did significantly differ in estimated full scale IQ (F (2, 110) = 14.38, p < .001), whereby 
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ODD/CD participants had lower IQ scores compared with both the ASD and the TDI groups. The 
three groups differed significantly on the RPQ total score (F (2, 102) = 19.52, p < .001), the ODD/
CD participants had the highest scores, compared with both the ASD and the TDI groups (see also 
Table 1). 
 The three groups differed significantly on self-rated ICU-total score (F (2,110) = 9.99, p < 
.001), the ODD/CD had higher scores than both the ASD and the TDI groups. Similar results were 
found on parent-rated ICU-total score (F (2,109) = 47.82, p < .001), whereby the ODD/CD group had 
the highest score, the TDI group the lowest, and the ASD group scored between those two groups. 
The self- and parent-rated CU traits correlated r = .47 (p < .001). In the ASD group and the ODD/
CD group, self-rated CU traits were lower than parent-rated traits (t (34) = -3.63, p < .001, r = .53 and 
t (48) = -2.4, p < .02, r = .33, respectively), whereas in the TDI group self-rated CU traits were higher 
than parent-rated traits (t (27) = 5.18, p < .001, r = .71). Participants were unevenly distributed among 
the four batches. Batch 1: both ASD and ODD/CD were equally represented (n=14 per group) and 
TDI the lowest (n=8). Batch 2: contained more ASD (n=24) compared to TDI (n=15) and ODD/CD 
(n=1). Batch 3: contained more ODD/CD (n=12) compared to TDI (n=5) and ASD (n=1). Batch 4: no 
samples of TDI were included (inclusion number was reached within previous batches) compared 
to ASD (n=10) and ODD/CD (n=10). Across batches, hormonal concentrations within each group 
(i.e. TDI, ASD, and ODD/CD) were the same for oxytocin, different for both cortisol (ASD only) and 
testosterone (all groups). Within ASD, cortisol levels were the lowest in batch two compared to batch 
one and four (batch three was excluded since it contained one sample only). For testosterone levels: 
the TDI group testosterone levels were the highest in batch three compared to one and two; the ASD 
group testosterone levels were the highest in batch one compared to batch four; within the ODD/CD 
groups testosterone levels were the highest in batch three compared to batch four. 
Hormonal differences between groups
There was a significant correlation between cortisol and testosterone levels across groups 
Table 3. Partial correlations, FDR corrected, across groups between oxytocin, cortisol, testosterone, cortisol-testosterone 
ratio.
Hormone
Oxytocin Cortisol Testosterone T/C ratio
Oxytocin WC 1.00 .14 .07 .03  
Cortisol WC 1.00 .55*** -.28**
Testosterone WC 1.00  .57***
C/T-ratio WC 1.00
Oxytocin AC 1.00 .08 .06 .09
Cortisol AC 1.00 .53*** -.25*
Testosterone AC 1.00  .60***
C/T-ratio AC 1.00
WC: Without correction, based on N=111; AC: After correction for IQ, comorbid ADHD, and medication use; Signiﬁcant 
correlations presented in bold, *p < .05, **p < .01, ***p < .001
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(r=.55, p < .001). The univariate F-tests showed a significant main group effect for oxytocin (F (2,100) 
= 5.39, FDR adjusted p = .006). This effect was due to a significant difference between TDI (M = .49, 
SD = .97) and ASD (M = -.22, SD = .90) (p = .002); and TDI and ODD/CD groups (M = -.12, SD = .94) 
(p = .011). Thus, both the ASD and ODD/CD group had significantly lower levels of oxytocin than the 
TDI group, whereas the ASD and the ODD/CD groups did not significantly differ from each other. 
There was no main group effect for cortisol (F (2,108) = 2.69, p = .073) but the main group effect for 
testosterone was significant (F (2,108) = 5.42, FDR adjusted p = .006). This effect was attributable to 
a significant difference between the ASD (M = -.26, SD = .99) and the ODD/CD groups (M = .42, SD 
= .99) (p = .001). The ODD/CD group had significantly higher levels of testosterone than the ASD 
group. The TDI group did not significantly differ from the ASD group or the ODD/CD group.
Relationship between aggression subtypes and CU traits and hormone levels
Next, we examined the correlations among the two (i.e. reactive or proactive aggression) subtypes of 
aggression, which was strong (r = .63, p < .001). Therefore, correlations were examined between total 
RPQ score and oxytocin, cortisol and testosterone levels over the whole sample and within groups. 
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Error bars: +/- 1 standard error. TDI: Typical Developing Individuals; ASD: Autism Spectrum Disorder; ODD/ CD: Oppositional 
Deﬁant Disorder / Conduct Disorder. C/T ratio: Cortisol/ Testosterone ratio. Groups differed (FDR corrected) from each other 
by their hormonal levels, with the ASD group characterized by relative low levels of oxytocin and testosterone, the ODD/ CD 
group by a relative low level of oxytocin and high level of testosterone, and the TDI group by relative high levels of oxytocin. 
Group levels were the same on cortisol; p-value:  **p < .01, ***p < .001
Figure 1. Average hormonal levels (z-scores) for the three target groups
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Our results showed that all of these correlations were non-significant (p’s > .09) (see also Table 4). 
 We observed no significant correlations between self-rated CU traits and oxytocin, but found 
significant correlations between self-rated CU traits and cortisol (r = .38, p < .001) and CU traits 
and testosterone levels (r = .37, p < .001) across the three groups. The correlations for cortisol were 
significant within ODD/CD only (r = .42, p < .05) (see also Table 4). Parent-rated CU traits were 
unrelated to oxytocin, but were significantly correlated with cortisol (r = .32, p < .01) and testosterone 
levels (r = .27, p < .05) across the three groups. No significant correlations were reported within 
groups. The correlations between cortisol and either self- or parent-rated CU traits became non-
significant after controlling for testosterone (p’s < .09).   
Group effects: driven by aggression subtypes and/or CU traits?
The main group effect for oxytocin in the ANOVA became non-significant (p’s > .07) after adding 
two (i.e. reactive aggression or proactive aggression) subscales of the RPQ as covariates, although 
there were no main effects of RPQ (p’s > .09).  Adding two subscales of the RPQ did not change 
the results of the group comparison of cortisol levels (i.e. remained non-significant), and there were 
no main effects of RPQ (p’s > .60). The main effect for testosterone became non-significant (FDR 
adjusted p’s > .02) after adding two subscales of the RPQ to the analyses, although there were no 
main effects of the RPQ (p’s > .08). 
 The main group effect for oxytocin remained significant (p = .003) after adding self-rated 
CU traits and became non-significant (p > .09) after adding parent-rated CU traits to the analyses, 
Table 4. Partial correlations across groups between hormones and aggression (RPQ-total score), and CU traits; with and 
without correction for estimated total IQ, comorbid ADHD, and medication use. 
Aggression CU traits CU traits
Across 
groups
Per group Across groups Per group - SR Per group - PR
rTDI rASD rODD/CD SR                PR rTDI rASD rODD/
CD
rTDI rASD rODD/CD
Oxytocin WC .02 .13 .09 .07 .11 -.15 .29 -.03 .22 .05 .04 -.35
Cortisol WC .02 .02 -.26 .07 .38*** .32** .09 .29 .42* .09 .25 .15
Testosterone 
WC
.16 -.13 -.20 .26 .37*** .27* .12 .21 .30 .20 .18 .12
C/T-ratio WC .10 .03 .00 .20 .00 -.03 .28 -.16 -.16 .31 -.03 .03
Oxytocin AC .02 .12 .04 .06 .06 -.22 .06 .17 .06 .24 .00 -.31
Cortisol AC -.11 .00 -.32 .03 .28* .23* -.08 -.21 .29 -.16 .34* .28
Testosterone 
AC
.03 -.13 -.20 .19 .31** .14 -.32 -.14 .26 -.11 .06 .08
C/T-ratio AC .07 .05 .00 .18 .05 -.11 .06 -.01 -.06 .29 -.29 -.27
TDI: Typical Developing Individuals; ASD: Autism Spectrum Disorder; ODD/ CD: Oppositional Deﬁant Disorder / Conduct 
Disorder; WC: Without correction, based on N=111; AC: After correction for IQ, comorbid ADHD, and medication use; CU: 
Callous Unemotional traits based on the self- (SR) and parent-rated (PR) ICU (Inventory of Callousness Unemotional) traits; 
RPQ: Reactive and Proactive Questionnaire – total score; 
Signiﬁcant correlations presented in bold, *p < .05, **p < .01, ***p < .001
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there were no main effects of self-rated (p > .14) or parent-rated (p > .95) CU traits. When adding 
either self- or parent-rated CU traits to the analyses did not alter the group results for cortisol (i.e. 
remained non-significant), while there were still main effects of both self-rated (F (1,106) = 10.75, 
p = .001), and parent-rated CU traits (F (1,105) = 4.78, p = .031). This indicates that both higher 
self- and parent-rated CU traits are related to higher cortisol levels, independent of group effects. 
The main group effect for testosterone remained non-significant for either self- or parent-rated CU 
traits (FDR adjusted p’s > .02). In addition, there was only a significant main effect of self-rated CU 
traits (F (1,106) = 4.99, p = .016). This suggests that higher self-rated CU traits are related to higher 
testosterone level, independent of group effects.
Sensitivity analyses
We ran sensitivity analyses since the three groups significantly differed on estimated full IQ, ADHD 
comorbidity, and medication use. Correcting for IQ did not alter the results of the ANOVA’s on 
oxytocin (i.e. remained significant), cortisol (i.e. remained non-significant), and testosterone (i.e. 
remained significant). So no main effect of IQ with group was found on oxytocin, cortisol, or 
testosterone (p’s > .45). Correcting for either ADHD or medication use also did not alter the results 
of the main analyses on oxytocin, cortisol, and testosterone (i.e. hormonal levels between the ASD 
Table 5. Means, standard deviations and range (minimum-maximum Z-scores) of the distribution of oxytocin, cortisol, 
testosterone, and cortisol-testosterone ratio for TDI, ASD, and ODD/CD groups.
Total group 1. TDI 2. ASD 3. ODD/ CD Contrasts
M
(N)
SD
(Min - 
Max)
M (N) SD
(Min - 
Max)
M
(N)
SD
(Min - 
Max)
M
(N)
SD
(Min - 
Max)
pWC pRPQ pCU
zOxytocin 0.00
(103)
0.97
(-2.34 – 
2.34)
0.49
(27)
0.97
(-1.83 – 
2.34)
-0.22
(43)
0.89
(-2.07 
– 2.07)
-0.12
(33)
0.93
(-2.34 
– 1.67)
1 > 2**
1 > 3**
2 = 3
1 = 2 = 3 1 > 2**
1 > 3*
2 = 3
zCortisol 0.00
(111)
0.96
(-1.87 – 
2.37)
-0.02
(27)
0.75
(-1.35 – 
2.10)
-0.19
(48)
1.02
(-1.87 
– 2.37)
0.29
(36)
0.97
(-1.86 
– 1.80)
1 = 2 = 3 1 = 2 = 3 1 = 2 = 3
Main 
effects of 
both SR** 
and PR*
zTestosterone 0.00
(111)
0.97
(-2.37 – 
2.37)
-0.04
(28)
0.74
(-1.86 
– 1.11)
-0.26
(49)
0.99
(-2.37 
– 1.80)
0.42
(34)
0.99
(-1.07 
– 2.37)
1 = 2
1 = 3
2 < 3***
1=2=3 1 = 2 = 3 
Main 
effect 
of SR*
zTestosterone-
cortisol ratio
0.00
(111)
0.97
(-2.37 – 
2.37)
-0.06
(28)
0.88
(-1.93 
– 1.47)
-0.08
(49)
1.04
(-2.37 
– 2.10)
0.16
(34)
0.93
(-1.29 
– 2.34)
1 = 2 = 3 1 = 2 = 3 1 = 2 = 3
Hormones are expressed in z-scores; 1.TDI: Typical Developing Individuals; 2.ASD: Autism Spectrum Disorder; 3.ODD/ CD: 
Oppositional Deﬁant Disorder / Conduct Disorder; min = minimum observed score; max = maximum observed score; pWC: 
p-value without correction; pRPQ: p-value corrected after adding either two subscales of the Reactive and Proactive 
Questionnaire (RPQ) to the analyses (results were similar including a correction for three subscales); pCU: p-value corrected 
after adding self- (SR) CU traits to the analyses (results were similar for parent-rated (PR) CU traits); p-value: *p < .05, **p < 
.01, ***p < .001.
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and ODD/CD groups remained non-significant). There were no main effects or interaction effects 
of comorbid ADHD with group (p’s > .11) or medication use with group (p’s > .14). Correction of 
the main analyses by excluding saliva samples sampled outside the timeframe of 9-10 a.m. resulted 
in the significant main group effect on oxytocin remaining; an altered main effect on cortisol (i.e. 
became significant, (F (2,82) = 3,16, FDR adjusted p = .048) only between ASD (M = -.41, SD = .54) 
and ODD/CD (M = .09, SD = .73); and an altered effect on testosterone (i.e. became non-significant). 
No significant group effects were reported on the testosterone-cortisol ratio. Results remained after 
including two subscales of the RPQ, self- or parent-rated CU traits to the analyses. Correcting for 
IQ, comorbid ADHD, or medication use did not alter the results, thus group effect remained non-
significant. Results were not altered excluding the participants with CD from the ODD/CD group.
Discussion
The current study examined whether basal saliva levels of oxytocin, cortisol, and testosterone differ 
between male adolescents with ASD or ODD/CD and TDI, and are related to either severity or type 
of aggression and/or CU traits within and across disorder. Our main findings are that 1) ASD and 
ODD/CD were associated with significantly lower levels of oxytocin than TDI, 2) ODD/CD had 
significantly higher levels of testosterone than the ASD whereas ASD did not differ from TDI in 
testosterone levels, and 3) higher levels of CU traits were related to higher levels of cortisol and 
testosterone, There were no group effects on cortisol levels. Group differences remained for oxytocin 
after correcting for the influence of CU traits, but were not significant after controlling for aggression. 
Results for testosterone became non-significant after correction for either CU traits or aggression. 
Across groups, however, proactive and reactive aggression were unrelated to all three hormonal 
levels. 
Oxytocin in ASD and ODD/CD and relation with aggression and CU traits
Our study was the first to compare two diagnostic groups (i.e. individuals with ASD and ODD/CD 
individuals) and a TDI group on basal saliva oxytocin levels. Our results are in line with the oxytocin 
deficit hypothesis of ASD (Fieldman et al., 2014; Parker et al., 2014) and, as a novel finding, show 
that oxytocin levels were also lower in individuals with ODD/CD compared to TDI. The latter result 
suggests that lower oxytocin levels may be a cross-disorder biomarker for deficient social processing 
including reduced social interaction, empathy, trust, and elevated social anxiety. In our sample, the 
ASD and in part the ODD/CD group had a SCQ score of above 12, which is an indication of deficits 
in social-communication skills. This in turn may increase the risk of misunderstandings, aggression, 
and potential conflict related to oxytocin. However, sensitivity analyses did not reveal significant 
correlations of the SCQ with each of the hormones. The predominant focus of the current literature 
on lower oxytocin levels in ASD is based on plasma levels, whereas our study assessed salivary 
oxytocin levels. A possible confounding effect worth considering, is whether the lower oxytocin 
levels in adolescents with ODD/CD are due to a long standing separation from their parent(s), as a 
consequence of being in a residential treatment setting (Levy et al., 2017). This would however not 
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explain lower oxytocin levels in adolescents with ASD, since they were not in residential treatment. 
While some studies have reported a significant relationship between higher oxytocin and reduction 
of risk seeking behaviour in TDI (Fujii et al., 2016) or between lower oxytocin and higher CU traits 
in ASD (Levy et al., 2015), our findings did not confirm an association between oxytocin levels and 
aggressive behaviour or CU traits in the dimensional analysis, which is in line with a recent meta-
analysis (Rutigliano et al., 2016).
  In the current study, we have used both self- and parent-reports of the ICU. Overall, the levels 
of CU traits reported in the current study were moderate to low. This might explain why we were 
unable to observe a significant relationship between oxytocin and CU traits regardless of disorder, 
while a recent study showed a strong association between low basal saliva oxytocin levels and high 
levels of CU traits (i.e. ICU score > 40) in male adolescents with conduct problems (Levy et al., 2015). 
Elevated oxytocin levels by means of intranasal administration may remedy social difficulties and 
improve social cognition for a brief period (Domes et al., 2013; Guastella et al., 2010). This warrants 
also further research into potential therapeutic use of oxytocin for ODD/CD by increasing social 
insight and decreasing aggressive behaviours towards others. Overall, our results contribute to the 
growing complexity in our understanding of the effects of oxytocin on social behaviour including 
individuals with psychiatric diagnoses. 
Cortisol in ASD and ODD/CD and relation with aggression and CU traits
The three groups (i.e. TDI, ASD, and ODD/CD) did not differ in basal saliva cortisol levels. These 
results are in contrast with reports on lower baseline cortisol levels in adolescents with ASD (e.g. 
Alink et al., 2008; Taylor & Corbett, 2014), but are in line with other findings in ASD (e.g. Corbett 
et al., 2016). Firstly, the absence of group differences in cortisol levels is not surprising as the 
current study assessed basal cortisol levels without the administration of a challenge that would 
allow the assessment of cortisol reactivity. Secondly, the hypothalamic-pituitary-adrenal (HPA) 
axis, with cortisol as its end product, is a dynamic system that not only responds to psychological 
and physical stress, but also exhibits a marked diurnal rhythm (Kirschbaum & Hellhammer, 1994). 
Therefore assessing cortisol at one time point may be prone to interpretation problems, especially 
when there was no strict control for time of sample collection (Northover et al., 2016). However, 
sensitivity analyses revealed that the results were not influenced by basal saliva samples that were 
sampled outside the study protocol window of 9-10am. Cortisol levels were further uncorrelated with 
dimensional aggression scores. 
Of note, we report, counterintuitively, a positive association between cortisol levels and CU traits. 
This is in contrast to studies reporting a negative association between basal cortisol levels and CU 
traits in for example ODD/CD participants (e.g. von Polier et al., 2013) or finding no significant 
association (e.g. Northover et al., 2016). However, the positive association in our study was driven 
by the link between cortisol and testosterone, and the positive association between CU traits and 
testosterone (i.e. correlations between cortisol and either self- or parent-rated CU traits became non-
significant after controlling for testosterone). 
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Testosterone in ASD and ODD/CD and relation with aggression and CU traits
Results on testosterone showed that individuals with ODD/CD had significantly higher levels of 
testosterone than those with ASD. In both children and adults with clinical diagnoses - such as ASD 
and ODD/CD - problems have been related to increased prenatal and postnatal testosterone levels 
(Barzman et al., 2013; Golubchik, Mozes, Maayan, & Weizman, 2009; Montoya, Terburg, Bos, & van 
Honk, 2012; Wen & Wen, 2014). The testosterone levels in the TDI group did not differentiate from 
either the ASD or ODD/CD groups. Equally, the ODD/CD group differences with the ASD group 
became non-significant, when two subscales of the RPQ were included in the analyses. Likewise, 
they also became non-significant when including self-rated CU traits. Taken together, this suggests 
that group differences in testosterone levels between the ASD group and the ODD/CD group were 
attributable to different levels of aggression and self-rated CU traits. The non-significant differences 
in testosterone levels between the clinical groups after correction for aggression or CU traits is in line 
with research showing correlations between testosterone levels and measurements of aggression 
(Archer et al., 2005). The testosterone-aggression relationship is weak, however this may be explained 
by the possible mediating factor of cortisol (Mehta and Josephs, 2010). Although our results are not 
in line with the current literature, research showed that high testosterone levels in combination with 
low cortisol a) predicted physical aggression in prison inmates (Dabbs et al., 1991), and b) supported 
a significant relationship with aggressive behaviours (Honk et al., 2003). Another explanation is that 
aggressive behaviour is often more psychological instead of physical, and the underlying motives of 
aggressive behaviour are heterogeneous (i.e. premeditated versus reactive aggression) (Eisenegger 
et al., 2011). As such, testosterone may facilitate dominance instead of aggression (Eisenegger et al., 
2010), and that testosterone would only increase aggression if that could increase one’s social status. 
From this point of view, it follows that high testosterone could promote more prosocial behaviour, 
if that that would improve social status. Another point may be the timing of the initial testosterone 
rise in puberty (onset) and the rate of testosterone change (tempo) may influence behaviour at this 
life stage (Duke et al., 2014). Though the adolescent groups were matched on age, assessments of 
puberty stage might have further illuminated the hormonal analyses. 
Adolescents are usually less reliable in their report of their externalizing behaviour (Smith, Pelham, 
Gnagy, Molina, & Evans, 2000). This is supported by our findings, in which our clinical groups 
rated themselves as having lower CU traits compared to higher parent-rated CU traits. Interestingly, 
within the TDI group this pattern was reversed. One explanation could be that ASD and ODD/
CD may have a different attitude towards their behaviour compared to their parents; such that 
the degree of conscientious in giving the correct information is different. For example, ASD and 
ODD/CD may see their behaviour as less severe compared to their parents. Regardless of source of 
informant in the current study, overall the levels of CU traits were moderate to low. Across groups, 
the lack of relationships between dimensional score of aggressive behaviour and each of the three 
hormonal levels may be masked by the presence of unmeasured co-occuring internalizing problems. 
The interaction between these exogenous factors (e.g. internalizing problems, trauma, and parental 
characteristics) may modify baseline hormone levels. For example, children with both CD and 
anxiety disorder are reported to have higher levels of salivary cortisol than children with CD without 
comorbid anxiety disorder (McBurnett et al., 1991). The vulnerability within an individual to express 
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more severe levels of aggressive behaviour could be based on different etiologies as suggested by 
Blair (2013), like perinatal factors, environmental factors in which context aggression is expressed 
(i.e. life-events, violence or neglect) or genetic vulnerability. Future studies should take into account 
both the externalizing as well as the internalizing problems of participants with ODD/CD.
Because many undesirable behaviours improve over time, despite continuing elevated hormone 
levels, it is possible that the speed of hormone change may be more important than the absolute 
hormone levels (Duke et al., 2014). Translated to our study, this may suggest that the degree of 
hormonal change of oxytocin, cortisol, and testosterone levels may be different across groups 
despite the development of persistent aggressive behaviour. Future studies should include a 
longitudinal design, to investigate the development of hormonal change and development of severity 
of aggression over time within the same individuals following stressful challenges. Promising new 
non-invasive methods to assess hormones may include hair cortisol, which allows for an estimate 
of long-term secretion over the course of several months (Stalder and Kirschbaum, 2012), and 
potentially fingernail cortisol, measuring periods of several weeks (Izawa et al., 2015).
To conclude, hormonal differences between both the clinical groups and the TDI group could also be 
seen in the light of its relation to contextual factors (e.g. being away from home in an institute), which 
may cause increased psychosocial stress, and perhaps not to the externalizing symptoms per se 
(Quinlan et al., 2017; Romero-Martinez & Moya-Albiol, 2016). Therefore, physiological measurements 
such as hormones, may be a reflection of a person’s state rather than a person’s trait (Weissenberger 
et al., 2017). In this light, physiological measurements cannot be seen as a biomarker, but rather 
seen as an internal instrument (i.e. a thermometer) of a person. Future research is warranted to 
investigate whether hormonal differences remain stable over time and could be defined as traits to 
describe individual’s characteristics.
Limitations
Our results need to be considered in the context of the study’s limitations. We included male 
adolescents in our study, thus we cannot extrapolate our findings to females with either ASD or 
ODD/CD. Hormone sampling did not occur at the same time of day across all participants due to 
practical reasons. However, the results stayed similar when excluding samples collected at another 
time. Testosterone was stored at -20°C, which has been shown to be less optimal to storing it at -80°C 
(Granger, Shirtcliff, Booth, Kivlighan, & Schwartz, 2004). However, all samples across all groups 
were processed in the same way so the assumption is made that any degradation of the hormones 
at -20°C may have changed absolute but not relative levels between the groups. One caveat is that 
our sample of TDI was smaller than the ASD and ODD/CD groups. This is because originally the 
current study was in part designed to sample ASD and ODD/CD groups to stratify by high and 
low CU traits which would result in equally participant numbers across CU straits. Both clinical 
groups contained a substantial number of participants using medication. However, antipsychotics 
and stimulant medications were stopped two days before and stimulants on the test day. Further, 
sensitivity analyses revealed results were not altered by the use of medication. As expected, our 
ASD and ODD/CD samples had also in part comorbid ADHD (Connor, Steeber, & McBurnett, 2010; 
Waschbusch, 2002). However, sensitivity analyses revealed that our results were not influenced by 
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the presence of comorbid ADHD. Future research is recommended to include ADHD severity instead 
of diagnosis only to explore the effect of ADHD severity on the three hormones.
Conclusion 
The current findings show that 1) the diagnostic groups differed by their pattern of hormonal findings, 
with individuals with ASD characterized by relative low levels of oxytocin, and those with ODD/CD by 
a relative low level of oxytocin and high level of testosterone; and 2) these group effects were partly 
driven by differences in severity of aggression and/ or CU traits between the groups. Further research 
should explore whether these baseline hormonal factors can be used as stratification markers to 
predict response to treatment or course of these disorders. 
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Table 6. Correlations between RPQ subscales across groups.
Aggression Dimension
RPQ Total RPQ proactive RPQ1 RPQ2 RPQ3
Based on two subscales RPQ reactive .88 .63  .63 .48  .63
RPQ proactive .92 1  .63 .87  .93
Based on three subscales RPQ 1 .88  1 .48 .63
RPQ 2 .77 1 .62
RPQ 3 .88 1
RPQ1: Reactive and Proactive Questionnaire - proactive subscale; RPQ2: reactive intern subscale; RPQ3: reactive extern 
subscale; RPQ total: Reactive and Proactive Questionnaire – total score; Signiﬁcant correlations presented in bold p≤ .001
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Abstract
Oppositional defiant disorder, conduct disorder (ODD/CD), and autism spectrum disorder (ASD) 
share poor empathic functioning and have been associated with impaired emotional processing. 
However, no previous studies directly compared similarities and differences in these processes for 
the two disorders. A two-choice emotional valence detection task requiring differentiation between 
positive, negative and neutral IAPS pictures was administered to 52 adolescents (12-19 years old) 
with ODD/CD, 52 with ASD and 24 typically developing individuals (TDI). Callous-unemotional 
(CU) traits were assessed by self- and parent-report using the Inventory of Callous-Unemotional 
traits. Main findings were that adolescents with ODD/CD or ASD both performed poorer than TDI 
in terms of accuracy, yet only the TDI –not both clinical groups– had relatively most difficulty in 
discriminating between positive versus neutral pictures compared to neutral-negative or positive-
negative contrasts. Poorer performance was related to a higher level of CU traits. The results of the 
current study suggest youth with ODD/CD or ASD have a diminished ability to detect emotional 
valence which is not limited to facial expressions and is related to a higher level of CU traits. More 
specifically, youth with ODD/CD or ASD seem to have a reduced processing of positive stimuli and/
or lack a ‘positive perception bias’ present in TDI, that could either contribute to the symptoms and/
or be a result of having the disorder and may contribute to the comorbidity of both disorders.
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The detection of emotional valence -the intrinsic attractiveness/’goodness’ (positive valence) or 
averseness/’badness’ (negative valence) of a person, object, or situation provides crucial information 
for decision making [4]. Emotions with the same valence (e.g., anger and fear or pride and surprise) 
produce a similar influence on judgments and choices. The detection of negative valence activates 
the behavioural inhibition system (BIS), leading to a withdrawal from the person, object or situation 
[26]. Similarly, the detection of positive valence activates the behavioural activation system (BAS), 
leading to an approach toward the person, object, or situation [22]. In daily life, emotional valence 
detection is frequently active during the recognition of facial expressions [60], providing crucial 
information on whether the other person is willing to positively interact with you or not. However, 
it is similarly crucial to correctly identify the emotional valence of non-facial stimuli and situations, 
since a reduced ability to detect the negative emotional valence of situations will inappropriately 
activate a tendency to approach the object or situation, causing potentially dangerous situations 
such as getting into fights or other self-harming situations [7]. Similarly, a reduced ability to detect 
the positive emotional valence of objects or situations will falsely activate a tendency to withdraw 
from the object or situation, leading for instance to social shyness and self-isolation [10]. As such, the 
correct processing of emotional content is essential to fully understand functional and dysfunctional 
behaviour.
 Emotional valence is processed in similar (i.e., limbic and prefrontal) brain areas across 
disorders [28]. In nearly all psychiatric disorders, an increased likelihood has been found for an 
altered and/or reduced detection of emotional valence [33]. Of specific interest in this domain are 
disruptive behaviour disorders –oppositional defiant disorder and conduct disorder (ODD/CD)– and 
autism spectrum disorder (ASD), since both disorders can be hypothesized to be characterized by a 
disbalance in the BIS/BAS [21, 45] as well as a pronounced reduction in empathy. This is in contrast 
with other disorders also characterized by a disbalance in the BIS/BAS system such as anxiety [31] or 
mood disorders [2]. Individuals with ODD/CD tend to approach people, objects, and/or situations 
that have a (clear) negative valence to people without ODD/CD more than controls (i.e., typically 
developing individuals and individuals with ADHD) [45]. A decreased emotional arousal has been 
found in individuals with CD when looking at emotionally evocative pictures, potentially explaining 
this phenomenon [55, 63]. In contrast, individuals with ASD tend to avoid people, (social) situations 
and sometimes objects that have a (clear) positive valence to individuals without ASD more than 
typically developing controls [44]. 
 Notwithstanding the differences between both diagnostic categories, differentiation between 
both is sometimes difficult in everyday clinical practice. About a quarter of children with ASD show 
comorbid ODD/CD [35], and the incidence of ASD symptoms in ODD/CD is also clearly raised [1, 
25]. Furthermore, both disorders frequently show comorbidity with ADHD (Hartman, Geurts, Franke, 
Buitelaar, & Rommelse, 2016; Van Steensel, Bogels, & de Bruin, 2013). This overlap shows that 
psychopathology does not exist in dichotomous entities (i.e., presence of absence of a disorder), 
and that liability for having one disorder may increase liability for having another (Blanco et al., 
2015; Caspi et al., 2014). Therefore, it may be important to focus on a research classification system 
for mental disorders based upon dimensions of functional systems, neurobiology and observable 
behaviour, such as the Research Domain Criteria (RDoC) project. RDoC supports research to 
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explicate fundamental biobehavioural dimensions (such as emotional valence detection) that cut 
across current heterogeneous disorder categories (Cuthbert & Insel, 2013). Studying emotional 
valence detection may give more insight into the (non-)overlapping cognitive features of categorical 
disorders.
It may be further hypothesized that an altered/reduced ability to detect emotional valence in ODD/
CD and ASD may be related to a reduced ability to understand, feel and show empathy found in both 
disorders [39]. Empathy is the capacity to recognize, understand and share the emotional states of 
others [18]. Empathy may be dissected into three domains, that is, emotional empathy, cognitive 
empathy and motor empathy [8]. Emotional empathy refers to experiencing emotions consistent 
with and in response to those of others. [9]. Cognitive empathy refers to reduced abilities to identify 
and describe how others may perceive situations [5], and to automatically track others’ mental states 
[29]. Motor empathy refers to automatically and unconsciously mirroring the facial expressions of 
another person, known as facial mimicry [9]. In CD, deficits in emotional empathy have been related 
to callous-unemotional (CU) traits [23]. CU traits (‘limited prosocial emotions’) have been adopted 
as a specifier to CD in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-
5), and are defined as a set of personality traits comprising lack of empathy, lack of remorse or guilt, 
shallow affect and being unconcerned about performance. Indeed, conduct problems and high CU 
traits have been found to be related to deficits in emotional empathy, whereas ASD was found to 
be related to cognitive empathy deficits [34, 53]. However, recent studies have shown that CU traits 
might be best seen as cross-disorder construct with increased prevalence not only in CD, but in ODD 
and ASD as well [30, 42]. As such, an altered emotional valence detection may underlie the increased 
prevalence of CU traits across disorders and may help understand the comorbidity rates between 
both disorders. 
 Therefore, the current study set out to examine the overlapping and specific features of 
altered emotional valence detection in individuals with ODD, CD or ASD and whether this is related 
to the severity of CU traits in both clinical groups. A two-choice emotional valence detection task was 
administered in adolescents with ODD/CD, or ASD, and in typically developing individuals (TDI). In 
each trial, two pictures with emotional valences were contrasted (neutral-positive, neutral-negative, 
negative-positive). As the literature on this topic is sparse, we did not formulate a hypothesis how 
the different diagnostic groups would perform, and whether a moderating role of CU traits could be 
detected.
Method
Participants
Initially, 166 male subjects were approached to participate, of whom 38 dropped out because of: 
refusal to participate (n = 28), not meeting inclusion criteria (n = 8), or not able to obtain consent 
of legally appointed guardian (n = 2). This resulted in a total sample of 128 male participants (n = 52 
patients with ODD or CD (ODD/CD), n = 52 patients with ASD, and n = 24 TDI group). Participants 
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with ODD or CD were grouped together, since both disorders are closely linked neurodevelopmental 
disorders of which ODD is either prodromal to CD (Biederman et al., 1996; Burke, Hipwell, & Loeber, 
2010) or a subsyndromal form of CD (Biederman et al., 1996). All participants aged between 12 
and 19 years (M = 15.3 years, SD = 1.9), 81% were of Caucasian origin. They were recruited between 
April 2011 and September 2014 as part of a larger study on empathy (CU2-study). Participants were 
recruited through clinical institutes in the Netherlands, specialized in severe disruptive behaviour 
problems (De Hoenderloo Group, Ottho Gerhard Heldring Foundation, and Woodbrookers) or severe 
psychiatric problems (Karakter, Child and Adolescent Psychiatry) and through information leaflets 
that were sent to families via the Dutch federation of Autism (NVA). Adolescents were excluded if 
they fulfilled one or more of the exclusion criteria (a) a combined diagnosis of ODD/CD and ASD, 
(b) an estimated total IQ < 80, and/or (c) suffering from a condition which may affect neurological 
or cognitive functioning, such as schizophrenia, bipolar disorder, alcohol and/or drugs dependency, 
presence of tics, language disorders (e.g., dyslexia) and epilepsy. The TDI group was recruited from a 
general community sample via city councils in the same geographical regions as the clinical groups. 
In- and exclusion criteria for the TDI group were similar to the ODD/CD and the ASD groups, except 
for having a clinical psychiatric diagnosis.
 Diagnoses in the ODD/CD and the ASD groups were established according to DSM-IV-TR 
[3] criteria by a multidisciplinary team based on information gathered by a child psychiatrist, a child 
psychologist, and a review of clinical and prior records (if available), including information available 
from school or other professional institutions involved with the child. Thus, a consensus diagnosis was 
assigned, which is seen as more reliable compared to structured interviews for assessing diagnostic 
categories [41]. In the TDI group, the absence of a clinical psychiatric diagnosis was assessed based 
on parent report. For all three groups, legal guardians were asked to fill out a digital version [58] of 
the National Institute of Mental Health Diagnostic Interview Schedule for Children (DISC-IV; [54]) 
Legal guardians were asked to fill out the following sections: Attention-Deficit/Hyperactivity Disorder, 
ODD, CD, Tic Disorder, Alcohol, Marihuana, Other Drugs, in order to control for possible psychiatric 
comorbidities. Because DSM-IV-TR diagnoses were automatically generated, an experienced child 
and adolescent psychiatrist (PH) and psychologist (MB) evaluated diagnostic findings of the 
computerized DISC. The use of non-psychotropic (5.5%) and antidepressant medication (2.3%) 
was allowed. If possible, psychotropic medication (i.e., stimulants, 21.8%, antipsychotics, 9.3%, 
atomoxetine, 2.3%) was stopped prior to testing. Stimulants were discontinued for at least 24 hours. 
Antipsychotics were discontinued for at least 72 hours. However, when discontinuation was thought 
to have severe deteriorating effects, medication was continued (ODD/CD: n = 12, ASD: n = 10).
Participants were required to have a minimum average estimated total full-scale intelligence quotient 
(FSIQ) of ≥ 80. FSIQ was estimated using four subtests of the Dutch version Wechsler Intelligence 
Scale for Children (WISC-III): Similarities, Vocabulary, Block Design and Picture Completion [65]. 
These selected WISC-III subtests are known to correlate between .90-.95 with the Full-scale IQ [27]. 
For children older than 16 years, the Wechsler Adult Intelligence Scale (WAIS-III) was administered 
[66]. When intelligence was assessed within a year prior to the inclusion, and either the WISC or 
WAIS was applied, we used the scores of that assessment. 
 This study was approved by the Dutch Central Committee on Research involving Human 
Subjects, protocol number NL26773.000.09 (Centrale Commissie Mensgebonden Onderzoek; 
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CCMO). Both parents and the adolescents (if 12 years and older) signed the informed consent.
Measures
A two-choice emotional valence detection task was used with a high load on set shifting abilities. This 
task has previously shown to be associated with differential reaction times in adults, being grouped 
as forensic psychiatric patients, psychopaths, and normal controls [12], indicating differentiating 
properties across different diagnostic groups of this task. The task required participants to pay 
attention to stimuli with a predefined affective load presented in the centre of the screen, and to 
respond as rapidly as possible by pressing the space bar for target stimuli (hits), while withholding 
the response to non-target stimuli. Stimuli consisted of pictures from the International Affective 
Picture System (IAPS) database which were validated for their valence [40], and grouped into three 
categories (positive and negative valence, and neutral; for examples see Figure 1). In each block, 
two valences were contrasted (neutral-positive, neutral-negative, negative-positive), to investigate 
whether changes in false positive reactions and in reaction time are related to specific (combinations 
of) emotions. Only two emotional valences were presented per block. Each valence-combination was 
presented twice in two different blocks varying the valence of target stimuli (50%) versus non-target 
stimuli (50%) to investigate whether changes in false positive reactions and in reaction time are 
related to stimulus order (i.e., the order in which specific combinations of emotions are presented. 
Thus, valence contrast was manipulated (with three emotional valences) and stimulus order (e.g., 
neutral stimuli as target stimuli and positive as non-target stimuli in block 1 and the reverse in 
block 2). This resulted in 6 experimental blocks (neutral-positive, positive-neutral; neutral-negative, 
negative-neutral; negative-positive, positive-negative), each with 32 trials. Each single block lasted 
approximately 45 seconds in duration, with a fixed 500 ms stimulus presentation and response 
window, followed by a 900 ms inter-stimulus interval. A short practice session of 10 trials with 
the same presentation rate preceded each block to learn the distinction between the two affective 
categories being used in each block. The practice block was automatically repeated once if the 
participant did not reach the 80% accuracy cut-off the first time. Thereafter, the experimental block 
Figure 1. Examples from the emotional valence detection task
On the left a positive stimulus, in the middle a neutral stimulus, on the right a negative stimulus
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was started. Outcome variables were the percentage of hits, the mean reaction time per block and 
the signal to noise ratio d’ (percentage hits – percentage false positives). 
 The test battery was shown on a Dell Latitude D530 laptop with a Windows Vista operating 
system. The task was presented using the MINDS-software program (version 1.2.7) [11], which is a 
digital test manager used to present a test battery. Participants were positioned in front of a laptop 
about 60 cm from a 15-inch screen with a resolution of 1024x768 pixels and a refresh rate of 60 Hz. 
Images were presented in the centre of the display with neutral grey background. Images were 15.5 x 
20.5 cm in size, covering a visual angle of 15 degrees vertically and 20 degrees horizontally. Finishing 
the total task took about 15 minutes. 
CU traits were assessed by self- and parent-report on the Inventory of Callous-Unemotional traits 
(ICU), Dutch translation [51]. The ICU contains 24 items, which are rated on a 4-point Likert scale 
ranging from 0 = does not apply at all to 3 = applies very well. Internal consistency of the Dutch ICU 
was shown to be good [19, 51]. In the current study Cronbach’s alpha was high (.80 for ICU-SR, .90 
for ICU-PR). Concurrent validity between the ICU and psychopathy scales is acceptable (r = .45-.68 
between ICU and Antisocial Process Screening Device [38], and Childhood Psychopathy Scale [51]. 
ASD symptoms were assessed by administering the Social Communication Questionnaire (SCQ) 
[52]. This is a 40-item parent-report questionnaire that asks about characteristic autistic symptoms. 
Each item is rated as either Yes or No. Nineteen items rate current behaviour and 20 items rate 
behaviour when the child was 4-5 years old. Cut-off score is ≥ 15. Sensitivity was found to range 
between .85-.88, Specificity was found to range between .72 and .78 in English-language versions [6, 
13, 14]. In this study, Cronbach’s alpha for the total SCQ was .75. For analyses, the current behaviour 
items were used.
Procedures
A short telephone screening and, subsequently, screening questionnaires were used to verify if 
families could participate. Those families were invited to visit one of the participating clinics. Testing 
of the participants took place in a quiet room at their clinical institute. The task described here was 
part of a broader neuropsychological assessment battery used in the ‘psychopathology and the lack 
of empathy’ (CU2) project. Youths completed the battery in approximately two hours and the order 
of the task administration was counterbalanced. Participants were motivated with small breaks and 
received a financial compensation (vouchers of € 20.00) after test administration.
Data analyses
In order to examine the group differences regarding emotional valence detection and set-shifting 
capacities, repeated measure ANOVAs were conducted with group as between subjects factor (3 
levels: TDI, ODD/CD, ASD), valence-contrast as within subjects factor (three levels: neutral-positive, 
neutral-negative, positive-negative) and response-set as within subjects factor (two levels: original 
set vs. reversed set). Analyses were separately run for percentage hits, reaction time of hits, and 
d’ (signal to noise ratio, calculated as percentage hits – percentage false positives). Analyses were 
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Table 1. Characteristics of the study population (N = 128)
Total group
 
 TDI   ODD/CD ASD
 M ±SD   M ±SD   M ±SD   M ±SD Contrasts
Age (years) 15.3 1.9  15.9 1.8  15.5 1.7  14.9 2.0 ns
FSIQ*** 99.4 11.1 106.1 8.1 92.7 8.9 102.7 11.1 ODD/CD < ASD = TDI
VIQ*** 100.1 14.0 108.3 9.7 90.5 12.5 103.8 12.7 ODD/CD < ASD = TDI
PIQ 99.6 14.1 103.7 14.1 95.1 12.6 101.3 14.5 ns
ICU-SR total score** 26.9 9.0 23.2 6.3 30.7 10.0 24.8 7.5 ODD/CD > ASD = TDI
ICU-PR total score*** 29.4 11.9 16.0 7.0 38.9 9.4 28.0 8.4 ODD/CD > ASD > TDI
SCQ total score*** 11.7 7.1 3.1 2.4 11.9 6.1 15.5 5.7 ASD > ODD/CD > TDI
N % n % n % n %
 128 100.0 24 18.8 52 40.6 52 40.6 Contrasts
Institute
Child and Adolescent 
Psychiatry
51 39.8 0 0 9 17.0 42 80.8
Youth Welfare 45 35.2 0 0 44 83.0 2 3.8
Municipalities 24 18.8 24 100 0 0 0 0
Dutch Association 
for Autism
8 6.3 0 0 0 0 8 15.4
Comorbidity** ODD/CD > ASD > TDI
ADHD 53 41.4 0 0 31 59.6 22 42.3
None 64 50.0 24 100 12 23.1 29 55.8
Missing 11 8.6 0 0 9 17.3 1 1.9
Medication1* ASD > ODD/CD > TDI
Yes 51 39.7 0 0 18 34.6 33 63.5
No 70 54.7 23 95.8 27 51.9 19 36.5
Missing 7 5.5 1 4.2 7 13.5 0 0
Ethnicity parents (n = 258)*** ODD/CD < ASD = TDI
Caucasian 207 80.9 46 95.8 60 57.7 101 97.1
African 19 7.4 0 0 19 18.3 0 0
Unknown 25 9.4 2 4.2 21 20.2 1 1.0
Missing 6 2.3 0 0 4 3.8 2 1.9
Highest level of education parents2* ODD/CD < ASD < TDI
Lower 8 6.3 0 0 5 9.6 3 5.8
Middle 36 28.1 3 12.5 14 26.9 19 36.5
Higher 60 46.9 21 87.5 10 19.2 29 55.8
Missing 24 18.8  0 0  23 44.2  1 1.9
1 If possible, psychotropic medication was stopped prior to testing. For 12 youths with ODD/CD and 10 youths with ASD 
discontinuation of medication was not possible. p-value after Bonferroni correction: * p < .05, ** p < .01, *** p < .001
2 Highest level of education parents: lower = primary education / preparatory lower-level vocational education; middle = 
preparatory middle-level vocational education; higher = higher-level vocational education / preparatory university education. 
TDI = typically developing individual; ODD/CD = oppositional deﬁant disorder / conduct disorder; ASD = autism spectrum 
disorder; ICU-SR = Inventory of Callous Unemotional traits – self-report; ICU-PR = Inventory of Callous Unemotional traits 
– parent-report; SCQ = Social Communication Questionnaire. M = mean; SD = standard deviation; ns = not statistically 
signiﬁcant (p > .05)
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run with and without IQ as covariate, and medication and comorbidity (i.e., ADHD present or not 
present) as between subjects factor. Covariates were entered separately to examine the unique 
effects on the results. Discrepancies in results were reported. Across and within groups, Pearson’s 
correlations between CU and ASD symptoms (SCQ current items) and task performance were 
examined. Correlational analyses between CU traits and task performance were run within groups. 
All analyses were carried out in SPSS version 24. Power-analysis indicated a sample size of N = 
102 was needed to achieve 95% power to detect main and interaction-effects of d ≥ .25 using the 
proposed repeated measure ANOVA with three groups. Missing data was 0% for the emotional 
valence detection task performance (N = 128) and ICU self-report questionnaire (N = 128), and 7.8% 
for the parent rated SCQ and ICU (N = 118). Missing data were not replaced.
Results
See Table 1 for sample characteristics. The majority (84.6%) of the ODD/CD group was diagnosed 
with having ODD, 15.4% with CD. Comorbid ADHD was found in 59.6% of the ODD/CD group and 
in 42.3% of the ASD group. In the clinical groups, 34.4% used psychotropic medication. Stimulants 
were the mostly prescribed medication type (21.8%), followed by antipsychotics (9.3%) and non-
psychotropic medication (5.5%), with stimulants being significantly more prescribed in the ASD 
group, compared to the ODD/CD group (p < .05). For 12 youths with ODD/CD and 10 youths with 
ASD discontinuation of medication was not possible. 
 The three groups did not differ in age but did significantly differ in IQ (F (2, 120) = 19.65, p 
< .001), whereby TDI (M = 106.1, SD = 8.1) and ASD (M = 102.7, SD = 11.1) had a higher mean IQ 
compared to ODD/CD (M = 92.7, SD = 8.9). The ODD/CD group showed significantly higher self-
reported CU-scores than both the TDI and the ASD groups, whereas the TDI and the ASD groups did 
not differ from each other (F (2, 125) = 9.04, p < .01). The ODD/CD group scored significantly higher 
on parent reported CU-traits than the ASD group, and the ASD group scored significantly higher 
than the TDI group (F (2, 115) = 57.06, p < .001). For SCQ scores, the ASD group scored significantly 
higher than the ODD/CD group, and the ODD/CD group scored significantly higher than the TDI 
group (F (2, 110) = 44.46, p < .001).
Task manipulation effects
Main effects of response-set were found for percentage hits, reaction time hits and d’, in which 
performance on the second (i.e., reversed set) was made with slightly slower RTs, percentage hits 
and lower d’, suggesting the reversed response-set taxed set shifting abilities. However, since there 
were no two-way (diagnosis by response-set) or three-way (diagnosis by response-set by valence-
contrast) effects on any of the outcome variables, for simplification further analyses were carried out 
with data collapsed for blocks contrasting the same valences. Main effects of valence-contrast were 
found on all parameters, in which discriminating between positive and neutral pictures appeared 
more difficult compared to negative versus positive or negative versus neural pictures, as reflected by 
fewer hits, longer RTs for hits and a lower d’. No differences were found for the ability to discriminate 
between negative versus positive and negative versus neutral. Please see Table 2 for results of the 
repeated measure ANOVAs. 
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Table 2. Descriptives of average scores per valence-contrast, response-set, and diagnosis; results of the repeated 
measures ANOVAs
TDI ODD/CD ASD Repeated measures ANOVA2 F; p; ƞ2
Percentage hits M (SD) M (SD) M (SD) Diagnosis 4.04; .02; .06
POS-NEU1 91.7 (9.0) 85.5 (14.5) 82.1 (23.2) Valence-contrast 14.5; <. 001; .19
NEU-POS 91.9 (9.1) 84.3 (16.2) 88.3 (12.4) Response-set 9.62; .002; .07
POS-NEG 95.6 (7.5) 91.6 (12.6) 89.0 (14.8) Diagnosis * valence-contrast ns 
NEG-POS 96.9 (4.5) 96.2 (5.8) 93.7 (17.3) Diagnosis * response-set ns
NEU-NEG 95.1 (9.4) 87.0 (16.0) 90.0 (11.6) Valence-contrast * response-set ns
NEG-NEU 96.4 (6.4) 91.5 (15.0) 93.4 (13.8) Diagnosis * valence-
contrast * response-set 
ns
Percentage false positives Diagnosis ns
POS-NEU 30.7 (26.6) 34.4 (26.8) 34.0 (26.2) Valence-contrast 43.7; <.001; .26
NEU-POS 24.0 (17.8) 31.2 (20.8) 34.5 (21.7) Response-set ns 
POS-NEG 14.6 (9.2) 19.4 (15.4) 21.8 (17.1) Diagnosis * valence-contrast ns
NEG-POS 22.4 (19.5) 17.4 (17.2) 21.2 (16.4) Diagnosis * response-set ns
NEU-NEG 19.0 (17.5) 23.8 (19.3) 22.5 (17.9) Valence-contrast * response-set ns
NEG-NEU 14.6 (15.4) 20.4 (18.9) 23.6 (19.7) Diagnosis * valence-
contrast * response-set 
ns
Reaction time hits Diagnosis ns
POS-NEU 521.5 (130.7) 488.6 (76.8) 512.0 (105.3) Valence-contrast 16.6; <.001; .12
NEU-POS 519.8 (82.7) 504.8 (100.5) 527.4 (95.5) Response-set 6.46; .01; .05
POS-NEG 469.3 (42.2) 488.6 (90.7) 505.1 (74.1) Diagnosis * valence-contrast 3.67; .006; .06
NEG-POS 465.0 (47.7) 470.0 (57.4) 497.8 (63.8) Diagnosis * response-set ns
NEU-NEG 481.8 (59.6) 514.4 (89.6) 522.3 (90.6) Valence-contrast * response-set 8.20; < .001; .06
NEG-NEU 448.3 (53.3) 470.6 (79.0) 492.4 (57.0) Diagnosis * valence-
contrast * response-set 
ns
Reaction time false positives Diagnosis ns
POS-NEU 468.4 (219.5) 428.2 (177.1) 473.8 (129.6) Valence-contrast 15.1; < .001; .20
NEU-POS 496.0 (115.4) 484.9 (132.1) 476.8 (128.4) Response-set ns
POS-NEG 390.8 (139.5) 370.3 (212.1) 443.4 (135.4) Diagnosis * valence-contrast ns
NEG-POS 338.3 (187.9) 375.0 (215.9) 438.5 (150.4) Diagnosis * response-set ns
NEU-NEG 353.4 (205.5) 461.2 (205.0) 420.4 (189.8) Valence-contrast * response-set ns
NEG-NEU 361.5 (151.9) 375.0 (202.6) 434.9 (134.6) Diagnosis * valence-
contrast * response-set 
ns
d’ (percentage hits – percentage false positives) Diagnosis ns
POS-NEU 61.0 (31.3) 51.1 (30.3) 48.1 (37.9) Valence-contrast 42.8; < .001; .41
NEU-POS 68.0 (21.6) 53.0 (28.4) 53.8 (25.3) Response-set 6.33; .01; .05
POS-NEG 81.0 (12.2) 72.2 (21.0) 67.2 (23.1) Diagnosis * valence-contrast ns
NEG-POS 74.5 (21.8) 78.7 (20.1) 72.6 (27.1) Diagnosis * response-set ns
NEU-NEG 76.1 (25.0) 63.2 (30.1) 67.6 (24.1) Valence-contrast * response-set ns
NEG-NEU 81.8 (17.7) 71.0 (28.6) 69.8 (28.0) Diagnosis * valence-
contrast * response-set 
ns
Note. This two-choice emotional valence detection task required participants to pay attention to stimuli with a predeﬁned 
affective load presented in the centre of the screen, and to respond as rapidly as possible by pressing the space bar for target 
stimuli, while withholding the response to non-target stimuli. The task consists of six blocks presented in random order, each 
with 32 trials. Stimuli consisted of pictures from the IAPS database, and grouped into three categories: positive, neutral and 
negative valence. 1 Because of randomization, type of valence-contrast did not relate to block order. 2 Repeated measure 
ANOVAs were conducted with group as between subjects factor (3 levels: TDI, ODD/CD, ASD), valence-contrast as within 
subjects factor (three levels: neutral-positive; neutral-negative; positive-negative) and response-set as within subjects factor 
(two levels: original set vs reversed set). TDI = typically developing individual; ODD/CD = oppositional deﬁant disorder / conduct 
disorder; ASD = autism spectrum disorder; M = mean; SD = standard deviation; ns = not statistically signiﬁcant (p > .05).
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Table 3. Descriptives of average scores per block number and diagnosis; results of the  repeated measures ANOVAs
TDI ODD/CD ASD Repeated measures ANOVA2 F; p; ƞ2
Percentage hits M (SD) M (SD) M (SD)
Block 11 96.6 (6.6) 89.3 (12.9) 91.0 (11.5) Diagnosis 4.04; .02; .06
Block 2 94.8 (7.8) 90.6 (14.4) 86.4 (19.6) Block number ns
Block 3 96.6 (5.2) 90.6 (12.0) 86.7 (19.9) Diagnosis * Block number ns
Block 4 93.5 (11.0) 88.2 (15.5) 92.1 (9.7)
Block 5 93.2 (7.8) 89.1 (15.5) 89.7 (16.1)
Block 6 92.7 (8.2) 88.1 (16.1) 90.8 (18.3)
Percentage false positives
Block 1 18.2 (14.7) 23.7 (22.3) 27.0 (21.4) Diagnosis ns
Block 2 14.8 (12.2) 20.8 (18.9) 25.6 (22.6) Block number ns
Block 3 22.9 (21.9) 24.5 (20.6) 26.8 (23.2) Diagnosis * Block number ns
Block 4 24.2 (22.9) 25.2 (19.5) 25.7 (18.9)
Block 5 23.2 (22.0) 28.4 (25.9) 26.7 (22.7)
Block 6 21.9 (17.7) 24.0 (17.0) 25.6 (15.7)
Reaction time hits
Block 1 468.6 (57.2) 480.0 (70.6) 517.4 (86.1) Diagnosis ns
Block 2 471.5 (58.5) 500.0 (100.0) 509.3 (77.5) Block number ns
Block 3 512.9 (152.3) 496.2 (90.3) 520.1 (82.2) Diagnosis * Block number ns
Block 4 487.0 (50.2) 488.2 (95.7) 504.5 (78.0)
Block 5 485.5 (55.4) 477.0 (66.4) 517.9 (75.4)
Block 6 480.3 (48.5) 495.5 (79.0) 487.8 (97.82)
Reaction time false positives
Block 1 451.3 (72.7) 446.7 (143.5) 474.7 (81.8) Diagnosis ns
Block 2 412.1 (68.6) 451.5 (142.8) 467.6 (94.1) Block number ns
Block 3 486.2 (148.2) 441.3 (116.5) 484.2 (132.2) Diagnosis * Block number ns
Block 4 440.1 (79.5) 460.4 (191.6) 471.1 (109.9)
Block 5 474.7 (187.4) 439.6 (107.2) 480.8 (105.5)
Block 6 455.9 (100.2) 478.3 (155.8) 482.0 (111.1)
d’ (percentage hits – percentage false positives)
Block 1 78.4 (17.8) 65.6 (25.2) 63.9 (24.9) Diagnosis 2.89; .06; .04
Block 2 80.0 (14.6) 69.8 (29.5) 60.8 (37.8) Block number Linear: 3.56; .06; .03
Block 3 73.7 (24.0) 66.1 (25.0) 59.5 (35.7) Diagnosis * Block number Linear: 2.76; .07; .04
Block 4 69.3 (31.5) 63.0 (27.5) 66.4 (21.3)
Block 5 70.1 (26.1) 60.7 (35.2) 63.0 (29.4)
Block 6 70.8 (21.3) 64.1 (27.5) 65.2 (22.9)
1 Because of randomization, block number did not relate to valence-contrast. 2 Repeated measure ANOVAs were conducted 
with group as between subjects factor (3 levels: TDI, ODD/CD, ASD) and block number as within subjects factor (6 levels: 1-6). 
TDI = typically developing individual; ODD/CD = oppositional deﬁant disorder / conduct disorder; ASD = autism spectrum 
disorder; M = mean; SD = standard deviation; ns = not statistically signiﬁcant (p > .05)
 5
154
Diagnostic effects
A main effect of diagnosis was found for percentage of hits (Table 2), with adolescents with ODD/
CD or ASD performing poorer than TDI (both p’s =.01), with no difference between adolescents 
with ODD/CD or ASD (p = .95) (Figure 2). Also, a trend main effect of diagnosis on d’ was present, 
with overall a poorer signal-to-noise ratio in adolescents with ODD/CD or ASD compared to TDI (p 
=.02 and .05, respectively), with no difference between adolescents with ODD/CD or ASD (p = .63). 
However, a trend-significant diagnosis * block order effect was found, with post-hoc tests showing 
that performance decreased linearly in the TDI group (F (1, 23) = 6.57, p = .017), but remained 
more stable in both clinical groups (ODD/CD: F (1, 51) = 2.95, p = .09; ASD: F (1, 51) = 0.51, p = 
.48). Furthermore, a diagnosis by valence-contrast was found for hit RT. Post-hoc tests showed that 
valence-contrast had no significant effect on RT in the ASD group (F (2,50) = 2.00, p = .15), whereas 
it did in the TDI group (F (2,22) = 5.25, p = .01) and the ODD/CD group (F (2,50) = 4.58, p = .02). 
The TDI group was slower in discriminating between positive versus neutral pictures than in the 
other two conditions (both p ‘s < .01) that did not differ from each other. In contrast, the ODD/CD 
group was faster in discriminating between positive versus negative pictures than in the other two 
conditions (p ‘s < .03) that did not differ from each other (Figure 3). Covarying for ASD symptoms 
did change the p-values but not the overall pattern of findings.
TDI ODD/CD ASD
100
95
90
85
80
75
POS-NEU POS-NEG NEU-NEG
Figure 2. Percentage hits (mean and standard error) by diagnosis
Moderating role of CU traits
Parent rated CU traits and ASD symptoms (SCQ current items) correlated significantly (r = .31, p < 
.001). Self-rated CU traits did not correlate with parent rated ASD symptoms (r = .04, p = .69). Self 
and parent-rated CU traits correlated significantly (r = .50, p < .001). Significant small correlations 
were found between ASD symptoms and slower reaction times in 3 out of 6 blocks (NEG-POS: r 
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= .21, p = .025; NEU-NEG: r = .22, p = .016; NEG-NEU: r = .25, p = .006), but not for measures of 
accuracy. Parent rated CU traits correlated with reduced accuracy on 2 out of 6 blocks (fewer hits: 
NEU-POS: r = -.21, p = .024; NEU-NEG: r = -.25, p = .006) and lower d’ scores (NEU-POS: r = -.25, p 
= .008; NEU-NEG: r = -.18, p = .048). Parent rated CU traits did not correlate with measures of speed. 
Figure 3. Reaction time (mean and standard error) in milliseconds to discriminate 
two pictures with distinct valence by diagnosis
TDI ODD/CD ASD
550
530
510
490
470
450
430
POS-NEU POS-NEG NEU-NEG
Similarly, self-rated CU traits did not correlate with measures of speed, but did correlate with poorer 
performance in terms of accuracy on 1 out of 6 blocks (NEU-POS: fewer hits r = -.30, p = .001; lower 
d’ r = -.30, p < .001). To examine the moderating role of CU traits, CU traits (parent and self-rated 
separately) were added to the main model as main effect as well as in a two-way interaction with 
diagnosis. No (trend) significant two-way interaction effect were found between diagnosis and CU 
traits on task performance, suggesting no support for a moderating role of CU traits in explaining 
the group differences in task performance. Running correlational analyses within groups, within the 
control group and ASD, no significant correlations were found between task performance measures 
and ASD or CU symptoms. Within the ODD/CD group, significant correlations were found between 
ASD symptoms and percentage false positives for discriminating between positive and neutral 
and between positive and negative pictures, with higher ASD symptom levels relating to a lower 
percentage of hits (r=-.33, -.31, respectively).
Sensitivity analyses
Adding IQ, age or comorbid ADHD did not alter the results. Taking into account medication use, the 
main effect of diagnosis and the diagnosis * block interaction on d’ in the analyses on performance 
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across time independent of valence-contrast became non-significant. Post-hoc analyses indicated no 
significant differences between the group with ODD (n = 44) and the group with CD (n = 8). On all 
parameters, estimated marginal means were quite similar for both groups, although slightly better 
in the CD group (Percentage hits: ODD M = 89.1, CD M = 91.0; reaction time hits: ODD M = 491.6, 
CD M = 478.0).
Discussion
This study aimed to investigate the overlapping and specific features of altered emotional valence 
detection in individuals with either ODD/CD or ASD and whether this is related to the severity of 
CU traits in both clinical groups. A two-choice emotional valence detection task was administered 
in 128 adolescents using validated pictures from the IAPS database [40]. Main findings were that 
adolescents with ODD/CD or ASD both performed poorer than TDI in terms of accuracy, yet only 
the TDI group –not both clinical groups– had relatively most difficulty in discriminating between 
positive versus neutral pictures compared to neutral-negative or positive-negative contrasts. Poorer 
performance was related to a higher level of CU traits. The results of the current study suggest youth 
with ODD/CD or ASD have a diminished ability to detect emotional valence which is not limited to 
facial expressions and is related to a higher level of CU traits. More specifically, youth with ODD/
CD or ASD seem to have a reduced processing of positive stimuli and/or lack a ‘positive perception 
bias’ present in TDI, that could either contribute to the symptoms and/or be a result of having the 
disorder, and may contribute to the comorbidity of both disorders. The continuous switching of 
response-set affected the performance of TDI more so than that of both clinical groups, albeit TDI 
had more room for deterioration in performance compared to both clinical groups.
 To the best of our knowledge, this is the first study to investigate and directly compare 
emotional valence detection capacities in youths with ODD/CD and those with ASD. Overlapping 
results for both groups were found for accuracy: both groups had more difficulty in detecting the 
emotional valence of the stimuli presented compared to the TDI group. This is in line with previous 
studies showing that emotion recognition deficits are found in both disorders [9, 44, 55]. Furthermore, 
in neither group, the valence contrast (i.e., discriminating between positive, negative and neutral 
valences) strongly affected performance, which was in striking contrast with the TDI. The TDI group 
showed clear difficulty in discriminating between positive and neutral valences in comparison to 
discriminating between negative and neutral or positive valences. It seems that the TDI group spent 
more time processing the stimuli given that positive vs. neutral was the most difficult differentiation 
based on the accuracy data. This may reflect a reduced processing of positive stimuli in those with 
ODD/CD or ASD compared to TDI. However, it may also tentatively be argued that TDI have a 
‘positive perception bias’ in which they have more difficulty in differentiating between neutral and 
positive valences, compared to both clinical groups. This seems in line with previous studies [57, 
59, 61] and our data suggest that this positive perception bias is absent in both clinical groups. 
The absence of a positive perception bias in both clinical groups may also suggest a more negative 
perception bias in both clinical groups, but it would then be expected that both clinical groups had 
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relatively more difficulty in discriminating between neutral and negative pictures, which was not the 
case. The current results therefore support the idea that the absence of a positive perception bias 
may either increase the risk of developing the social interaction problems as present in ASD and 
ODD/CD and/or may be the result of having social interaction problems.
 In this study, we expected differential impairment in emotional valence detection between the 
clinical groups, However, differences between the ODD/CD group and the ASD group were small 
and nonsignificant. There are several possible explanations for this negative finding. It may be that 
both groups had difficulty in distinguishing emotional valence because we used pictures without 
differentiating emotions specifically. Research regarding emotional face recognition has shown that 
emotion recognition in ODD/CD seems to be impaired for negative emotions only (Bons et al., 
2013). For youths with ODD/CD this impairment may be related to fearful, and to a lesser extent, sad 
emotion only (Herpers, Scheepers, Bons, Buitelaar, & Rommelse, 2014), while emotion recognition 
in ASD seems to be impaired across all emotions (Bons et al., 2013). Another explanation may be 
that we used static pictures and not dynamic. Similar research in ODD/CD has focused on the use 
of dynamic pictures (Bons et al., 2013). However, as youths with CP show other responses other 
responses to real-life situations than to hypothetical situations (Herpers, Scheepers, Bons, Buitelaar, 
& Rommelse, 2014), one could infer that recognizing the emotional valence of static pictures may 
be more difficult to youths with ODD/CD than dynamic pictures. Youths with ASD seem to be less 
sensitive to static pictures than to dynamic pictures, whereas whether there is such a correlation for 
youths with CD is unknown (Bons et al., 2013). A further explanation could be that the duration of 
stimulus presentation was too short, as ASD youths seem to need more time for a correct reaction 
(Oberman, Winkielman, & Ramachandran, 2009; Schwenck et al., 2012). Yet, stimulus duration of 
500 ms (i.e., >160 ms), as presented in our study, should suffice for correct identification of emotional 
valence (Oberman et al., 2009). A last possible explanation to mention here is that research shows 
that youth with conduct problems may experience emotional valence differently from other youth. 
Negative emotion, especially aggression, may be related to approach, whereas anxiety may be related 
to withdrawal (see also Van Honk and Schutter (2006), and (Blair, 1995). Furthermore, negative 
emotion may be amusing, especially to youth with conduct problems and high CU traits (De Wied et 
al., 2012). However, these possible explanations need further investigation.
 Diminished ability to detect emotional valence was related to a higher level of CU traits, 
although we found no support for a moderating role of CU traits in explaining the group differences 
in task performance. In youth with conduct problems, high CU traits have been found to be related 
to a subjective pleasant judgement to negative images, compared to neutral and positive pictures 
[43], but see [47, 56] possibly explaining more difficulty discriminating between negative, neutral and 
positive pictures in the current study. Furthermore, in comparison to youth with conduct problems 
and low CU traits and normal controls, youth with conduct problems and high CU traits were found 
to show decreased distraction from distressing pictures [32, 36, 37], pinpointing to a decreased 
activation of the BIS in youth with high CU traits. The latter appears particularly so for children with 
high CU traits that have no major environmental factor (i.e., maltreatment) explaining the presence 
of CU traits, showing a smaller acoustic startle response when viewing negative IAPS pictures [17]. 
Our data and that of previous studies may suggest a diminished ability to detect emotional valence 
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is related to an increased level of CU traits. As such, our findings are in line with a recent study in 
which an emotional Go/No-go task was applied, reporting that the difficulties that children with 
combined CU traits and oppositional conduct problems have in processing emotions are more of an 
emotional rather than an attentional nature [20].
 Self-reported CU traits were found to be related to poorer detection of positive pictures, while 
parent-reported CU traits were related to poorer detection of positive and negative pictures. As already 
mentioned, it may be that ODD/CD youth with high CU traits may experience negative pictures in a 
positive way (De Wied et al., 2012), and therefore find difficulty in discriminating valence. However, 
poor detection of positive pictures is more difficult to explain. It may be that ODD/CD youth with 
high CU traits may experience negative pictures in a positive way (De Wied et al., 2012), and thus 
find difficulty in discriminating valence. One could argue that either neutral or positive pictures are 
misinterpreted also, as youth with conduct problems and high CU traits have problems to correctly 
identify emotion when expressed facially, vocally and through bodily postures (see also (Herpers 
et al., 2014). As such, our finding could implicate that youth with conduct problems and high CU 
traits have difficulty in identifying emotional valence in a more general way. However, to clarify the 
underpinnings of this difficulty further research would be needed.
 Deviant performance on this emotional valence detection task could have been caused by 
executive functioning (EF) difficulties, since task performance not only required emotional valence 
recognition, but also behavioural inhibition, learning new rules and unlearning old rules and 
switching of response set. Surprisingly, when data were analysed with performance indices measured 
across blocks when continuous demands were placed on switching-abilities between response-rules, 
working memory and inhibitory control, no major group differences emerged. If anything, the TDI 
group showed more difficulty with maintaining the high accuracy level over time than both clinical 
groups did (who had poorer performance already from the first block onwards). These findings 
suggest that previously reported weaknesses in executive functions [15, 24, 29, 48] and to a lesser 
extent in individuals with ODD/CD [46], did not explain the current results of diminished ability to 
detect emotional valence of objects, situations or people by youth with ODD/CD or ASD. 
 Despite its strengths, such as the direct comparison of an ODD/CD group and an ASD 
group, and its focus on an emotional valence detection task, our study also showed limitations. The 
emotional valence detection task tapped into multiple processes (behavioural inhibition, attentional 
bias, recognition of emotional valence, working memory and reversal learning), making it difficult 
to precisely pinpoint why subjects with ODD/CD or ASD had difficulty with the task. However, when 
analyses were repeated explicitly examining effects of continuous switching of response-set on 
performance, both clinical groups did not perform worse than the TDI group, making it unlikely that 
these broader EF processes strongly influenced the overall poorer performance of both clinical groups 
in terms of valence detection. Both clinical groups contained a substantial amount of participants 
using medication. However, antipsychotics were stopped two days before and stimulants on the 
test day, making it unlikely that medication strongly influenced results. However, correcting for 
medication use only influenced results for d’, but not for the other measures. Furthermore, when 
studying disorders such as ODD, CD, or ASD, it is important to take comorbidity into account, as 
both disorders are known to be highly comorbid with attention-deficit/hyperactivity disorder (ADHD) 
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[16, 64]. ADHD is known to be related to significant impairment on EF tasks [67] as well as emotional 
valence detection [50]. However, sensitivity analyses revealed results were not influenced by the 
presence of a comorbid diagnosis of ADHD. Another limitation that should be noted is that we do 
not know if the findings are unique to ODD/CD and ASD, or whether they reflect a deficit that cuts 
across those with psychopathology relative to TDI. An additional clinical group without core deficits 
in empathy could further add to the significance of our findings.
 In conclusion, the results of the current study suggest youth with ODD/CD or ASD have 
a diminished ability to detect emotional valence which is not limited to facial expressions and is 
related to a higher level of CU traits. More specifically, youth with ODD/CD or ASD showed marked 
difficulty in the distinction between neutral and positive pictures, compared to TDI. We hypothesized 
that this may be due to reduced processing of positive stimuli, or to a lack of ‘positive perception 
bias’ which seems to be present in TDI. Both tendencies could either contribute to the symptoms 
and/or be a result of having the disorder, but may contribute to the comorbidity of both disorders. 
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Abstract
Autism Spectrum Disorder (ASD), Oppositional Defiant Disorder (ODD), and Conduct Disorder 
(CD) are often associated with emotion recognition difficulties. This is the first eye-tracking study 
to examine emotional face recognition (i.e., gazing behavior) in a direct comparison of male 
adolescents with Autism Spectrum Disorder or Oppositional Defiant Disorder/Conduct Disorder, 
and typically developing (TD) individuals. We also investigate the role of psychopathic traits, callous–
unemotional (CU) traits, and subtypes of aggressive behavior in emotional face recognition. A total 
of 122 male adolescents (N=50 ASD, N=44 ODD/CD, and N=28 TD) aged 12–19 years (M=15.4 
years, SD=1.9) were included in the current study for the eye-tracking experiment. Participants were 
presented with neutral and emotional faces using a Tobii 1750 eye-tracking monitor to record gaze 
behavior. Our main dependent eye-tracking variables were: (1) fixation duration to the eyes of a 
face and (2) time to the first fixation to the eyes. Since distributions of eye-tracking variables were 
not completely Gaussian, non-parametric tests were chosen to investigate gaze behavior across 
the diagnostic groups with Autism Spectrum Disorder, Oppositional Defiant Disorder/Conduct 
Disorder, and Typically Developing individuals. Furthermore, we used Spearman correlations to 
investigate the links with psychopathy, callous, and unemotional traits and subtypes of aggression as 
assessed by questionnaires. The relative total fixation duration to the eyes was decreased in both the 
Autism Spectrum Disorder group and the Oppositional Defiant Disorder/Conduct Disorder group 
for several emotional expressions. In both the Autism Spectrum Disorder and the Oppositional 
Defiant Disorder/Conduct Disorder group, increased time to first fixation on the eyes of fearful faces 
only was nominally significant. The time to first fixation on the eyes was nominally correlated with 
psychopathic traits and proactive aggression. The current findings do not support strong claims for 
differential cross-disorder eye-gazing deficits and for a role of shared underlying psychopathic traits, 
callous–unemotional traits, and aggression sub-types. Our data provide valuable and novel insights 
into gaze timing distributions when looking at the eyes of a fearful face.
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When communicating with others, non-verbal communication modalities such as body movements, 
hand gestures, and facial expressions yield essential information, in addition to verbal communication. 
Decoding facial expressions is one of the most efficient ways for understanding others’ emotions and 
feelings. Individuals with psychiatric disorders as Autism Spectrum Disorder (ASD), Oppositional 
Defiant Disorder (ODD), and Conduct Disorder (CD) exhibit deficits in regulating emotions 
and problems inhibiting aggressive tendencies [45, 46]. This may in turn explain dysfunctions in 
interpreting emotions of facial expressions. ASD are early onset neurodevelopmental disorders defned 
by core impairments in social interaction and verbal and non-verbal communication, stereotyped 
and restricted patterns of interest  and activity, and abnormal sensory processing according to DSM-
5 criteria [1]. ODD is characterized by angry and  irritable mood, and argumentative, Defiant, and 
disobedient behavioral patterns. CD is characterized by a pattern  of aggressive, destructive, and/or 
deceitful behaviors that violate the rights of others according to the Diagnostic and Statistical Manual 
of Mental Disorders (DSM-5) criteria (APA, [1]. In this paper, we will combine ODD and CD into one 
diagnostic group, since both disorders are closely linked neurodevelopmental disorders of which 
ODD is either prodromal to CD or a subsyndromal form of CD [9]. The rationale for comparing these 
two distinct diagnostic cohorts (ASD versus ODD/CD) is that both involve social/communication 
problems and deficits in empathy (related to cognitive  and emotional empathy, respectively). 
 In the latest version of the DSM-5, callous–unemotional (CU) traits were added as a specifer 
for a more severe form of CD labeled as having ‘limited prosocial emotions’ [1]. This form of CD 
is particularly associated with reductions  in empathy when responding to fear, sadness, pain, and 
happiness of others [12]. ASD has also been associated with  dysfunctional empathic functioning 
[1, 44, 73] and with increased levels of CU traits [55]. However, commonly  deployed diagnostic 
questionnaires for ASD lack specificity to probe for CU traits, the relationship remains elusive. 
Nevertheless, empathy regulation is defned by two different constructs, namely (1) cognitive empathy 
(i.e., the ability to understand another’s feelings) and (2) emotional empathy (i.e., the experience of 
emotion, elicited by an emotional stimulus) [27]. 
 Individuals with ASD often appear to have cognitive  empathy deficits, but demonstrate 
average levels of emotional empathy [27, 49, 76]. In contrast, those with behavioral disorders (CD 
and ODD) show the opposite pattern  (e.g., [16, 13]). Looking at facial emotion recognition from a 
behavioral perspective, no significant differences were detected when comparing ASD adolescent 
individuals to CD and TD individuals [51].  
 Eye tracking in ASD reports inconsistent findings regarding gazing at emotional faces. For 
an extensive meta-analysis and a summary of the reported differences during development, see [21, 
41, 64]. The variation in reported results  may partly be due to the variability in the methods utilised 
to study eye gazing in emotion recognition paradigms. Studies differ on their use of table-mounted 
remote eye-tracking  devices or head-mounted ones. They also differ on their use  of static and 
dynamic facial stimuli and the core characteristics of the faces (e.g., gender, intensity of emotions, 
and the  appearance of the faces). In addition, many methodological issues cannot be properly 
controlled for which introduces  additional heterogeneity. Studies differ in sampling frequencies 
of eye-tracking devices, the selection strategy of areas  of interest, fixation classifcation filters, and 
the informed use of parametric or non-parametric statistical tests. Some of the earlier eye-tracking 
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studies in adults and adolescents with ASD reported that less attention was paid to the eyes and 
other core features of faces [68] or focused more on  the mouth and less on the eyes [53, 60]. Other 
studies confirmed that adults with ASD gazed less at the eye region  while exploring a face [25, 43]. 
In contrast, more recent studies have not observed significant differences between  individuals with 
ASD and typically developing youth in eyegazing behavior [78, 82, 83]. More broadly speaking, gazing 
at the eyes can facilitate more accurate and faster responding to several emotions like fear, surprise, 
and disgust [6] and thus enable better social interaction. Numerous experimental studies have found 
strong evidence for reduced accuracy in identifying negative emotions in individuals with ASD [4, 7, 
25, 48, 84], although there is no consensus in the field. 
 Overall, insufficient gazing to the eyes can lead to  impaired emotional recognition which 
may influence disruptive behaviors and increase social anxiety in individuals with ASD [25].  
 Antisocial behavior is also associated with poor recognition and processing of fearful faces 
[56]. Recent studies  confirm impaired recognition of multiple emotions (anger, fear, and happiness) 
in adolescents with CD relative to TD individuals [35, 36, 80]. Furthermore, children with greater 
behavioral problems (as indexed through the Psychopathy Screening device) also showed poorer 
recognition of angry, sad, and fearful facial expressions [10]. Those children and adolescents with 
both CD and high CU traits showed more pervasive impairments in emotional recognition than 
those with low CU traits [33, 36]. Recently, the first well-powered eye-tracking study on a large cohort 
of male and female adolescents with CD has been published. Martin-Key et al. [57] used an emotion 
recognition task with both static and dynamic morphed faces. They found that male adolescents 
fixated less on the eyes when viewing fearful and sad expressions. Although the differences were 
considered small, the  authors suggest that behaviorally detected emotion recognition deficits were 
not mediated by abnormal fixation patterns [57]. 
 ASD symptoms may moderate the relationship between CU traits and aspects of emotional 
empathy [70]. Pijper et al. [70] suggest that CU traits are inversely related to empathic  sadness at 
low levels of ASD symptoms, while others document it only for higher levels of ASD symptoms 
[65]. Psychopathic traits seem to predict lower numbers of fixations  and fixation durations to the 
eye region in fearful faces in TD male adolescents [29]. Individuals with ASD also have  elevated 
levels of aggressive behavior compared to TD individuals [47], although aggression is not a core 
symptom of  ASD and is typically less severe in ASD than ODD/CD [3]. For CD and ODD, both 
proactive and reactive aggression are considered hallmarks of the disorder [17], and the relation  of 
subtype of aggression and eye-tracking patterns of emotional face processing is unclear. From a 
broader perspective,  it seems that many concepts (i.e., psychopathic traits, CU traits, and subtypes 
of aggression) in different disorders (i.e., ASD, ODD, and CD) seem to be interlinked and associated 
with each other, while actual direct links remain elusive and a direct comparison is missing. 
 In summary, eye-tracking data in the literature related to emotional face processing 
are inconsistent in ASD and  studies have not been properly replicated in large wellphenotyped 
psychiatric cohorts for CD and ODD. These  relationships still remain elusive and the field suffers 
from inconsistency in approach to data collection and analyses and using fairly small sample sizes 
[41]. Our relatively large cohort (total N=122; ASD =52, ODD/CD =42, TD =28) consisting of male 
adolescents enables us to examine the common and unique eye-tracking patterns of emotional face 
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processing in individuals with either ASD, ODD, or CD, in comparison with TD, and explore the 
possible modulatory  role of CU traits, psychopathic traits and subtypes of aggression. We hypothesize 
that high CU traits, high psychopathic  traits, and heightened proactive and reactive aggression will 
be associated with less time spent to the eye region for negative emotions (e.g., sadness, fear, and 
anger) in both male adolescents with ASD or CD/ODD. Furthermore, we hypothesize that both male 
adolescents with ASD and ODD/ CD will show similar differences on the time to first fixation to the 
eye region of an emotional face. 
Methods
Recruitment of participants
Initially, 423 individuals were approached to participate in a larger study on empathy (CU2 study). 
Individuals with an ODD/CD diagnosis were approached via institutes specialized in severe juvenile 
psychiatric problems (Karakter, Child and Adolescent Psychiatry) or severe disruptive behavior 
problems (De Hoenderloo Group, Otto Gerhard Heldring Foundation, and Woodbrookers). 
Individuals with ASD were recruited via information leaflets that were sent to families by the Dutch 
federation of Autism (NVA). The typically developing individuals’ control groups were recruited via 
leaflets that were sent to a community sample. These individuals were selected on the basis of 
their geographical location. The recruitment period lasted from April 2011 to September 2014. Of 
those approached, 265 did not respond or were not interested to participate. Of the 158 that were 
interested in participation, 18 did not meet the inclusion criteria (see below for more information). 
Two participants did not obtain consent from a legally appointed guardian and 6 participants were 
not able to participate due to their personal situation. In total, 132 were included for the broader CU2 
study. Of the 132 participants, 6 participants did not undergo the extensive eye-tracking battery. Of 
the 126 participants, 4 participants had to be excluded based on exclusion criteria for eye-tracking 
data quality. Thus, all the presented data are from the 122 participants (50 with ASD, 44 with ODD 
or CD and 28 TD individuals). All participants were male adolescents [age range (12–19 years old, 
mean age=15.26 years, SD=1.9]. Main participant and demographic characteristics are summarized 
in Table 1. The difference between the number of participants initially approached and the final 
inclusion in this eye-tracking study is considerable large. In many cases, participants with ODD/CD 
were not interested in participating in an extensive clinical study. Many had behavioral problems and 
were often not in a position to participate. There were restrictions to leave closed institutions or their 
personal situation did not allow participation. Here, one can think of the occurrence of violent and/
or oppositional incidents, escape attempts, and (temporary) dysfunctional relationships with their 
caregivers 
Inclusion and exclusion criteria for participation
All participants who were recruited from clinical institutes obtained a clinical ASD or ODD/CD 
diagnosis prior to the study. Clinical diagnoses (ODD/CD and ASD) were established according to 
the DSM-IV-TR criteria [5] by a multidisciplinary team (experienced psychiatrist and psychologist). In 
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a large proportion of our ASD participants, the clinical diagnoses were confirmed by clinical scores 
on the ‘golden standard’ of the ADOS and ADI, although this was not a fixed criterion for inclusion 
in this study. They both gathered information and reviewed (prior) clinical records and information 
provided by schools and other agencies involved in the care of the adolescent. This workflow ensured 
that the proper clinical diagnosis was confirmed, before individuals were included in the current 
study. This is a robust and more reliable approach compared to only using structured interviews for 
the allocation of individuals to clinical groups [54]. For all the three groups, caretakers (i.e., biological 
parents or legal guardians) were asked to fill out a digital version of the National Institute of Mental 
Health Diagnostic Interview Schedule for Children (DISC-IV; [77]). Parents and/or caregivers had 
to complete the following sections of the DISC-IV: Attention-Deficit/Hyperactivity Disorder, ODD, 
CD, Tic Disorder, alcohol, marihuana, and other drug use. The social communication questionnaire 
(SCQ) was used as an instrument to assess ASD characteristics across the three groups (ASD, 
ODD/CD, and TD). For the typically developing group, the absence of a clinical psychiatric diagnosis 
was assessed based on the DISC-IV parent interview [77]. The outcomes of the DISC-IV and the SCQ 
were evaluated by an experienced child and adolescent psychiatrist (PH) and psychologist (MJB). We 
excluded participants who fulfilled one or more of the exclusion criteria (a) a combined diagnosis of 
ASD and CD/ ODD, (b) an estimated total IQ<80); and/or (c) suffering from a condition which may 
affect neurological or cognitive functioning, such as schizophrenia, bipolar disorder, alcohol and/
or drugs dependency, language disorder (e.g., dyslexia), epilepsy, and the presence of tics. The TD 
individuals were not allowed to have a clinically established psychiatric diagnosis to participate. The 
other inand exclusion criteria were the same as for the clinical groups. Participants with a diagnosis 
of ODD or CD from the CU2 project were grouped together in this study, because both disorders 
are on a spectrum of behavior problems and aggressive tendencies. In addition, the ODD/CD group 
included only a few CD participants to be handled as a stand-alone group.
Medication use
The use of non-psychotropic and anti-depressant medication was allowed for the inclusion in the 
study. If possible, psychotropic medication (i.e., antipsychotics, stimulants, and atomoxetine) 
was stopped prior to testing. Stimulants were discontinued for at least 24 h prior to participation 
and antipsychotics for at least 72 h. Only in cases, when a health care professional judged the 
discontinuation to have potential severe detrimental effects, the medication was not stopped. In 
total, 9 participants with ODD/CD and 8 participants with ASD were still on medication during the 
testing days.
Cognitive assessments
Participants were required to have a minimum average estimated total full-scale intelligence 
quotient (FSIQ) IQ of≥80. The FSIQ was estimated using four subtests of the Dutch version of the 
Wechsler Intelligence Scale for Children (WISC-III): Similarities, Block Design Picture Completion, 
and Vocabulary [85]. These WISC-III subtests are known to be highly correlated (r=0.90–0.95) with 
full-scale IQ [40]. For the participants that were 16 years or older, the Wechsler Adult Intelligence 
Scale III (WAIS-III) was administered [86].
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Procedures
A short telephone screening and, subsequently, screening questionnaires were used to verify if 
families could participate. Those families were invited to visit one of the participating clinics. Testing 
of the participants took place in a quiet room at the test location. Experimenters used stimulus 
deprived rooms to limit the influence of distraction. Participants were given short breaks and received 
a fnancial compensation (vouchers of € 20.00) for this test administration. Ethical approval 
Ethical approval
This study was approved by the Dutch Central Committee on Research involving Human Subjects, 
protocol number NL26773.000.09 (Centrale Commissie Mensgebonden Onderzoek; CCMO). Both 
adolescents (if 12 years of age and older) and their legally appointed guardian provided written 
informed consent.
Description of clinical measures
Social communication questionnaire (SCQ)
The social communication questionnaire is a 40-item parentreport questionnaire that investigates 
ASD characteristics on a binary scale (yes/no). The questionnaire contains 19 items on current 
behavior and 20 items on the period when the child was 4–5 years old [75]. A cut-offf score of>10 was 
used as a positive screening outcome on ASD characteristics. TD participants could only be included 
when they did not have a clinical score on the parent-rated SCQ (i.e., raw scores of<10). In calculating 
the total score, the first item was excluded, because it only probed for suficient language ability. The 
English version of the SCQ has a sensitivity ranging between 0.85 and 0.88 and a specificity between 
0.72 and 0.78 [8, 19, 20]. The Cronbach’s alpha for the total SCQ score was 0.75 in the final sample.
Inventory of Callous-Unemotional traits (ICU)
The Inventory of Callous–Unemotional traits (ICU) assesses CU traits in adolescents, divided into 
three subscales: uncaring, callousness, and unemotional [37]. We used the official Dutch translated 
version of this questionnaire. Internal consistency of the Dutch ICU was shown to be good [34, 74]. 
The ICU exists of 12 positively framed items and 12 negatively framed items. Items are rated on a 
4-point scale ranging from 0 (‘not at all true’) to 3 (‘definitely true‘). The uncaring scale consists of 
8 items, the callousness subscale of 11 items, and the unemotional subscale of 5 items. An example 
of an item on the uncaring scale is ‘I am concerned about the feelings of others’. An example 
item for the callousness scale is: ‘I seem very cold and uncaring to others’. Finally, an example of 
the unemotional scale: ‘I do not show my emotions to others’. Subscale scores are calculated by 
summing the individual item scores. The reverse and ‘opposite’ framing of sentences is taken into 
account in the scoring. Subsequently, the total score is calculated by summing up the subscale 
scores. A higher total score reflects a higher levels of CU traits. We administrated both the parent 
version (legal guardian) and the self-rated version of the ICU. For the final sample, the Cronbach’s 
alpha for the self-report was 0.78 and the Cronbach’s alpha for the parent report was 0.90.
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Youth Psychopathic Trait Inventory (YPI)
The youth psychopathic traits inventory (YPI) is a 50-item self-report questionnaire [2]. It has been 
designed to assess core psychopathic personality traits for adolescents of 12 years of age and older. 
It reflects 3 dimensions of psychopathy: the grandiose manipulative, callous–unemotional, and 
impulsive–irresponsible [24]. Higher YPI total scores reffect the presence of high psychopathic traits. 
Internal consistency has been reported as 0.94 Cronbach’s alpha for the total score of the YPI, 
0.82 for the grandiose–manipulative subscale, 0.64 for callous–unemotional subscale, and 0.76 for 
impulsive–irresponsible subscale.
Reactive and Proactive Aggression questionnaire (RPQ)
The Reactive and Proactive Aggression Questionnaire (RPQ) was developed by Raine et al. [71]. 
In the current study, the Dutch translation of the well-validated 23-item RPQ was used which is 
designed to probe for reactive and proactive aggression in children and adolescents from the age of 
8 years of age and older [22]. The reactive subscale has 11 items. Example questions include: ‘He/she 
gets mad or hit others when they tease him/her’ and ‘He/she damages things when he/she is mad’. 
The proactive subscale has 12 items. Example questions for this subscale are: ‘He/she damages or 
breaks things for fun’ and ‘He/she threatens and bullies other kids’. The questions of the RPQ do not 
reference to a certain time period in the past or current behavior. Participants just have to report how 
often they have engaged in particular behaviors. The total score of the RPQ is calculated by summing 
all items together. The Cronbach’s alpha for the RPQ was 0.91 in our final sample.
General study protocol
Participants and their legal guardians that gave informed consent were screened using the DISC-
IV interview device [77]. The information of the DISC-IV was combined with the clinical diagnosis 
information to allocate participants into the different groups. The participants and their legal 
guardians were asked to fill out questionnaires (paper and pencil) separately from each other. This 
could either be at home or at the test location. For the test location, experimenters used a stimulus 
deprived quiet room. The influence of external noise and distraction was limited. For completing the 
questionnaires at home, the participants and their legal guardians were asked to sit in a quiet room 
with as few external distractions as possible.
Task design
We used an emotional recognition task that consisted of 60 trials with static images of emotional 
and neutral faces. Each trial always had the same structure: ‘fixation cross (1 s)–facial stimulus 
(6 s)–question—gray screen (3 s)’. The rationale behind the presentation of the gray screen was 
twofold. First, we wanted to avoid the confound of pupil response to the differences in light intensity 
of the facial stimuli (presented on a black background) and the questions (presented on a white 
background). Second, the use of the gray screen countered potential ‘wash over effects’ of gazing 
at emotional faces and neutral faces and vice versa. Trials with emotional faces and neutral faces 
were interleaved. The whole task consisted of two sessions of 30 trials that was interrupted by a 
short break. Both the sessions had a different order of the presentation of the emotional and neutral 
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faces. All used faces were balanced on gender, ethnicity, and in the adult age range. A set of face 
stimuli were selected from the online NimStim of Facial Expressions set (available to the scientifc 
community at http://www.macbr ain.org/resources.htm) [81]. The faces differed on the intensity of 
portrayed emotion from high to low. Both the types of emotion and the portrayed intensity have 
been previously validated [42]. The Dutch question asked to the participants was presented on the 
screen and can be translated as ‘What kind of emotion did you see?’. The participants always had 
five answer options: neutral, happy, sad, angry, and fear. The order of the answers on the screen was 
balanced over the trials.
Figure 1. Percentage of total ﬁxation duration on the eyes of fearful faces
Data pre-processing
We exported the fixation data from Tobii studio 2.2.08 and used Matlab 2016B [58] to pre-process 
the eye-tracking data. We used stringent data exclusion and inclusion criteria. Trials were excluded if 
there was no fixation data for 25% or more of the trial duration. At least 1.5 s of the 6 s trial duration 
had to contain valid eye-tracking data. To overcome and counter potential artifacts, we did not take 
the first 100 ms of the trail into account for the time to first fixation. In the first 100 ms, it is hard to 
disentangle ‘real fixations’ from potential measurement artifacts or limitations of the used apparatus 
with sampling rate of 50. Moreover, we excluded participants in which 50% or less of the trials were 
valid. Applying these criteria led to the exclusion of 4 participants (2 participants with ASD and 2 
with ODD/CD).
Normality of distributions
We investigated the distributions of all our eye-tracking output variables and checked for violations of 
normality. We used skewness and kurtosis to establish normality values (see supplementary Table 1 
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for more information). For all three groups and all the eye-tracking variables, normality could not be 
completely assumed. This led to the choice to use non-parametric statistics such as the Kruskal–
Wallis tests [18], non-parametric Mann–Whitney post hoc tests, and Spearman correlations. The 
Spearman correlations are rank order free and resistant to violations of normality assumptions. 
In this way, we could ensure that eye-tracking variables in milliseconds would still have biological 
plausible meaning.
Statistical analysis
We applied a non-parametric trial-based approach to investigate gazing behavior on the AIO (eyes, 
mouth, and rest of the image) of emotional and neutral faces [18]. For all our three main eye-tracking 
variables (total fixation duration, time to first fixation, and percentage total fixation), we used Kruskal–
Wallis one-way ANOVA tests (two-tailed, significance level α = 0.05) to test for group differences. 
For the variable ‘time to first fixation’ on the eye AIO, we investigated the relative distribution 
(percentagewise) for all three groups (ASD, ODD/CD, and TD) for values in time bins of 50 ms. To 
overcome and counter potential artifacts, we did not take the first 100 ms of the trial into account 
for the time to first fixation. In the first 100 ms, it is hard to disentangle ‘real fixations’ from potential 
measurement limitations of the used apparatus. We ran five tests separately for all the different 
emotions (anger, sad, fear, and happiness) and neutral faces (see Fig. 1). We applied Bonferroni 
corrections for multiple testing (two-tailed, significance level, α = 0.01). We performed Mann–
Whitney post hoc tests to examine the specific directionality of effects between the groups. The same 
rationale was followed for all of our eye-tracking variables. For the investigation of behavioral results 
of the emotion recognition task, we looked at the percentages of correct answers per group and 
tested for group differences via t tests after z score transformations. Furthermore, we investigated 
Table 2. Eye-tracking results for gazing at the eyes
Total fixation 
duration 
N Degrees of 
freedom 
Chi-Square Significance Contrasts post hoc test 
Anger 774 2 511.5 p = .003  TD > ODD/CD**
Fear 835 2 15.1 p < .01  TD > ODD/CD**
Sad 816 2 0.6 p = .74 n.s.
Happy 835 2 15.2 p = .001
Neutral 2866 2 31.2 p < .001 TD > ASD*** TD > ODD/CD ***
Time to first fixation
Fear 248 2 6.11 p = .047 TD >ASD = ODD/CD*
Anger 222 2 4.04 p = .1 n.s.
Sad 234 2 2.47 p = .5 n.s.
Happy 264 2 5.79 p = .055 n.s.
Neutral 116 2 3.25 p = .19 n.s.
n.s.: Not signiﬁcant, *=p<.05; **=p<.01***=p<.001
TD: typically developing individuals; ASD: autism spectrum disorder; ODD: oppositional deﬁant disorder; CD: conduct disorder
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the correlation (Spearman test, two-tailed, significance level α=0.05) between eye-gazing pattern for 
emotional faces with CU traits (total score of ICU, and YPI CU subscale scores), psychopathic traits 
(YPI total score), and severity of aggression (RPQ scores for proactive and reactive aggression).
Results
Descriptive results
See Table 1 for sample characteristics. The three groups did not differ in age, but significantly differ 
in estimated full-scale IQ (FSQ). A post hoc test revealed that the FSQ was lowest for the ODD/CD 
Figure 2. Time to ﬁrst ﬁxation in milliseconds on the eyes of fearful faces.
Figure 3. Distributions of the time to ﬁrst ﬁxation on the eyes of fearful faces for 100-1000 milliseconds. Timebins are 50 
milliseconds each.
TD: typically developing individuals; ASD: autism spectrum disorder; ODD: oppositional deﬁant disorder; CD: conduct disorder
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group, and highest in the TD group, while the ASD group scored in between of the two. There was 
no significant difference between the ASD group and the TD group. The three groups significantly 
differed on SCQ, post hoc test revealed that the ASD group scored higher than the ODD/CD group. 
Regarding selfrated CU traits, the ODD/CD group showed significantly higher CU scores than both 
the TD and ASD groups, whereas the TD and ASD groups did not differ from each other. Regarding 
the parent-rated CU traits, the ODD/CD group scored significantly higher than the ASD group, and 
the ASD group scored significantly higher than the TD group. The three groups differed significantly 
from each other on aggressive behavior (RPQ total score). A post hoc test showed that the ODD/CD 
group had significantly higher scores on the RPQ total score then both the ASD and the TD groups. 
The ASD group did not differ from the TD group. Regarding reactive aggression, the ODD/CD group 
had significantly higher scores than both the ASD and TD groups. The ASD group and the TD group 
did not differ from each other. Regarding proactive aggression, the ODD/CD group had significantly 
higher scores than both the ASD and TD groups. The ASD group and the TD group did not differ 
from each other (Table 2). 
Eye-tracking results and behavioral results
We found a main group effect for relative total fixation time to the eye region for fearful (Kruskal–Wallis 
one-way ANOVA, [χ2  (df=2, N=835)=15.1, p<0.01] (presented in Fig. 2), angry [χ2  (df = 2, N = 774) = 
Figure 4. Spearman correlations between the time 
to ﬁrst ﬁxation on the eyes of fearful faces and the 
total score of the YPI.
TD: typically developing individuals; ASD: autism spectrum disorder; ODD: oppositional deﬁant disorder; CD: conduct disorder
Figure 5. Spearman correlations between the time to 
ﬁrst ﬁxation on the eyes of fearful faces and proative 
aggression (RPQ-proactive subscale)
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511.5, p < 0.01], happy [χ2  (df=2, N=835)=15.2, p=0.001], and neutral faces [χ2  (df=2, N=2866)=31.2, 
p<0.001]. The N number is representing the number of trials per emotion per experimental group. 
When correcting for multiple comparisons via Bonferroni correction (p=0.05/5=0.01), these 
main effects remained significant. Mann–Whitney post hoc tests revealed that the TD group had 
significantly more fixations to the eye region than the participants with ASD or ODD/CD for fearful, 
angry, happy, and neutral faces, whereas the ASD and ODD/CD groups did not differ from each 
other. There was no main group effect for sad faces [χ2  (df=2, N=819)=0.6, p=0.7]. We found a main 
group effect for the time to first fixation towards the eye region for fearful faces [Kruskal–Wallis one-
way ANOVA, χ2  (df=2, N=248)=6.11, p=0.046] (Fig. 3). When correcting for multiple comparisons 
via Bonferroni (0.05/5=0.01), this main group effect did not survive. We performed Mann–Whitney 
post hoc tests to investigate the directionality of this nominal significant main effect. That revealed 
that both groups with ASD or ODD/ CD took significantly longer time to first fixate on the eyes of 
a fearful face, compared to TD participants. We did not fnd any main group effects on time to first 
fixation to the eye AIO for sad, angry, happy, and neutral faces. The behavioral results for the emotion 
recognition task are presented in Table 3. We looked at the percentages of correct answers and the 
group differences via t tests via normalized z scores. We found significant differences between the 
ODD/CD group and the TD group for the happy faces (p < 0.005) and sad faces (p = 0.01). We also 
found differences between the ODD/CD group and the ASD group for neutral faces (p<0.05), sad 
faces (p=0.03), and fearful faces (p=0.02). These are all nominal significants, since only the result 
for happy faces survives Bonferroni correction (0.05/5=0.01).
Correlations eye-tracking variables and behavioural traits
Only in the ODD/CD group, we found a nominal significantly negative Spearman correlation between 
the time to first fixation at the eyes of fearful faces and psychopathic traits (r = 0.35, p = 0.02) (Fig. 4). 
When correcting for multiple comparison via Bonferroni correction (p=0.05/5=0.01), the Spearman 
correlation did not survive this correction. In addition, proactive aggression was also negatively 
correlated (r=− 0.33, p=0.04) with time to first fixation to the eyes of fearful faces in the ODD/ CD 
group. When correcting for multiple comparison via Bonferroni correction (p = (0.05/5) = 0.01), this 
correlation also did not survive (Fig. 5). For the other three emotions; happiness, sadness, anger, and 
neutral faces, the psychopathic traits, CU traits, and aggressive tendencies did not correlate with any 
of the eye-tracking variables on any of the AOIs.
Emotions TD ODD/CD ASD Contrast Significance
Neutral 69.3 66.1 63.2 ODD/CD – TD* p = 0.046
Angry 46.6 45.5 41.0
Happy 96.1 91.7 90.3 ODD/CD – TD*** p = 0.005
Sad 59.9 52.1 46.1 ODD/CD – TD*
ODD/CD – ASD*
p = 0.01
p = 0.03
Fearful 84.0 80.6 75.2 ODD/CD – ASD* p = 0.02
*Depicted are the percentages correctly recognized emotional faces The effects are bases on t-tests, normalized with 
z-transformation. n.s.: Not signiﬁcant, *=p<.05; **=p<.01***=p<.001. 
TD: typically developing individuals; ASD: autism spectrum disorder; ODD: oppositional deﬁant disorder; CD: conduct disorder
Table 3. Behavioral results emotion recognition task*
 6
180
Control-analyses
To check if our effects were not driven by the known significant differences in intelligence, ADHD 
comorbidity and medication use between groups, we undertook additional analyses. We regressed 
out full-scale intelligence (FSQ) from the model. The Spearman correlation between the total YPI 
score and the time to first fixation on the eyes was not significant anymore (r = 0.26, p=0.14). For 
the ASD group, the correlation was significant (r = 0.31, p = 0.04), but did not survive Bonferroni 
correction (p = 0.05/5 = 0.01). The Spearman correlation between proactive aggression and time to 
first fixation on the eyes of fearful faces was not significant anymore (r = 0.18, p = 0.3). Concluding, the 
regression of fullscale intelligence scores from the model did not change the directions of the effect 
and all Spearman correlation still did not survive correction for multiple comparison. Furthermore, 
we ran analyses to control for the effects of ADHD comorbidity and medication use (for details, see 
supplementary Tables 2, 3, 4, and 5). In the sample, 50 (28 subjects with ODD/CD and 22 subjects 
with ASD) of the 122 subjects had a comorbid ADHD diagnosis, and in the case of 9 participants, 
information was missing. For both control analyses, we excluded those participants with either ADHD 
(or missing information) or on medication (or missing information). The directions of the effects in 
both control analyses did not differ from the effects in the main analysis for total fixation duration, 
relative total fixation duration, and time to first fixation. Moreover, we ran control analysis for the 
Spearman correlation with behavioral traits (psychopathic traits and proactive aggression). In this 
case, we only selected participants without ADHD or that were not using medication (or missing 
information). The direction of the effects between the time to first fixation on the eyes of fearful 
faces in the ODD/CD group and psychopathic traits (YPI total score) and proactive aggression (RPQ 
proactive aggression subscale) did not change (see supplementary Table 5 for these results).
Discussion
This study aimed to investigate common cross disorder and unique disorder-specific patterns of eye 
gaze during emotional face processing by a head-to-head comparison of male adolescents with either 
ASD, or ODD/CD, compared to TD for eye-tracking measures (1) time to first fixation on an AIO, 
(2) total fixation duration to an AOI, and (3) percentage of total fixation duration on an AOI relative 
to the rest. We also examined the modulating role of CU and psychopathic traits, and aggression 
subtypes. We chose not to include subjects with a combined diagnosis of both ASD and ODD/
CD to facilitate a clear crossdisorder comparison. In this way, we are not looking at the combined 
comorbid group (with a diagnosis of both ASD and ODD/CD) and cannot compare synergistic 
effects arising from the comorbidity of these disorders. Our results showed that (1) participants 
with either ASD or ODD/CD both did fixate proportionally and significantly less on the eye region 
of emotional faces (with sadness excepted) and neutral faces, compared to TD. (2) participants 
with either ASD or ODD/CD both took longer time to first fixation on the eye region in fearful faces, 
but not in faces with the other emotions/emotional expressions (i.e., neutral, anger, sadness, and 
happiness). However, this effect did not survive multiple comparison correction. (3) When looking at 
the relationship between eye gazing and CU traits, psychopathic traits, and aggression, we found a 
seemingly opposing effect. Higher scores for psychopathic traits and of proactive aggression within 
the ODD/CD group were nominally significant associated with shorter time to first fixation at the eye 
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region for fearful faces compared to the TD group. All three groups were paying more attention to 
the eye region compared to the mouth region and other parts of the face. Since these effects did not 
survive multiple comparison and regressing out full-scale intelligence scores did not change this, we 
did not fnd solid evidence for the hypothesized relationships. 
 Some studies have indicated that excessive attention to the mouth region may be adaptive for 
ASD children with well-developed language skills [72]. More recent work falsifies the gaze aversion 
to the eyes in infants [59]. These findings are not confirmed in our high-functioning adolescent 
male population with ASD. The differential results can be explained by differences in methodology 
across laboratories and also the high heterogeneity in gazing behavior for individuals with ASD. The 
different age ranges of samples and their intelligence profiles may also partly explain differences in 
findings [41]. 
 Earlier studies reported poorer recognition of emotional facial expressions in individuals with 
CD [36, 87] and also abnormally low amygdala activations to fearful or angry emotional faces in 
individuals with CD, particularly those with high CU traits [50, 67]. We observed both in the ODD/
CD and ASD groups proportionally less gazing at the eye region of emotional and neutral faces. This 
suggests that less gazing at the eye region of emotional faces might still be a cross-disorder trait that 
is not unique to ASD, but shared with other disorders like ODD/CD, which  is in line with findings 
that emotion recognition problems characterize a wide range of child psychiatric disorders, varying 
from ASD, ADHD, and CD to mood and anxiety disorders and eating disorders and schizophrenia 
[23]. 
 The novelty of our study is that we are providing insight into differences of eye-gazing 
behavior on fearful faces between clinical groups that are well-phenotyped and look at the links with 
psychopathic traits, CU traits, and aggression. We found that the time to first fixation is delayed for 
the ODD/CD group for the time to first fixating on the eyes of fearful faces. A delayed first fixation to 
fearful eyes might lead to slower processing and delayed evaluating of the fearful state of the other 
person. Small distortions in synchrony of emotional communication between individuals due to 
delayed processing of emotional information may already disrupt social interactions and predispose 
to inadequate and even harmful behavior [14, 53]. 
 There was a nominally significant negative correlation in our ODD/CD group between the time 
to first fixation to the eyes of fearful faces and psychopathic personality traits (YPI). This effect did 
not survive multiple comparison correction. This dimensional effect concerning higher psychopathic 
traits is opposite the group effect of eye gazing in our ODD/CD participants that gaze later to the 
eyes of fearful faces. The absence of a relationship between psychopathic/ CU traits and gaze fixation 
in both the ASD group and the TD group might be due to the smaller variance in psychopathy 
and CU scores (for details, see Table 1) in these groups. It might be that a selection bias led to the 
oversampling of participants lower than average on psychopathic traits, CU traits, aggression for 
those that score average or high might be less willing to be subjected to testing in a clinical research 
setting. 
 In general, a modulating role of psychopathic traits is consistent with findings in functional 
MRI studies, where amygdala activation to fearful or angry faces is low in the presence of high 
psychopathic and high in their absence [50, 67]. Klapwijk et al. [51] also found decreased amygdala 
responses in both adolescents with ASD and individuals with CD and high CU traits. We also found 
a possible association with the severity of in particular proactive aggression and time to first fixation 
on the eyes of fearful faces. Children as well as adolescents and adults with ODD/CD and high levels 
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of psychopathy/CU traits are more likely to have high levels of proactive aggression [26, 39]. Our 
data does seem to suggest a potential link between ODD/CD, high psychopathic traits, proactive 
aggression, and impaired fear processing. 
 Although we document similar patterns of abnormal gaze behavior to emotional faces in 
ASD and ODD/CD, the underlying mechanism might be disorder specific. There are three theories 
trying to explain abnormal emotional face processing in ASD. First, gazing at faces and eyes in 
particular may lead to increased (negatively valence) emotional responses in individuals with ASD 
and even found to be aversive [31]. Looking at the mouth is then just a byproduct of avoiding gazing 
at the eyes. Second, another theory poses that individuals with ASD cannot “read the language of the 
eyes”, i.e., they do not understand visual information from the eyes which may be linked to problems 
in using a Theory of Mind [52]. The failure to use information from the eye region in combination with 
an ability to use visual information from the mouth for speech related processing is driving the deficit 
of excess fixation on the mouth and diminished fixation on the eyes. Third, another explanation is 
that individuals with ASD are suffering from impaired social orientation and that the “most social” 
part of the face, the eye region lacks saliency and does not arouse suficient intrinsic interest to be 
looked at [41]. Unfortunately, our paradigm and our results not allow us to differentiate between 
these potential explanations. 
 Impaired affective responses and emotional processing in CD has been addressed by three 
main theories [32]. The attention to the eyes hypothesis proposes that emotion processing deficits 
in CD/psychopathy arise from a lack of spontaneous attention to the eye region [30, 28] which 
negatively affect the processing of all emotional expressions. The distress-specific hypothesis states 
that individuals with CD/psychopathy fail to effectively process in particular others’ expressions of 
distress (fear and sadness). As a result, their antisocial actions are not inhibited by aversive feelings 
of remorse and guilt, resulting in callous behavior and shallow affect [15, 11]. Finally, the enhanced 
selective attention hypothesis [63, 61, 62] states that the enhanced ability to focus on a task and 
to ignore goal irrelevant stimuli underlies affective deficits. This superior selective attention can 
enhance the top–down ability to suppress emotional information that is irrelevant to one’s goals, 
for example, another person’s distress if the psychopath wants to steal their money. Since the gaze 
pattern with proportionally less attention to the eye region was observed for all emotions except for 
sadness, our results are mostly in line with the attention to the eye hypothesis or the enhanced ability 
to focus hypothesis. 
 Our groups did not differ with respect to the total fixation duration on the eyes while processing 
sad faces. Other studies have shown that emotional recognition deficits for sadness are present in 
people with ODD/CD [79, 87]. These discrepant findings may be due to differences between studies 
in sample selection and characteristics. The Woodworth and Waschbusch [87] sample consisted of 
both male and female children with high levels of CU traits, which is quite different from our male 
adolescent sample. The Stevens et al.’s [79] sample did not use a formal clinical diagnosis of ODD 
or CD and selected participants on the basis of a score of 25 or higher on the psychopathy screening 
device [38]. 
 Despite its strengths, such as the direct comparison of a well-powered ASD and ODD/CD 
group and its focus of gaze behavior by means of eye-tracking measures which ruled out the influence 
of social desired expected answers of questionnaires, our study also showed limitations. We were 
not able to control the gaze duration to the fixation cross prior to the faces that were portrayed on the 
screen. As half of our trials contained neutral faces, we did not have enough trials per emotion to look 
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into the effects of gender, ethnicity, and the intensity effects of the emotions portrayed on the faces. 
The stimuli used in this study were selected from a validated database of emotional expressions: 
including stimuli with facial characteristics such as wrinkles and facial hair. Facial characteristics can 
be seen as a factor that may influence the study outcomes. In contrast to studies that use morphed 
faces, our facial stimuli are closer to emotional faces in the real world. On the other hand, this 
might potentially revert the attention of the participants and confound the outcome. Both diagnostic 
groups also contained a substantial amount of participants with comorbid ADHD and/or using 
medication. Although antipsychotics (where possible) were stopped 2 days before, and stimulants 
on the test day, we cannot rule out possible medication effects. However, sensitivity analyses revealed 
that results were not influenced by the presence of a comorbid diagnosis of ADHD or by medication 
use.
Implications
Considering the consequences of aggression, there is a need for a better understanding of 
underlying causes and maintaining factors. The current study contributes to the enhancement of this 
understanding by revealing (1) two cross-disorder traits for ASD and ODD/CD; (2) disorder-specific 
traits for ODD/CD with proactive aggression as a potential factor. Future research is warranted to 
examine possible other crossdisorder traits (e.g., biological and genetic) and/or disorderspecific 
traits; and (3) adding to knowledge and understanding in fractioning empathy to emotional stimuli 
by means of eye-gazing processing as a part of the MATRICS project (http://matrics-project.eu/). 
MATRICS examines the neural, genetic, and molecular factors involved in the pathogenesis of 
aggression/antisocial behavior and that in relation with callous–unemotional traits. 
 Moreover, as the current treatments, which mainly involve skill training, are not suitable 
or developed to alter implicit characteristics, other methods are needed to improve the efficacy 
of aggression treatment, and techniques like virtual reality seem to be promising [66, 69]. Clinical 
implications are mainly optimization of psychological interventions by therapists requiring eye-
gazing information. A future study would definitely also beneft from the presentation of both static 
and dynamic faces as stimuli and comparing outcomes.
Conclusions
To conclude, we reported that male adolescents with ASD or ODD/CD looked less at the eyes in 
fearful, angry, happy, or neutral emotional expressions. They also took nominal significantly more 
time to first fixate on the eyes of fearful faces compared to TD. Those male adolescents with ODD/
CD that exhibit faster first fixations on the eyes of fearful faces had nominal significant higher 
scores on psychopathic traits. Nevertheless, we did not fnd strong evidence that survived multiple 
comparisons to support that in ASD and ODD/ CD higher scores on CU traits, psychopathy, and 
aggression were related to eye gazing on the eyes of fearful faces. Our data do provide valuable and 
new insight into the gaze behavior distributions of ODD/CD and ASD groups when looking at the 
eyes of emotional faces.
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Supplementary table 1. Normality indices of eye tracking variables
All subjects 
- skewness
All subjects 
- kurtosis
ASD group 
- skewness
ASD group 
- kurtosis
ODD/CD 
group - 
skewness
ODD/CD
Group  - 
kurtosis
TD
group
skewness
TD 
group -
Kurtosis
 Fixation duration
-1.34 5.79 -2.40 10.56 -0.52 2.74 -0.63 2.37
Fear -0.95 4.42 -0.69 3.58 -1.10 4.83 -0.72 2.34
Sad -1.20 5.23 -1.50 6.21 -0.91 3.78 -0.55 2.46
Happy -1.30 5.66 -1.99 9.24 -0.82 3.15 -0.73 2.90
Neutral -0.05 2.57 -0.07 3.07 0.10 2.51 -0.22 2.00
Time to first fixation
Fear 2.96 10.65 3.41 14.95 2.86 9.85 2.26 4.83
Anger 3.35 12.75 3.85 19.51 3.12 10.20 3.09 10.47
Sad 3.29 12.7 2.88 9.99 3.46 13.64 3.29 11.81
Happy 2.80 8.15 3.02 10.38 2.48 5.70 2.94 8.67
Neutral 3.50 14.35 3.34 12.58 3.46 13.64 3.53 15.25
TD: typically developing individuals; ASD: autism spectrum disorder; ODD: oppositional deﬁant disorder; CD: conduct disorder
Supplementary table 2. Control analysis ADHD comorbidity
Total fixation duration N Degrees of 
freedom
Chi-Square Significance Contrasts Post hoc tests
Anger 458 2 14.83 p = .001  TD > ODD/CD**
Fear 461 2 21.01 p < .001  TD > ODD/CD*
Happy 467 2 13.48 p = .01  TD > ODD/CD**
Neutral 1575 2 51.50 p < .001  TD > ODD/CD*
Time to first fixation
Fear 120 2 6.07 p = .04  TD = ODD/CD (n.s)
n.s.: Not signiﬁcant, * = p<.05; ** = p<.01, ***= p<.001
TD: typically developing individuals; ASD: autism spectrum disorder; ODD: oppositional deﬁant disorder; CD: conduct disorder
Supplementary table 3. ADHD-comorbidity control analysis for the correlation with YPI and RPQ
Group Spearman (R) Significance
Correlation time to first fixation - YPI
Fear TD -.17 p = .42
Fear ASD .04 p = .84
Fear ODD/CD -.27 p = .45
Correlation time to first fixation - RPQ proactive subscale
Fear TD -.08 p = .76
Fear ASD -.10 p = .63
Fear ODD/CD -.63 p = .08
* = p < .05, ** = p < .01, *** = p < .001
TD: typically developing individuals; ASD: autism spectrum disorder; ODD: oppositional deﬁant disorder; CD: conduct disorder
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Supplementary table 4. Control analysis for medication use during testing days
Total fixation duration N Degrees 
freedom
Chi-Square Significance Contrasts post hoc tests
Anger 476 2 5.50 p = .06 TD = ASD (n.s.) TD > ODD/CD*
Fear 487 2 6.76 p = .03 TD = ASD (n.s.) TD > ODD/CD*
Happy 484 2 6.45 p = .04 TD = ASD (n.s.) TD > ODD/CD*
Neutral 1653 2 8.27 p = .02 TD > ASD* TD > ODD/CD**
Time to first fixation
Fear 120 2 6.07 p = .04  TD < ASD* TD = ODD/CD (n.s.)
n.s.: Not signiﬁcant, * = p < .05, ** = p < .01, *** = p < .001
TD: typically developing individuals; ASD: autism spectrum disorder; ODD: oppositional deﬁant disorder; CD: conduct disorder
Supplementary table 5. Control analysis medication use during testing days
Group Correlation (Rs) significance
Time to first fixation – YPI - total
Fear TD -.18 p = .4
Fear ASD -.02 p = .9
Fear ODD/CD -.22 p = .3
Correlation time to first fixation RPQ - proactive 
Fear TD -.07 p = .78
Fear ASD -.15 p = .54
Fear ODD/CD -.41 p = .07
TD: typically developing individuals; ASD: autism spectrum disorder; ODD: oppositional deﬁant disorder; CD: 
conduct disorder
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General discussion
194
As part of a larger project on empathy in aggressive male adolescents (i.e. CU2 project), the 
purpose of this thesis was to examine proactive and reactive subtypes of aggression, aggression 
with or without CU traits, and their genetic, (neuro)endocrine, (neuro)cognitive, and behavioural 
underpinnings as transdiagnostic markers. The main question in this thesis was whether there is 
evidence for across-disorder (i.e. transdiagnostic) or disorder specific markers regarding aggressive 
behaviour and/or CU traits in a study that compares male adolescents with the clinical disorders 
ODD/CD or ASD and typically developing individuals (TDI). This trans-diagnostic approach may 
improve our understanding of the biological substrate of aggression, and contribute to the improved 
understanding of the aetiological and clinical heterogeneity of aggression and inform cross-disorder 
interventions in clinical practice. In addition, this thesis aimed to provide an overview of the efficacy 
of non-pharmacological treatments for conduct disorder problems. 
 First, a summary of the main results per chapter will be presented, followed by a discussion 
and integration of the individual chapters in the context of the literature. Second, a critical reflection 
on the strengths and limitations of this thesis will be given, along with future directions emerging 
from this research. To conclude, implications for clinical practice and directions for future research 
will be provided, and a brief conclusion will be given.
Summary of the main results 
The efficacy of non-pharmacological interventions in children and adolescents with a clinical CD 
diagnosis and/or clinical CD problems (including ODD problems) and who have an IQ of minimally 
80 is described in the systematic review and meta-analysis in chapter 2. Although we specifically 
searched databases for non-pharmacological treatments other than psychological treatments, 
all identified studies used psychological (behavioural) treatments. Results from 17 randomised-
controlled trial studies (of which only three included a blinded observer to rate conduct problems) 
showed that psychological treatments have a small effect in reducing parent-, teacher- and observer-
rated CD problems in children and adolescents with clinical CD problems/diagnosis. Overall effect 
size based on parent-reports was 0.37 (95% CI = 0.27–0.47), based on teacher-reports 0.21 (95% CI 
= 0.12–0.49), and based on observer-reports 0.26 (95% CI = 0.06–0.47). In the studies included in 
this review, CD problem outcomes were mainly scored with the CBCL and the ECBI questionnaires. 
Most studies were of very poor to fair quality and reported treatment effects with small effect sizes. 
Comorbidity, gender, age, number of sessions, duration, intervention type, setting, medication use 
or dropout percentage did not influence the effect of treatment. Future studies need to provide 
detailed information about randomisation and blinding arrangements, to triangulate parent reported 
measures. Furthermore, there is insufficient evidence to support any one psychological treatment 
over another in this patient group (including parenting programmes). 
 In chapter 3 a systematic review was conducted to examine the evidence for genetic 
underpinnings of aggression and to determine to what degree prior studies have examined aggression 
phenotypes that fit neatly, or at all, into the RDoC framework. This review focused on three types of 
genetic studies: 40 twin studies, 277 molecular genetic studies of aggression in humans, 34 genetic 
studies of aggression in drosophila, and 86 studies on aggressive phenotypes in mice. Around 50% 
of the variance in aggressive behaviour in humans was explained by genetic influences. Non-shared 
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environmental influences were moderate. With regard to shared environments, studies implicated 
small or no influences: About half of the reviewed studies report no influence of shared environment 
while other studies indicate estimates between 0.15 and 0.35. As human molecular genetic studies 
of aggression are in an early stage, the strongest molecular evidence comes from animal models 
comparing aggressive and non-aggressive rodent strains or documenting the effect of loss or gain 
of candidate gene functions. Many constructs or operationalisations of aggression in animal models 
appear to be context-specific and should be cautiously translated to human behaviour. 
 In chapter 4 the hormones oxytocin, cortisol, and testosterone were examined in relation 
to (severe) aggressive behaviour and/or empathy in a total of 114 subjects with either ODD/CD 
(n=37), or ASD (n=49), or without a psychiatric disorder (TDI, n=28). Both the ASD and the ODD/
CD groups had significantly lower levels of oxytocin than the TDI group, and the ODD/CD group 
had significantly higher levels of testosterone than the ASD group. There were no group effects 
on cortisol levels. Group differences remained for oxytocin after correcting for the influence of CU 
traits, but became non-significant when controlling for aggression subtypes as measured by the 
reactive and proactive aggression questionnaire. Results for testosterone became non-significant 
after correction for either CU traits or aggression. Across groups, higher levels of CU traits were 
related to higher levels of cortisol and testosterone, however, proactive and reactive aggression were 
not correlated with all three hormonal levels. These findings suggest that the severity of CU traits 
is related to both higher cortisol and testosterone levels, but not to oxytocin levels. The positive 
association in our study was driven by the link between cortisol and testosterone, and the positive 
association between CU traits and testosterone (i.e. correlations between cortisol and either self- or 
parent-rated CU traits became non-significant after controlling for testosterone). 
 In chapter 5 emotion processing was investigated during a neuropsychological (emotional 
Go/No-go) task. In this study, a total of 128 subjects participated, with either ODD/CD (n=52) or ASD 
(n=52), or without a psychiatric disorder (TDI, n=24). Results showed no group differences regarding 
the rate of false positive reactions. In addition, the ASD group was slower than the TDI group and 
the ODD/CD group on two out of three valence discriminations (negative-neutral and negative-
positive). In contrast, reaction time in the ODD/CD group did not differ significantly from the TDI 
group on any of the three valence discriminations. The TDI group showed significant difficulty in 
contrasting positive with neutral pictures compared to negative-neutral or negative-positive pictures, 
whereas this effect was absent in both the ASD and the ODD/CD groups. CU traits, comorbidity 
with ADHD, and medication use were not related to task performance. Adolescents with ODD/CD 
performed in the range of the TDI group, whereas the ASD group was clearly slower than the TDI 
group regardless of type of emotion. Both the ASD and the ODD/CD groups differed from the TDI 
group who presented a ‘positive perception bias’ by being rather slow in differentiating positive from 
neutral valence. The results suggest that adolescents with ODD/CD or ASD seem to have a reduced 
processing of positive stimuli and/or lack a ‘positive perception bias’ present in TDI, that could 
either contribute to the symptoms and/or be a result of having the disorder, and may contribute to 
the comorbidity of both disorders.
 In chapter 6 the common (cross-disorder) and unique (disorder specific) emotional face 
processing deficits, as reflected in the time to first fixation and fixation duration were examined in a 
197
total of 122 male participants, consisting of individuals with either ODD/CD (n=44) or ASD (n=50), 
and TDI (n=28). Furthermore, the relationship of psychopathic traits (including CU traits) and 
aggressive behaviour with eye-tracking measures was examined. Results showed that total fixation 
duration on the eyes in emotional and neutral expressions (except for sadness) was significantly 
lower in both the ASD and the ODD/CD groups, compared to TDI. Time to first fixation on the 
eyes of fearful faces was significantly longer in both the ASD and the ODD/CD groups compared to 
TDI. For the other emotional or neutral faces, no significant effect was found. On the other hand, 
psychopathic traits and severity of particularly proactive aggression were significantly negatively 
correlated with both total fixation duration and also time to first fixation to the eyes of fearful faces 
in the ODD/CD group.
Integration and discussion of the results
In the search of a better understanding of aggressive behaviour with or without CU traits, an 
integrated model of aggression, was provided in chapter 1, which included different levels: 1) 
genetic, (neuro)endocrine, and neural level (i.e. brain mechanisms), 2) cognitive and affective 
level, 3) behavioural level, and 4) environmental influences. Certain aspects (i.e. genetics, (neuro)
endocrine, task performance, and eye tracking) were included given the scope of the current thesis. 
As mentioned in the general introduction, it is recommended to include in future research also 
other possible factors such as environmental risk factors and brain regions related to information 
processing, and look into interactions between all these mechanisms. This will provide additional 
insights in the search of a better understanding of the origins, the maintenance, and development of 
persistent aggressive behaviour. Results from this thesis have shown, in part, a relationship between 
different trans-diagnostic markers and aggressive behaviour and/or CU traits, which deliver some 
suggestions on how to improve and/or develop psychological treatments. This will be discussed 
more in detail below.
To start with, the results (i.e. the small effect sizes of psychological interventions) as provided 
in chapter 2, may lead to two conclusions that are not necessarily opposing. The first is that CD 
problems are persistent and rather refractory to treatment. The second is that there is much room 
for improvement of psychological interventions for CD problems, to make them more effective (see 
below). Individual studies showed great variety of treatment efficacy in reducing conduct problems, 
depending on which questionnaire(s) (e.g. behavioural outcomes) was (were) chosen. While this 
allows generalizability of treatment effects across a range of CD problems, future studies should use 
a more homogeneous set of outcome measures to improve comparability across studies. Alongside 
the questionnaire(s) of treatment outcome, it is important to investigate possible moderators (i.e. 
gender, age, number of sessions, duration, intervention type, setting, medication use or dropout 
percentage) of treatment effect, since this information is needed to further optimize psychological 
treatment strategies. In our meta-analysis we did not find support for these moderators influencing 
treatment efficacy, but this may be linked to the overall poor quality of the studies. In addition, many 
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studies failed to provide important details, such as subtypes of aggression and presence of CU traits, 
which may have influenced the results. 
 Findings from our meta-analysis and recent reviews (e.g. Baumel, Pawar, Mathur, Kane, 
& Correll, 2017) raise questions on how to improve current or develop new treatments, since in 
the literature a recurrent conclusion is that overall results show small to moderate effect sizes of 
psychological interventions. Instead of delivering interventions in a standardized way, one of these 
directions could be the focus on subtypes of aggression and/or CU traits, as research confirms the 
need for direct and specific treatment approaches (Fung, 2017). Improving insights of understanding 
subtypes of aggression with or without CU traits may help to create more homogeneous treatment 
groups for different treatments, or even more desirable, preventive interventions. For example, 
targeting reducing proactive and reactive aggression there are effective treatments (such as the 
multimodal intervention Aggression Replacement Training [ART] (Brännström, Kaunitz, Andershed, 
South, & Smedslund, 2016) which can be used in the clinical practice, although they do not appear 
effective in reducing CU traits (see also Smeets, PhD Thesis “subtyping aggression and predicting 
cognitive behavioural treatment response in adolescents - what works for whom?”, 2017). The need 
for the targeting  of cases with aggression and CU traits is high (given the high social, criminal, 
and economic consequences): one possibility is additional parent-management training or empathy 
training. CU traits are accompanied with other severe clinical behavioural problems such as reactive 
and proactive aggression, and some have suggested that deficits in decision making behaviour 
(reflected in decreased striatal and ventromedial prefrontal cortex responsiveness) (Blair, 2013) may 
underlie this. For example, to these brain regions, research shows that adolescents with ODD/CD 
(comorbid with ADHD) and adolescents with psychopathic traits have deficits in decision making, 
resulting in choosing significantly smaller amounts of immediate reward than waiting for a larger 
delayed  award (Matthys et al. 2013; White et al. 2014). In line with this, a recent study shows that 
reduced amygdala-ventromedial prefrontal cortex activity during high provocation in the ultimatum 
game task (social fairness game) predicts the level of reactive aggression in youths with ODD/
CD (White et al., 2016). Cognitive biases, such as weak executive skills, may inhibit adaptation to 
environmental stress and increase risk for aggression. Psychological treatments may benefit from 
an individualized approach that depends on the weaknesses and strengths of the (neuro)cognitive 
characteristics of the child and the adolescent (Matthys, Vanderschuren, Schutter, & Lochman, 2012). 
 Psychological treatments targeting aggression problems show that children and adolescents 
may develop more knowledge of impulse control and alternative behavioural responses (Matthys 
et al., 2012). It is thought that the acquirement of knowledge makes the cognitive system more 
flexible as it now has more representations of the environment and more ways to achieve a particular 
behavioural outcome (Lovden, Backman, Lindenberger, Schaefer, & Schmiedek, 2010). It has been 
suggested that children and adolescents with ODD/CD problems are the ones with the least knowledge 
and insights into their own behaviour and have limited alternative behavioural response options. 
Perhaps focusing on improving this understanding may also contribute to gaining control over one’s 
impulses. As such, programmes such as the U.S. based Mendota Juvenile Treatment Center Program 
(MJTC) are demonstrating significant treatment response in CD youth.The development of skills 
and knowledge about control over aggressive impulses might be at risk by the presence of rather 
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persistent cognitive distortions. As these distortions are often used to protect a positive self-image, 
to neutralize feelings of blame and guilt, and to trivialize aggressive behaviour (Barriga, Hawkins, 
& Camelia, 2008; Helmond, Overbeek, & Brugman, 2014). As a result, disproportionate aggression 
may be strengthened and/or maintained. In addition, despite the stable character of CU traits (Fanti, 
Colins, Andershed, & Sikki, 2017; Scheepers et al, 2010) research on psychological treatment (e.g. 
socio-emotional, cognitive processing, multimodal or behavioural therapy) showed that high levels 
of CU traits can decrease over time (varying per individual) (Muratori et al., 2015; Wilkinson et 
al., 2015). This suggest that children and adolescents with elevated CU traits are not “untreatable” 
and that these children can show reductions in both their CU traits and their antisocial behaviour 
(Wilkinson, Waller, & Viding, 2016), although they typically begin treatment with poorer premorbid 
functioning and can still end with higher levels of aggressive behaviour (Wilkinson et al., 2016). The 
improvement in functioning in those with high CU traits coupled to antisocial behaviour is evident 
in intervention programmes such as the MJCT. Additional single and/or a combination of different 
treatments (e.g. parent management training, modulation of arousal level, and/or empathic skills 
training) could target these CU traits in youth further. More specifically, based on the social learning 
model of Bandura, adolescents appear to learn to express and share their emotions by observing 
their peers doing so. This group setting improves their understanding of other people’s emotions 
and empathy level, which seems to be more effective than individual treatment (Muratori et al., 2015). 
In addition, a study of Masi et al. (2016) shows that medication added to psychosocial treatments 
could reduce aggression, but not CU traits. This is highlighted further by the clinical observations that 
psychostimulants such as methylphenidate that reduce aggression do not necessarily improve social 
behaviour per se. Thus adding medication is not of additional value when aiming to reduce levels of 
CU traits. Overall, this highlights the need for clinical practice to investigate whether high levels of 
CU traits are present in individual with aggression because additional or different treatments may 
be  needed. In order to direct specific treatments, better understanding of the possible biological 
mechanisms involved in aggressive behaviour and CU traits is likely to be helpful. Stratification 
by the use of biomarkers may help to identify biologically more homogenous subgroups, to which 
treatment could be focused and accommodated. These biomarkers can be stratified for example on 
genetic, (neuro)endocrine, (neuro)cognitive, and behavioural levels in order to examine subtypes 
of aggression and the role of CU traits. Alongside behavioural questionnaires to measure CU traits, 
also physiological measurements such as baseline heart rate and its variability to stressors could 
be a biological correlate of CU traits (Ortiz & Raine, 2004; Stadler et al., 2008; Van Hulle, Corley, 
Zahn-Waxler, Kagan, & Hewitt, 2000). Research show that children and adolescents with CD and CU 
traits have a lower magnitude of heart rate change (de Wied, van Boxtel, Matthys, & Meeus, 2012). 
In individuals who manifest restrained, controlled aggression are less likely to be affectively unstable; 
their aggression is instrumental, in the sense that it is normally used to achieve a goal beyond 
harming a victim (van Goozen, Fairchild, Snoek, & Harold, 2007). The level of arousal of individuals 
engaging in this form of aggression is thought to be low, as evidenced by their low baseline heart 
rate and skin conductance levels, although it is not known whether their arousal levels are also low 
during the commission of violent or antisocial acts themselves. 
 Overall, the results in the current thesis in combination with current research advocates the 
 7
200
need for more detailed psychological treatments based on better defined homogeneous groups (e.g. 
based on aggression subtypes and/or biological factors), and targeted specifically on the presence/
absence of high CU traits.  
Biological factors such as genetic factors might play a role in the development or maintenance of 
aggressive behaviour, and it is less likely to be explained by a few candidate genes (e.g. MAOA, 
5HTTLPR, COMT, DRD4), but rather by a complex interaction between multiple genes (Vassos, 
Collier, & Fazel, 2014). Results from chapter 3 showed that there is a lot of research on different genes 
in animal research, but not all of their findings are investigated or confirmed in human research. 
Overall, there is a risk of bias arises in the cited studies, given that the power to detect shared 
environmental influences is often low in biometric analyses of twin data and these studies assume 
that the environmental effects are free of influence by genetic effects (Burt, 2013). First results 
from genome-wide association of human studies are emerging (Tielbeek et al., 2017). Molecular 
genetic findings may also be sex-specific (see also see also van Donkelaar, PhD Thesis “Genetic and 
neurobiological mechanisms underlying aggression subtypes”, 2018). Molecular genetics offers no 
immediate solution to the problem of aetiological heterogeneity. 
 Regarding the RDoC approach, research confirm links between aggression genes/
environmental risk factors and brain regions relevant to aggressive behaviour (Fonagy & Luyten, 
2017). However, this does not provide an answer to the question whether the studied brain regions 
are mediating or moderating between genes and behaviour in ODD/CD in particular. This illustrates 
the complex map of biological pathways from gene to behaviour via the brain. Although research in 
ADHD is more advanced regarding risk genes, life stressors, and ADHD symptoms (van der Meer, 
Hartman, et al., 2017; van der Meer et al., 2016; van der Meer, Hoekstra, et al., 2017; van der Meer 
et al., 2015), this work may provide a template that might also be used for aggression and antisocial 
behavioural research. Future research is warranted to investigate the possible causal influence of 
brain regions involved in aggression and CU traits on the expression of genes and their epigenetic 
markers coding for the influence of the environment throughout life. 
Based on the results from the study in the hormonal concentrations (chapter 4) we can conclude 
that there are group effects on both testosterone (both disorder-specific and across disorders) 
and oxytocin (between clinical and non-clinical individuals (i.e. ODD/CD and ASD showed lower 
oxytocin levels compared to TDI)). Thus at (neuro)endocrine level, the type of hormone is important 
to differentiate across disorders (i.e. based on oxytocin concentrations) or between disorders (i.e. 
based on testosterone concentrations); these effects were driven by the dimensional (i.e. partly 
driven by CU traits) findings. Further research is warranted to replicate our findings, and should 
explore whether these baseline hormonal factors can be used as stratification markers to predict 
response to treatment or course of ODD/CD and ASD or map on other independent variables. The 
design of this study does not create the option to investigate whether the differences in hormonal 
concentrations between and across groups are a result of a person’s trait or a reflection of a person’s 
inner state. This question could be answered by conducting for example an experimental intranasal 
oxytocin study, by which hormonal concentrations could be observed both in the short and long term 
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and how this may improve empathy which in turn may reduce aggressive behaviour (see also clinical 
implications). The observational design of the CU2 project does preclude to draw conclusions about 
the causality of the association between hormonal concentrations and aggression and/or CU traits. 
 It is of note there is an overall developmental model on CU traits, as this was formerly 
described as being stable across the development, although this view has recently been disputed 
(Wilkinson, Waller, & Viding, 2016). Alongside this finding, recent results suggest that CU personality 
attributions present in toddlers and preschoolers are different compared to older children (Fonagy 
& Luyten, 2017). More specific, CU attributions in toddlers and preschoolers do not include a 
distinguishing feature such as a lack of emotional responsiveness. This suggests not only to take 
into account a developmental approach, but also a person-based approach (i.e. how are the CU 
personality attributions presented within a person) in research on CU traits. Currently, several EU-
funded research consortia such as AGGRESSOTYPE, MATRICS, and FemNAT-CD are collecting data 
towards this goal in children and adolescents with CD. 
 Multi-informant ratings (self- and parent-rated questionnaires) in the CU2 project are a 
strength of this thesis. Results in chapter 4-6 indicate that the link between CU traits and outcome 
measures is rater-specific. Regarding the (neuro)endocrinological level: cortisol concentrations were 
related to either higher self- or parent-rated CU traits, and testosterone concentration were only 
related with self-rated CU traits. Regarding the (neuro)cognitive level: no rater specified links of CU 
traits were reported with poorer performance in terms of accuracy within the emotional valence study. 
Within the eye-tracking study, eye-tracking parameters were regardless rater not at all linked with CU 
traits but more on a general level with psychopathic traits. The latter is in line with previous research 
on the associations between CU traits and general and maladaptive personality traits indicating that 
CU traits tend to be located in different parts of the personality space (Decuyper, De Bolle, De Fruyt, 
& De Clercq, 2011; Decuyper, De Clercq, De Bolle, & De Fruyt, 2009; Roose, Bijttebier, Decoene, 
Claes, & Frick, 2010). This underscores the multifaceted nature of psychopathic traits. Assessment 
of CU traits solely based on self-reports potentially leads to bias due to lack of self-knowledge, 
deception, and impression management. Individuals scoring high on maladaptive personality traits 
are even more likely than other people to have distorted views of themselves (Oltmanns & Carlson, 
2013). Indeed, some groups believe that colecting both self- and parent-rated version of the Youth 
Psychopathic Trait Inventory (YPI) and the Inventory of Callous Unemotional Traits (ICU) may offer 
improved insight into CU traits than either alone (Fanti et al., 2017). The DSM recommends that 
several informants are necessary to diagnose the specifier “with limited prosocial emotions”, thus 
including multiple sources may lead to assess CU traits in a more complete and accurate way. Given 
the additional resources needed in both research and clinical samples to collect data from different 
informants, it is important to determine whether distinct informants add incremental and valid 
information in the assessment of CU traits (Decuyper, De Caluwe, De Clercq, & De Fruyt, 2014).
Results from chapter 5 does not provide evidence to differentiate based on clinical disorders, since 
the clinical groups had diminished ability to process positive stimuli compared to the TDI group. 
These findings are in line with a recent study in which an emotional Go/No-go task was applied, 
reporting that the difficulties that children with combined CU traits and oppositional conduct 
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problems have in processing emotions are more of an emotional rather than an attentional nature 
(Ezpeleta et al., 2017). In addition, both clinical groups had decreased total fixation duration for 
several emotional expressions compared to the TDI group (see also chapter 6). Overall, the results 
suggest that individuals with both ODD/CD and ASD have diminished emotion processing at the 
neural level. Furthermore, it is not clear whether task performance of individuals with ODD/CD and 
ASD is explained by their indifference or lack of motivation to deliver an optimal performance. 
 Not being able to recognise and process emotions may have detrimental effects for treatment 
adherence and outcome. For example, children and adolescents may need more time and guidance 
in understanding and/or practicing in what they learn in treatment. Thus the treatment focus should 
be targeted on individual’s characteristics and include targeted treatment on homogeneous groups. 
In addition, as suggested above, treatments focusing on targeting for example amygdala or insular 
cortex, may involve fMRI neurofeedback, transcranial magnetic brain stimulation or transcranial 
direct current stimulation (Dambacher et al., 2015). The latter two are promising techniques that 
may be able to further clarify the role of the prefrontal, temporal, and insular cortices in mediating 
aggressive behaviour.
 The tests administered in the two neurocognitive studies in the current thesis (chapter 5 and 
6) did not address issues of learning from reinforcement and punishments. Within this perspective, 
it is also advised to include more targeted tests such as the reinforcement approach to treatment. 
As this approach is focused on rearranging environmental contingencies so that withholding from 
aggressive behaviour is more rewarding than expressing it. Within the clinical practice, this approach 
can be used in functional analysis of aggressive behaviour with or without CU traits. This analysis 
focuses on the functional relations between the different aspects of the aggressive behaviour and 
environmental variables (e.g. Burger, 1994). A functional analysis seeks to determine how aggressive 
behaviour has been learnt and maintained by means of positive and negative reinforcements (e.g. 
more attention from parents or friends, avoiding aversive social situations), and prosocial behaviour 
has been discouraged through punishment (Kendall, Slavenburg, van Bilsen, 2013).
 In this thesis, we also looked at the demographic factors such as IQ, socio-economic status, 
and smoking, but found no relationship with mechanisms (i.e. (neuro)endocrine and (neuro)
cognitive) of aggressive behaviour. This suggests that the investigated mechanisms in this thesis were 
not influenced by these demographic variables. An exception is the association between medication 
use and signal to noise ratio (d’ scores, calculated as percentage hits – percentage false positives on 
the affective GoNoGo task) signal to noise ratio (i.e. calculated as percentage hits – percentage false 
positives), indicating that individuals of both clinical groups being treated with medication had lower 
d’ scores than adolescents without medication (see also chapter 5). 
Strengths, limitations, and future directions
Strengths of this thesis were as follows: a systematic review was conducted to provide an extensive 
overview of psychological treatments and treatment efficacy targeting conduct problems in both 
children and adolescents. Moreover, an extensive overview was provided of quantitative and 
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molecular genetic studies of aggressive behaviour in both humans and animals. Another strength 
was the use of different methodological approaches such as multi-informant (i.e. self-rated and 
parent-rated), objective measures and potential biomarkers rather than just subjective reports (e.g. 
which ruled out the influence of social desired expected answers) in a direct comparison of an ODD/
CD group and an ASD group. Despite its strengths our results need to be considered in the context 
of the study’s limitations
Quality of existing studies
In addition to the limitations in the studies based on the CU2 project, there are also limitations to 
the two review chapters (i.e. chapters 2 and 3). Overall, reviews are always limited by the quality of 
existing studies. To allow better evaluation of the quality of studies, future randomized controlled 
trials should provide detailed information on their methods of randomization and blinding and 
on the fate of all trial participants (including dropouts). Many constructs or operationalisations of 
aggression in animal models appear to be species-specific and should be cautiously translated to 
human behaviour.
Role of CU traits
Further, our sample of TDI was smaller than the ASD and ODD/CD groups. This is because originally 
the CU2 project was in part designed to sample ASD and ODD/CD groups to stratify by high and low 
CU traits. Until recently, there was no clear cut-offf score for the inventory of callous-unemotional 
traits (ICU) questionnaire used in the current thesis. Docherty et al., (2017) conducted a large study 
in adolescents in the community as well as detention facilities and provided cut-offf scores (based on 
predicted probabilities of >.5) as follows: for youth report ICU, 28; for parent report ICU, 30; for teacher 
report ICU, 33; for the model with all three types of report, the cut-offf for youth was 40, for parents 
30, and for teacher 36. However, in practice, in the CU2 project there were not enough participants 
with high CU traits to implement such a stratification, as the resulting high-scoring group would 
have been too small. Furthermore, recent taxometric research showed that the latent structure of CU 
traits is best described as dimensional rather than categorical (Herpers, Klip, Rommelse, Greven, & 
Buitelaar, 2016). A common problem in research in psychiatric disorders is that individuals with the 
more severe clinical manifestations are less likely to participate in research. That also happened in our 
CU2 project, where many adolescents with rather severe acute behavioural problems (i.e. occurrence 
of violent and/or oppositional incidents, escape attempts and severely dysfunctional relationships 
with their caregivers) were considered as too “instable” or “dangerous” to participate. As a result, 
their institute did not allow them to participate in research projects, and/or their parents/caregivers 
were unwilling to provide informed consent. In addition, these youngsters were also themselves 
less likely to give informed consent. Not being able to include severe cases of ODD/CD in the CU2 
project may have led to selection bias and an incomplete sample where possible subgroups (e.g. 
high on CU traits) have been left out. As a consequence, our results may be generalized to ODD/CD 
with moderate CU traits in particular. 
 Within clinical disorders there is much heterogeneity too (e.g. severity of CU traits within 
CD), although this was not investigated within the current thesis. Participants with a diagnosis of 
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ODD or CD from the CU2 project were grouped together in this thesis, because both disorders are 
on a spectrum of behaviour problems and aggressive tendencies. In addition, the ODD/CD group 
included only a few CD participants to be handled as a stand-alone group. Therefore, outcomes 
of the chapters in this thesis included mainly ODD participants, which limits the ability to make 
disorder-specific conclusions. In order to control for the possible influence of CD, post hoc analyses 
were run with and without CD participants, and results tended to be similar. 
Role of medication
Both clinical groups in the CU2 project contained a substantial number of participants using 
medication. However, antipsychotics were stopped, where possible, two days before and stimulants 
on the test day. Further, possible confounding effects of medication were controlled for or examined 
statistically where possible, making it unlikely that medication strongly influenced results. 
Early- or late-onset CD
Whether participants had early- or late-onset CD was not included in the current study, although we 
intended to collect this information. However, we were unable to retrieve this relevant information 
on the onset of CD, as it was often not provided in the case files. Furthermore, onset of CD could 
often not be objectively stated by participants and/or their parents/caregivers for various reasons. 
For example, it happened that information provided by adolescents with CD was in contradiction 
with information provided by their parents/caregivers. In a majority of cases the biological parents 
were not available for answering our questions and legal guardians were not always informed about 
the onset of problems. 
Environmental factors
We did not include contextual information (e.g. neglect or traumatic life events), while this information 
is important regarding the expression and aetiology of aggression. For example, a history of aggressive 
behaviour, may contribute to the probability that developmental changes in hormones will influence 
behaviour (Susman, Granger, Murowchick, Ponirakis, & Worrall, 1996). Future studies should take 
care to collect this data particularly in light of future efforts to examine epigenetic markers of CD.
Measurements
The studies in the current thesis found that a small percentage of variance of aggression was 
explained by both categorical (i.e. small group differences) and dimensional aspects (i.e. subtypes 
of aggression, and/or CU traits), regarding molecular genetics and (neuro)endocrine factors, 
(neuro)cognitive task performance, and eye tracking parameters. The amount of variance explained, 
highlights the need for future research. Future directions may include 1) to focus on developing 
neural and (epi)genetic network-based analytic approaches to identify causal genes and networks 
and to clarify the relationship of genes and networks with aggressive behaviour; and 2) to further 
delineate the species specific and non-specific domains of aggressive behaviour as well as escalated 
or abnormal aggression, and to clarify the overlapping yet distinct causal genes and networks 
underlying these separable domains, particularly overlooked domains such as frustrative non-reward. 
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In addition, future research should also pay attention to the assessment of aggressive behaviour 
with several objective as well as subjective instruments, such as observations, questionnaires by 
different informants (e.g. parent-, teacher-, and self-reports), neurocognitive measurements and 
also using fMRI assessment (brain studies) to also take into account brain mechanisms in relation 
to for example reinforcement learning as the inability for those with high CU traits to learn from 
punishment may be an important point of intervention for CU trait moderation in the future. 
Demographics
The CU2 project included only male adolescents, thus we cannot extrapolate our findings to females 
with either ASD or ODD/CD. Future research should take into account both females and males. 
Recent data suggest that there may be sex-specific biological factors underpinning aggression 
(Tielbeek et al., 2017). 
 Whether the findings in this thesis are unique to ODD/CD and ASD or whether they reflect 
results that also apply to those with other forms of psychopathology remains unclear. An additional 
clinical group without core deficits in empathy and/or emotion regulation, such as attention deficit 
hyperactivity disorder (ADHD) not comorbid to either ASD or ODD/CD (Graziano & Garcia, 2016), 
could further add to the significance of our findings.
Genetics
The complex nature of ODD/CD and ASD necessitates large multi-study collabora¬tions and big-data 
efforts to include transdiagnostic markers which may in turn clarify heterogeneity, comorbidity and 
inform cross-disorder interventions in the clinical practice. Therefore, especially when conducting 
research on a challenging study population, such as ODD/CD, large international collaborations 
are useful that combine research questions, data, and expertise in order to conduct research in 
larger study samples and of higher quality. A cognomic approach (i.e. a better understanding of 
links between cognition and the brain at a molecular level) in analysis is still largely missing from 
the literature, potentially due to the lack of sufficiently large imaging samples (see also see also van 
Donkelaar, PhD Thesis “Genetic and neurobiological mechanisms underlying aggression subtypes”, 
2018).  Thus, adding a cognomics approach to future research projects could enlighten the model 
of aggression as presented in chapter 1. In addition, it is unclear whether outcomes in pathways, 
such as neural pathways, is a consequence of chronic disease or long-term treatment rather than 
being related to disease aetiology. Therefore, cognomics of disease-related genes should also be 
performed in typically developing subjects. 
Hormones
While basal hormonal concentrations in human studies including ASD and ODD/CD are relatively 
understudied, there is extensive literature on intranasal oxytocin trials in clinical populations samples 
including for example ASD (Bakermans-Kranenburg & van, 2013; Dadds et al., 2014; Weisman, 
Zagoory-Sharon, & Fieldman, 2014). Intranasal oxytocin may have therapeutic benefits, as Domes 
et al. (2007) showed that oxytocin has a modulating effect on amygdala activity as a response on 
emotional faces. Elevating oxytocin levels by means of intranasal administration may remedy social 
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difficulties and improve social cognition for a brief period (Domes et al., 2013; Guastella et al., 
2010), although previous reviews and individual studies showed effective but temporary results of 
intranasal oxytocin administration in improvement of social functioning. Recent research showed 
that in ASD in particular, efficacy for improvement of social impairment was equivocal, partially due 
to mixed methodological designs, dosing regimens, and outcome measures (DeMayo, Song, Hickie, 
& Guastella, 2017). Furthermore, it remains unclear what the long-term effects are of intranasal 
oxytocin administration and/or the effects of multiple administrations over a period of time. This 
also warrants further research, in which promoting affiliation and empathy of intranasal oxytocin will 
need to be tested in selected cohorts of high-aggressive patient groups such as ODD/CD with high 
CU traits.
Cognition and neurophysiology
The studies in this thesis were part of the larger CU2 project which includes additional assessments 
of various aspects of empathy, of which not all could be examined in the scope of this thesis. 
The CU2 project examined in a cross-sectional design whether different aspects of empathy were 
differentially affected across reactive and proactive aggression. Three different ways to measure 
different components of empathy were conducted: 1) mimicry by means of electromyogram of 
the facial musculator (motoric), 2) physiological measures such as sympathetic nervous system 
response of heart rate and skin conductance (which represents the “fight/flight” emotional response) 
and 3) (neuro)psychological tasks, such as theory of mind task (cognition). Identification of these 
components and whether these components are cross-disorder or disorder specific provides 
additional insights to the current models of aggression and this could deliver ideas on how to 
improve and/or develop effective treatments. Future research on treatment could also explore (neuro)
psychological tasks such as theory of mind task (i.e. cognitive empathy) and use this information 
in the development and evaluation of a personalized treatments for both aggression subtypes such 
as reactive and proactive aggression. Cognitive empathy was also a part of the CU2 project and this 
data is currently being preprocessed to be analyzed. 
 Future research is warranted to explore different aspects of empathy, taking into account 
physiological measures such as autonomic response of heart rate and skin conductance (markers 
of arousal) as objective instruments to provide information about an adolescent’s inner state (van 
Dooren, de Vries, & Janssen, 2012). This may in turn help children and adolescents with conduct 
problems to become aware of physical tension in their body and emotions, and take actions to 
reduce or control their emotions like going to a less stressful room to calm down which may prevent 
escalating aggressive and antisocial behaviour. 
Suggestions for treatment
It is suggested that psychological treatments lead to change in associated brain functioning, 
although this needs to be confirmed in research yet. As stated above, future research could include 
brain imaging technologies (e.g. TMS) to enhance these psychological treatments. While TMS can 
enhance or disturb brain activity in a specific region by means of electromagnetic induction, tDCS 
induces low electric currents into brain tissue to either decrease or increase the excitability of the 
207
stimulated areas (Dambacher et al., 2015). While the use of biofeedback of arousal to normalize 
physiological deviance as in neuro-feedback treatment of ADHD has shown to be effective (Chapin 
& Russell-Chapin, 2014; Caria, Sitaram, & Birbaumer, 2012; Larsen, 2012), it has not been followed 
by controlled biofeedback trials for paediatric aggression. Thus, future research is warranted to 
investigate whether arousal modulation in young children at high risk for CD and with CD (low 
arousal and high CU traits), and real-time fMRI neurofeedback in adolescents with CD are effective 
in reducing aggression.
 Taken from a different perspective on ‘traditional’ face-to-face contact in treatment, quite 
recently, researchers have examined the efficacy of digital oriented treatment programmes in 
reducing disruptive behaviour (Baumel et al., 2017), which includes the potential for increased 
accessibility for participants. Results showed that digitally assisted parent training programmes are 
effective in reducing aggressive behaviour across a range of therapy formats (e.g. with and without 
therapist support) applied in real-world settings. Thus, future research could focus on digital oriented 
treatment targeting homogeneous subgroups of aggression and/or CU traits in order to increase 
treatment efficacy in reducing aggression.
Current research projects
The findings of the current thesis fit within the current model of aggression as presented in the 
general introduction and add in part to a large international research project which examines other 
aspects of the aggression model. This international research is also known as: aggression sub-typing 
for improved insight and treatment innovation in paediatric psychiatric disorders (AGGRESSOTYPE). 
This project employs highly innovative approaches in humans and animal models and maximize the 
project’s output by optimally balancing the use of large, existing data sets with new data acquisition. 
Through this, a knowledge chain from molecule to behaviour will be built, investigating known and 
novel genes, gene-networks and their epigenetic interactions, and mapping their mode of action 
from the molecular via the cellular to the brain-circuit level. Based on innovative bio-informatics 
multimodal data integration, this interdisciplinary research will lead to novel, accurate algorithms for 
reliable aggression prediction, which will be validated in existing longitudinal studies in children and 
tested for their predictive value in adult outcome. In addition to this approach towards prevention, 
promising non-pharmacological biofeedback will be tested for personalised treatment and prevention 
of overt aggression. The neural, genetic, and molecular basis for this biofeedback will be investigated 
in another project known as: multidisciplinary approaches to translational research in conduct 
syndromes (MATRICS). The overarching goal of the MATRICS project is to test the key hypothesis that 
different aggression phenotypes result from differential impairment of arousal mechanisms which 
in turn dysregulates three basic neural functions: regulation of control mechanisms of aggression, 
emotional value rating of others, and empathy and moral decision making. Thus, MATRICS proposes 
to deconstruct current classifications of aggression phenotypes into these three neural systems that 
are coupled with hypo- and hyper-arousal mechanisms. To study these functions, same psychological 
tasks in both animal aggression models and human disruptive behaviour disorders samples are 
conducted, concurrent with the assessment of neural, neurochemical, genetic, autonomic nervous 
system and endocrinological markers. 
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Clinical implications
Insights of similarities and/or differences in mechanisms across disorders may be helpful to improve 
current or develop new psychological treatments, since the current efficacy of these interventions is 
low. This is important for researchers, clinicians, and justice officials to be able to determine which 
treatment to advice for children, adolescents and their parents in order to reduce aggression. First, 
results from chapter 1 in this thesis show that, in order to prevent future aggression problems, there 
is a need for prevention and intervention programmes for children and adolescents, which should 
already be given already in (elementary) schools. These programmes should focus on aspects such 
as development of coping strategies on how to deal with aggression like self-control, empathic skills, 
expression of emotions and reward sensitivity. In order to develop programmes that are effective 
in preventing aggression and antisocial behaviour, researchers should take into account the role of 
false-positives and false-negatives along in early detection screening tools, there is a need for effective 
screening tools. It is important to consider false-positive issues in the context of individual studies by 
taking the specific features of individual study designs into account and by considering both factors 
that enhance and factors that reduce the risk of obtaining and reporting false-positive findings. Such 
a balanced view could help prevent an unnecessary devaluation of non-pharmacological treatments 
and pave the way for a more productive discussion on how to make reliable and innovative scientific 
discoveries in this field. Second, alongside these preventive strategies, it is important for child mental 
health professionals to be aware of environmental risk factors influencing development, especially 
those relating to violence (e.g. dysfunctional family life, harsh and inconsistent parenting, abuse 
and neglect). These environmental risk factors could be reduced by the focus on improving parental 
guidance in raising their child. Finally, nearly all reported findings in chapter 4-6 were dependent 
on aggressive behaviour and/or CU traits in both ASD and ODD/CD participants, which suggests a 
cross-disorder role of aggression and CU traits. Importantly, this speaks in favour of a cross-disorder 
approach to treatment where (neuro)endocrine or (neuro)cognitive problems are the primary focus 
instead of a diagnosis, which could be an indication to form more homogeneous treatment groups
Conclusion
The multiplicity of factors associated (i.e. environmental, genetics, (neuro)endocrine, cognitive, and 
behavioural factors) with the emergence, development and maintenance of aggressive behaviour 
suggests that aggression is a complex behaviour involving many different processes. Additionally, these 
factors may all be associated with each other, which makes unravelling the underlying mechanisms 
even more complicated. Insights of different mechanisms may help to identify more homogeneous 
subgroups for development and or improvement of customized medical and/or psychological 
treatments. Current research on psychological treatments in particular, show a modest effect on 
reducing (severe) aggressive behaviour, which may in part be a result of the heterogeneity of both 
across and within clinical disorders. This issue could be tackled by increased insights of biomarkers 
which may help to identify more homogeneous subgroups. As human molecular genetic studies 
of aggression are in an early stage, the strongest molecular evidence comes from animal models 
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comparing aggressive and non-aggressive strains or documenting the effect of gene knockouts. 
Furthermore, individuals with either ODD/CD or ASD, or without a clinical disorder partially differed 
on (neuro)endocrine and (neuro)cognitive factors. More specific, hormonal concentrations, emotion 
processing, time to first fixation and fixation duration were different between disorders. However, 
we do not know if these findings are unique to ODD/CD and ASD or whether they reflect a deficit 
that cuts across those with psychopathology relative to TDI. An additional clinical group without 
core deficits in empathy could further add to the significance of our findings. The work in this thesis 
contributes to enhancement of understanding and knowledge of trans-diagnostic markers based on 
scientific research focused on both a diagnostic and a dimensional approach. In the longer term, 
current and future research results will contribute to reduce the impact of adaptive aggression on 
society. 
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Nederlandse samenvatting
Wanneer de meeste mensen denken aan agressie, denken ze aan woede op de weg, fysieke gevechten 
en geweldadige misdaden. Niet alle agressie is echter slecht. Agressie kan adaptief zijn doordat 
men zichzelf bijvoorbeeld beschermt tegen indringers of kinderen probeert te beschermen tegen 
bedreigingen. Problemen ontstaan wanneer agressie te ver wordt doorgevoerd, wordt herhaald, 
abnormaal escaleert en geweldadig wordt. 
 Problemen gerelateerd aan agressie bij jonge mensen vallen onder de noemer agressieve 
gedragsstoornis, waaronder oppositionele-opstandige stoornis (oppositional defiant disorder; ODD) 
en gedragsstoornis(conduct disorder; CD) te brengen zijn. De termen CD en ODD zijn afkomstig 
uit de DSM (Diagnostic and Statistical Manual of Mental Disorders) een van de meest gebruikte 
internationale classificatiesystemen in de geestelijke gezondheidszorg. Aan CD en/of ODD wordt 
voldaan wanneer het negatieve gedrag ernstig is, vaker voorkomt dan gemiddeld, daarnaast al 
langere tijd aanwezig is en niet wordt veroorzaakt door omstandigheden. Beide stoornissen zijn zeer 
complex, zowel klinisch als op etiologisch vlak. Meer kennis is nodig over genetische, biologische, 
(neuro)cognitieve en gedragsmatige kenmerken van agressie in ODD en/of CD. In 2013 werd een 
nieuwe versie van de DSM gepubliceerd waarbij extra kenmerken zijn toegevoegd als onderscheid 
voor een ernstigere vorm van CD met beperkte sociale emoties. Deze kenmerken worden in het 
Engels callous unemotional (CU) traits genoemd, vrij vertaald als kille en emotieloze kenmerken. 
CU traits worden gekenmerkt door symptomen als gebrek aan empathie, kilheid/oppervlakkigheid, 
gebrek aan spijt of schuldgevoel (American Psychiatric Association [APA], 2013).  Deze vorm van 
CD is geassocieerd met vermindering van specifieke vormen van empathie, met name in reactie 
op angst, verdriet, pijn en geluk van anderen (Blair, 2013). Verminderde empatische functies is ook 
een kenmerk van autisme spectrum stoornissen (autism spectrum disorder; ASD) (Herpers, Klip, 
Rommelse, Greven, & Buitelaar, 2016; APA, 2013; Rogers, Viding, Blair, Frith, & Happe, 2006). 
Mensen met ASD hebben ook verhoogd agressief gedrag in vergelijking met controle deelnemers 
(Hill et al., 2014), hoewel agressie geen kern symptoom is van ASD en agressie in ASD over het 
algemeen minder ernstig is in vergelijking met ODD/CD (APA, 2013). 
 Tot op heden hebben we een beperkt begrip van de gedragsmatige, (neuro)cognitieve en 
biologische processen die ten grondslag liggen aan CU traits/beperkte empathie en agressief 
gedrag in ODD/CD en ASD. CU traits en agressie en hun onderliggende processen kunnen 
dienen als transdiagnostische markers die een brug vormen tussen stoornissen en biologische 
grondslag van gedrag (Rodriguez-Seijas, Eaton, & Krueger, 2015; Walkup, Mathews, & Green, 2017). 
Deze transdiagnostische markers tussen de klinische groepen en biologische basis voor gedrag 
zou heterogeniteit en comorbiditeit kunnen verklaren en suggesties aanleveren voor stoornis-
overstijgende interventies in de klinische praktijk. Dit proefschrift onderzoekt de proactieve en 
reactieve subtypen van agressie, agressie met of zonder CU traits en hun genetische, (neuro) 
endocrine, (neuro)cognitieve en gedragsmatige onderbouwing als transdiagnostische markers 
door middel van een studie van mannelijke adolescenten met ODD/CD of ASD in vergelijking met 
adolescenten zonder psychiatrische stoornis. Dit proefschrift is ook gericht op het leveren van een 
overzicht van de effectiviteit van psychologische behandelingen.
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In hoofdstuk 2 bevinden zich de resultaten van een literatuurstudie (meta-analyse) naar 17 studies 
gericht op psychologische behandelingen van kinderen en adolescenten met een klinische diagnose 
CD en/of CD problemen in het klinische gebied (inclusief ODD problemen) en een minimaal IQ van 
80. Hoewel we specifiek in databases gezocht hebben naar non-medicamenteuze behandelingen 
anders dan psychologische behandelingen, hebben alle geïdentificeerde studies gebruik gemaakt van 
psychologische (gedragsmatige) behandelingen. Resultaten van 17 gerandomiseerd-gecontroleerde 
studies (onder wie slechts drie studies met geblindeerde observeerders voor het scoren van conduct 
problemen) lieten zien dat psychologische behandelingen een klein effect hebben op het verminderen 
conduct problemen in kinderen en adolescenten met klinische CD problemen/diagnosen op basis 
van rapportages door ouder(s) (Cohen’s d = .37, 95% CI = 0.27–0.47), leerkracht (Cohen’s d = .21, 
95% CI = 0.12–0.49) en observeerder (Cohen’s d = .26, 95% CI = 0.06–0.47). 
 De studies geïncludeerd in deze literatuurstudie hebben CD problemen voornamelijk gescoord 
door middel van de CBCL en de ECBI vragenlijsten. De meeste geïncludeerde studies waren van erg 
lage tot redelijke kwaliteit en rapporteerden kleine behandeleffecten. Comorbiditeit, geslacht, leeftijd, 
aantal sessies, duur, interventie type, setting, medicatie gebruik of dropout percentages hadden geen 
invloed op het effect van de behandeling. Het is belangrijk dat toekomstige onderzoeken details geven 
rondom randomizatie en regelingen rondom geblindeerdheid, rapportages door ouder(s). Op basis 
van deze literatuurstudie is er onvoldoende bewijs om een specifieke psychologische behandeling 
aan te wijzen als meest effectieve in vergelijking met de andere psychologische behandelingen 
binnen de klinische groep van CD en/of CD problemen (inclusief behandelingen gericht op ouders).
In hoofdstuk 3 was een systematische review uitgevoerd om te onderzoeken of er bewijs is voor 
genetische onderbouwing van agressie en om te bepalen in welke mate voorgaande studies fenotype 
van agressie hebben onderzocht dat nauw aansluit, of helemaal niet, in het kader van RDoC. Het 
huidige review richt zich op drie typen genetica onderzoeken: 40 tweelingen onderzoeken, 277 
moleculaire genetische onderzoeken van agressie in mensen, 34 genetische onderzoeken van 
agressie in fruitvliegjes en 86 onderzoeken naar fenotype van agressie in muizen. Rond 50% 
van de variantie van agressief gedrag in mensen was verklaard door genetische invloeden. Niet-
gedeelde omgevingsinvloeden was matig. Gedeelde omgevingsinvloeden lieten een klein of geen 
effect zien: ongeveer de helft van de gereviewde onderzoeken rapporteerden geen invloed van een 
gedeelde omgeving, terwijl andere onderzoeken een schatting aangeven tussen 0.15 en 0.35. Op 
mens georiënteerde moleculaire genetische onderzoeken van agressie zijn in een vroege fase; sterk 
moleculaire bewijs komt van dier modellen. Hierin worden agressieve en niet-agressieve knaagdier 
stammen vergeleken op het potentiële effect van verlies of toename van genen. Veel constructen 
of operationalisaties van agressie in diermodellen blijken context specifiek te zijn en men dient 
voorzichtig te zijn met deze bevindingen te vertalen naar menselijk gedrag. 
In hoofdstuk 4 werden de hormonen oxytocine, cortisol en testosteron onderzocht in relatie tot 
(ernstig) agressief gedrag en/of empathie bij 114 deelnemers met ofwel ODD/CD (n = 37) of ASD 
(n = 49), of zonder een psychiatrische stoornis (controle, n = 28). Zowel de ASS- als de ODD/CD-
groepen hadden significant lagere niveaus van oxytocine dan de controle groep; de ODD/CD-groep 
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had significant hogere niveau’s van testosteron dan de ASD-groep. Er waren geen groepseffecten op 
cortisolspiegels. Groepsverschillen bleven voor oxytocine na correctie voor de invloed van CU traits, 
maar werden niet significant bij het controleren op agressie subtypen zoals gemeten door de reactieve 
en proactieve agressievragenlijst. Resultaten voor testosteron werden niet-significant na correctie 
voor beide CU traits of agressie subtypen. Over de groepen heen genomen, waren hogere niveaus 
van CU traits gerelateerd aan hogere cortisol- en testosteronspiegels, maar proactieve en reactieve 
agressie waren niet gecorreleerd met alle drie de hormonale niveaus. Deze bevindingen suggereren 
dat de ernst van de CU traits gerelateerd is aan zowel hogere cortisol- als testosteronniveaus, maar 
niet aan oxytocinespiegels. De positieve associatie in onze studie was te danken aan het verband 
tussen cortisol en testosteron en de positieve associatie tussen CU traits en testosteron (dat wil 
zeggen: correlaties tussen cortisol en CU traits met zelf- of ouder rapportages werden niet significant 
na correctie voor testosteron).
In hoofdstuk 5 werd de emotieverwerking onderzocht tijdens een neuropsychologische taak 
(emotionele Go/No-Go). In deze studie namen in totaal 128 proefpersonen deel, met ofwel 
ODD/CD (n = 52) of ASD (n = 52), of zonder een psychiatrische stoornis (controle, n = 24). De 
resultaten toonden geen groepsverschillen met betrekking tot het aantal fout-positieve reacties. 
Bovendien was de ASD-groep langzamer dan de controle groep en de ODD/CD-groep op twee van 
de drie valentie-discriminaties (negatief-neutraal en negatief-positief). Daarentegen verschilde de 
reactietijd in de ODD/CD-groep niet significant van de controle groep op een van de drie valentie-
onderscheidingen. De controle groep vertoonde aanzienlijke moeilijkheden bij het contrasteren van 
positieve met neutrale beelden in vergelijking met negatief-neutrale of negatief-positieve beelden, 
terwijl dit effect afwezig was in zowel de ASD- als de ODD/CD-groepen. CU traits, comorbiditeit met 
ADHD en medicijngebruik waren niet gerelateerd aan taakprestaties. Adolescenten met ODD/CD 
uitgevoerd in het bereik van de controle groep, terwijl de ASD-groep duidelijk langzamer was dan 
de controle groep, ongeacht het type emotie. Zowel de ASD- als de ODD/CD-groepen verschilden 
van de controle groep die een ‘positieve perceptie-vooroordeel’ vertoonde door vrij langzaam te zijn 
in het differentiëren van positieve en neutrale valentie. De resultaten suggereren dat adolescenten 
met ODD/CD of ASS een verminderde verwerking van positieve stimuli lijken te hebben en/of een 
‘positieve perceptieafwijking’, wat aanwezig is in controle adolescenten, die ofwel kan bijdragen aan 
de symptomen en/of een gevolg kan zijn van het hebben van de aandoening en kan bijdragen aan de 
comorbiditeit van beide aandoeningen.
In hoofdstuk 6 werden de algemene (cross-disorder) en unieke (stoornis specifieke) emotionele 
gezichten verwerking, zoals weerspiegeld in de tijd tot de eerste fixatie en fixatieduur, onderzocht bij 
in totaal 122 mannelijke deelnemers, bestaande uit jongeren met ofwel ODD/CD (n = 44) of ASD (n = 
50) en controle (n = 28). Verder werd de relatie van psychopathische kenmerken (inclusief CU traits) 
en agressief gedrag met eye-tracking-maatregelen onderzocht. De resultaten toonden aan dat de 
totale fixatieduur van de ogen in emotionele en neutrale expressies (behalve voor verdriet) significant 
lager was in zowel de ASS- als de ODD/CD-groepen, vergeleken met controle groep. Tijd tot eerste 
fixatie op de ogen van angstige gezichten was significant langer in zowel de ASS- als de ODD/CD-
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groepen in vergelijking met controle groep. Voor de andere emotionele of neutrale gezichten werd 
geen significant effect gevonden. Aan de andere kant waren psychopathische kenmerken en de ernst 
van bijzonder proactieve agressie significant negatief gecorreleerd met zowel de totale fixatieduur als 
ook de tijd tot de eerste fixatie aan de ogen van angstige gezichten in de ODD/CD-groep.
De klinische praktijk 
Inzichten van overeenkomsten en/of verschillen in mechanismen van verschillende psychopathologie 
kunnen nuttig zijn om de huidige of nieuwe psychologische behandelingen te verbeteren, omdat 
de huidige effectiviteit van deze interventies laag is. Dit is belangrijk voor onderzoekers, clinici en 
gerechtspersoneel om te kunnen bepalen welke behandeling moet worden aanbevolen voor kinderen, 
adolescenten en hun ouders om agressie te verminderen. 
 Ten eerste laten de resultaten van hoofdstuk 1 in dit proefschrift zien dat, om toekomstige 
agressieproblemen te voorkomen, er behoefte is aan preventie- en interventieprogramma’s voor 
kinderen en adolescenten, die al op (basis-) scholen zouden moeten worden gegeven. Deze 
programma’s zouden zich moeten richten op aspecten zoals het ontwikkelen van copingstrategieën 
over hoe om te gaan met agressie zoals zelfbeheersing, empathische vaardigheden, uitdrukking 
van emoties en beloningsgevoeligheid. Om programma’s te ontwikkelen die effectief zijn in het 
voorkomen van agressie en antisociaal gedrag, is er behoefte aan effectieve screeninginstrumenten, 
waarbij rekening moet worden gehouden met de rol van o.a. vals positieven in deze instrumenten. 
Het is belangrijk om valspositieve kwesties in de context van individuele onderzoeken te overwegen 
door rekening te houden met de specifieke kenmerken van individuele onderzoeksontwerpen 
en door rekening te houden met zowel factoren die verbeteren als factoren die het risico van het 
verkrijgen en melden van fout-positieve bevindingen verminderen. Een dergelijk evenwichtig beeld 
kan een onnodige devaluatie van niet-medicamenteuze behandelingen helpen voorkomen en de weg 
banen voor een productievere discussie over hoe betrouwbare en innovatieve wetenschappelijke 
ontdekkingen op dit gebied kunnen worden gedaan. 
 Ten tweede is het naast deze preventiestrategieën belangrijk voor professionals in de 
kindergeneeskunde om zich bewust te zijn van omgevingsrisicofactoren die van invloed zijn op de 
ontwikkeling (bijvoorbeeld disfunctioneel gezinsleven, streng en inconsistent ouderschap, misbruik 
en verwaarlozing). Deze omgevingsrisicofactoren kunnen worden beperkt door de focus te leggen 
op het verbeteren van ouderlijke begeleiding bij het opvoeden van hun kind. 
 Ten slotte waren bijna alle gemelde bevindingen in hoofdstuk 4-6 afhankelijk van agressief 
gedrag en/of CU traits bij zowel ASD- als ODD/CD-deelnemers, wat duidt op een rol van 
agressie en CU traits in de stoornis. Dit is een aanwijzing voor het vormen van meer homogene 
behandelingsgroepen, waarbij de (neuro) endocriene of (neuro)cognitieve problemen centraal staan, 
in plaats van een diagnose.
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Conclusie
De veelheid van factoren (milieu, genetica, (neuro) endocriene, cognitieve en gedragsfactoren) die 
verband houden met de opkomst, ontwikkeling en instandhouding van agressief gedrag suggereert 
dat agressie een complex gedrag is dat vele verschillende processen omvat. Bovendien kunnen deze 
factoren ook allemaal weer verband houden met elkaar, waardoor het ontrafelen van de onderliggende 
mechanismen nog ingewikkelder wordt. Inzichten in de verschillende mechanismen kunnen helpen 
om meer homogene subgroepen te identificeren. Dat is belangrijk voor de ontwikkeling en verbetering 
van aangepaste medische en psychologische behandelingen. Huidig onderzoek naar psychologische 
behandelingen toont een bescheiden effect op het verminderen van (ernstig) agressief gedrag bij 
kinderen en adolescenten met een psychiatrische stoornis, wat deels het gevolg kan zijn van de 
heterogeniteit van de klinische stoornissen. Dit probleem kan worden aangepakt door biomarkers 
te vinden voor meer homogene subgroepen. Omdat humane moleculaire genetische studies van 
agressie zich in een vroeg stadium bevinden, is het sterkste moleculaire bewijs afkomstig van 
diermodellen die agressieve en niet-agressieve stammen vergelijken. Onderzoek uit dit proefschrift 
laat zien dat mannelijke adolescenten met psychiatrische stoornissen ASD, ODD/CD verschillen in 
hormonale concentraties, emotieverwerking, en de manier waarop ze kijken naar een emotioneel 
gezicht. Toch is onbekend of deze bevindingen uniek zijn voor deze psychiatrische stoornissen of 
dat ze een tekort weerspiegelen dat aanwezig is bij mensen met psychopathologie ten opzichte van 
mensen zonder psychopathologie. Een extra klinische groep zonder beperkingen op het gebied van 
empathie kan het belang van deze bevindingen verder vergroten. Het werk in dit proefschrift draagt 
bij aan het begrip en de kennis van trans-diagnostische markers op zowel een diagnostische als een 
dimensionale benadering. Op de langere termijn zullen huidige en toekomstige onderzoeksresultaten 
bijdragen aan de vermindering van adaptieve agressie op de samenleving.
219
 *
Referenties
American Psychiatric Association. (2013). Retrieved 
from www.dsm5.org 
Blair, R. J. R. (2013). The neurobiology of psychopathic 
traits in youths. Nat Rev Neurosci, 14(11), 786-799. 
doi:10.1038/nrn3577 
Herpers, P. C., Klip, H., Rommelse, N. N., Greven, C. 
U., & Buitelaar, J. K. (2016). Associations between high 
callous-unemotional traits and quality of life across 
youths with non-conduct disorder diagnoses. Eur 
Child Adolesc Psychiatry, 25(5), 547-555. doi:10.1007/
s00787-015- 0766-5  
Rodriguez-Seijas, C., Eaton, N. R., & Krueger, R. F. 
(2015). How Transdiagnostic Factors of Personality 
and Psychopathology Can Inform Clinical Assessment 
and Intervention. J Pers Assess, 97(5), 425-435. 
doi:10.1080/ 00223891.2015.1055752 
Rogers, J., Viding, E., Blair, R. J., Frith, U., & Happe, F. 
(2006). Autism spectrum disorder and psychopathy: 
shared cognitive underpinnings or double hit? 
Psychol Med, 36(12), 1789-1798. doi:10.1017/
s0033291706008853 
220
221
Curriculum Vitae
Mireille Huvenaars-Bakker was born on the 14th of January 1985 in Wageningen, The Netherlands 
and grew up in neighboring village Wekerom. After completing secondary education at Het Streek 
in Ede (2003), she moved to Nijmegen to study Clinical and Developmental Psychology at Radboud 
University Nijmegen. During both her Bachelor’s and Master’s degree she coached children with an 
Autism Spectrum Disorder and/or Attention Deficit Hyperactivity Disorder both on an individual as 
well as group level. She spent six months in Curaçao for a clinical internship. After completing her 
Master’s, she worked as a research assistant coordinating the data collection and ethical approval 
for several international studies at Radboud University Medical Center. She also spent seven months 
at University of South Australia, Adelaide, to investigate blood flow velocity in very young children 
by using transcranial doppler technology. Back in The Netherlands, she came back to Radboud 
University Medical Center to start her PhD research working closely with Karakter Child and Adolescent 
Psychiatry in Nijmegen. Her PhD-project focused on genetic, hormonal, and cognitive factors of 
aggression in male adolescents. The results of this project are described in this thesis and were 
also presented at several international conferences (e.g. AACAP, EFCAP, ISRA, ECP). Additionaly, 
she was involved in several side-projects, such as the supervision of bachelor- and masterstudents, 
internships, and assisting in tutoring courses in developmental psychopathology, neuropsychology, 
psychology in the clinical practice and gave lectures regarding emotion at the Radboud University 
Nijmegen. Importantly, she always combined her research with clinical work. She strongly believes 
the collaboration between research and practice is imperative for the development of these two 
fields. Currently, she is a healthcare psychologist at the Karakter Child and Adolescent Psychiatry 
and a co-developer at Learning & Resilience focused on empathy, compassion and resilience. In the 
future, she aspires to bring her research skills to practice-driven research, and finally to combine this 
with clinical work.
 *
222
223
List of publications
L. Hennissen, M.J. Bakker, J.K. Buitelaar, and D.R. Coghill (2017). Systematic review on Methylphenidate 
exposure and the long-term cardiovascular adverse effects in children, adolescents, and adults. CNS 
Drugs. 31(3):199-215. DOI: 10.1007/s40263-017-0410-7.
M.J. Bakker, C.U. Greven, J.K. Buitelaar, and J.C. Glennon (2016). Practitioner Review: 
Nonparmacological Treatments in Children and Adolescents with Conduct Disorder: a systematic 
review and meta-analysis. JCPP J Child Psychology Psychiatry. 58(1):4-18. DOI: 10.1111/jcpp.12590.
M.J. Bakker*, K. Veroude*, Y. Zhang-James*, N. Fernàndez-Castillo*,B. Cormand, S.V. Faraone 
(2015) Genetics of aggressive behavior: An overview. Am J Med Genet B Neuropsychiatr Genet. DOI: 
10.1002/ajmg.b.32364. ( * Shared first authors)
Glennon J.*, Purper-Ouakil D.*, Bakker M.J., Zuddas A., Hoekstra P., Schulze U., Castro-Fornieles J., 
Santosh P.J., Arango C., Kölch M., Coghill D., Flamarique I., Penzol M.J., Wan M., Murray M., Wong 
I.C., Danckaerts M., Bonnot O., Falissard B., Masi G., Fegert J.M., Vicari S., Carucci S., Dittmann R.W., 
Buitelaar J.K.; PERS Consortium. (2014) Paediatric European Risperidone Studies (PERS): context,
rationale, objectives, strategy, and challenges. Eur Child Adolesc Psychiatry. 23(12):1149-60. DOI: 
10.1007/s00787-013-0498-3. ( * Shared first authors)
M.J. Bakker, J. Hofmann, O.F. Churches, N.A. Badcock, M. Kohler, H. Keage (2014) Cerebrovascular 
function and cognition in childhood: a systematic review of transcranial Doppler studies. BMC 
Neurology. DOI: 10.1186/1471-2377-14-43.
P.C.M. Herpers, M.J. Huvenaars-Bakker, C.U. Greven, K.S. Nijhof, A.N., Baanders, J.K. Buitelaar, 
N.N.J. Rommelse. Emotional Go/No-go task performance in Adolescents with Oppositional Defiant 
Disorder or Conduct Disorder and with Autism Spectrum Disorder. (Submitted)
M.J. Huvenaars-Bakker*, C. Bours*, J. Tramper, A.N. Baanders, K.S. Nijhof,, N.N.J. Rommelse, P. 
Medendorp, F. Scheepers, J.C. Glennon, J.K. Buitelaar. Emotional face processing in adolescents 
with ASD or ODD/CD: an eye-tracking study. ( * Shared first authors; Submitted)
 
M.J. Huvenaars-Bakker, A. Jansen, J.C. Glennon, A.N. Baanders, K.S. Nijhof, F. Scheepers, C.U. 
Greven, J.K. Buitelaar. Aggression Phenotypes in Adolescents with Aggression Problems: do they 
differ in oxytocin, cortisol, and/or testosterone? (Submitted)
 *
224
225
Dankwoord
Met de nodige naïviteit begon ik eind 2014 aan mijn promotietraject en euforisch las ik in december 
2017 de verlossende woorden: mijn manuscript was goedgekeurd! De afgelopen vier jaren zijn een 
enorm leerzaam traject geweest. Gedurende mijn promotietraject heb ik veel geleerd over wetenschap 
beoefenen, mezelf, om te gaan met voor- en tegenslagen, en de wereld van wetenschap. Ik ben heel 
blij dat ik al die tijd omringd was door geweldige en getalenteerde mensen die met passie naast 
mij hebben gewerkt om dit proefschrift te realiseren. Ik wil graag de volgende mensen daarvoor 
bedanken.
Allereerst wil ik mijn promotor, Jan, bedanken voor de mogelijkheid om van je te leren. Ik heb enorm 
veel bewondering voor je kennis en dat je naast alle ballen in de lucht houden ook nog tijd had om 
samen een rondje te hardlopen rondom het Colloseum tijdens een van de vele projectmeetings. Corina, 
thank you very much for your guidance during my project, I feel very lucky to have had you on the 
team. Jeffrey, thank you for your unconditional faith in me as a researcher.
Ik heb de eer gehad om met fijne mede-collega onderzoekers aan de slag te gaan met CU2 data 
en daarbij wil ik in het bijzonder Nanda, Danielle, Pierre, Evita, Carsten, Natalia en Kim bedanken. 
Dankzij jullie kennis, brainstormsessies en gezelligheid hebben we een paar prachtige papers 
neergezet! Met veel plezier kijk ik terug op de vele buitenlandse projectmeetings waar ik samen met 
team Nijmegen: Marjolein, Jill en Shahrzad naar toe ging. Dank jullie wel voor het samen ontdekken 
van de fantastische plekken waar we heen gingen en te leren van elkaars expertise.
Graag wil ik de geliefde onderzoeks-collega’s van Karakter (a.k.a. (ex-)kippetjes) en Psychiatrie van het 
Radboudumc in het zonnetje zetten: Kirsten, Jennifer, Loes, Mirjam, Yvette, Leonie, Saskia, Daphne, 
Anoek, Jolanda, Andrieke, Iris, Yvonne, Annemieke, Nienke, Manon, Margreet, Francesca, Karlijn, 
Desiree, Zita, Danique: Dank jullie wel voor de gezellige researchmeetings, het delen van PhD-euvels, 
ik-heb-nu-koffie-nodig-momentjes, even een frisse neus halen in park Brakkestein, groepsfoto in de 
badkuip en congres avonturen. Mijn promotietraject was onvergetelijk dankzij jullie!
Er zijn altijd mensen op de achtergrond die je eigenlijk niet ziet of hoort, maar een onmisbare rol 
hebben bij het uitvoeren van een project zoals dat van mij. Dankjewel Nadine voor het plannen 
van afspraken en je hulp. In het bijzonder wil ik ook graag de Otho Gerard Heldering Stichting, 
De Hoenderloo groep en de Woodbrookers bedanken voor het mogelijk maken om deelnemers te 
werven. Aansluitend wil ik graag ook alle deelnemers van het CU2 project bedanken voor hun inzet. 
De werving van de deelnemers bleek een hele klus te zijn (weglopers, ouders die met moeite op
te sporen waren, test spullen sjouwen, deelnemers motiveren) die ik nooit had kunnen klaren zonder 
de hulp van de fantastische stagiaires: Rogier, Annelore, Anne, Suzanne, Fieke, Marleen, Carlijn, 
Seyma, Bernadette, Katinka, Marlies en Linda. Samen met jullie gingen we als een speer en hebben 
we met zijn allen de dataverzameling kunnen afsluiten, yes we did it!
 *
226
Lieve Silvia, Wendy en Rik. Wat een fantastisch avontuur was het toendertijd om samen met jullie 
het studentenleven te ontdekken en wat zijn jullie mij dierbaar. Afzonderlijk van elkaar zijn jullie van 
onschatbare waarde geweest tijdens mijn promotietraject, bedankt voor de ontelbare koffiemomentjes, 
samen het metro-krantje lezen, onvoorwaardelijke steun, schrijfdates en vele dansjes.
Lieve dr. Frau Stone en dr. Herr. N., wie had dat gedacht dat terwijl we bleu op studiereis ronddoolde 
in Budapest en elkaar leerde kennen, we alledrie een  promotietraject zouden aangaan. Ik kijk graag 
terug op onze gesprekken in vloeiend Duits en onze wetenschappelijke discussies over het leven van 
een PhD’r en de lol die we samen hierover hebben. Een memorabele date is natuurlijk die ene waarbij
jullie Andreas hebben geintroduceerd in mijn leven, waarvoor eeuwig dank :)
Gedurende mijn studenten- en PhD-tijd heb ik verschillende mensen leren kennen die elk een 
bijzonder plekje in mijn hart hebben gekregen. Stefanie, je fantastische nuchtere kijk op het leven, 
onze potjes schaak bij de ijssalon en wandelingen zijn mij erg dierbaar. Suus, dankjewel voor wie je 
bent en je tip dat Kerstliedjes ook prima al in september kunnen worden geluisterd. Lieve Yvonne, 
ooit als huisgenootjes begonnen in het Tirol’r huis, wat is jouw humor en beide-benen-op-de-grond
mentaliteit toch goud waard. Shaha, thank you for just being you, your strength is an example to 
me, I don’t know (yet ;) how you manage it all. Lieve ‘Old School Friends’: Yuli, Anoeshka, Mariske, 
Heleen, Roos, Lieke, Tamara. Werkelijk over alles kunnen we het met elkaar hebben, lachbuien, 
huilen, feitjes opduikelen over grootste milieuvervuiling, Kerstkaart filmpjes maken, wat zijn jullie 
toch een heerlijke vriendengroep! Dank jullie allemaal voor het meeleven. meedenken en de nodige 
afleiding en ontspanning te vinden in de afgelopen jaren, op naar nog vele jaren samen!  Lieve Ricky, 
Yvonne en Wilka -De Dushi’s- wat hebben we toch een bijzondere vriendschap. Onze herinneringen 
aan Curaçao en weekendjes samen weg zijn mij erg dierbaar. Bedankt voor jullie nuchtere blik, 
onvoorwaardelijke steun en verfrissende Amstel Brights! Wekelijks blaren kweken in de boulderhal van 
Nijmegen, bedankt voor de aanmoedigingen, delen van frustraties en meeleven: Kevin, Dirk, Joost, 
Tobias, Pieter, Dennis (a.k.a. de klimplantjes). Bijzonder dierbare herinneringen heb ik aan Lowlands 
en vooral met de mensen waarmee ik daar naar toe ben gegaan en heb leren kennen: lieve Miriam, 
Teun, Miel, Ilonka, Wouter, George, Loes, Alex, Linda, Frank, Bart, Laura. Jullie hilarische acties en 
steun tijdens en buiten onze festival dates zorgden voor de nodige ontspanning en relativering. Wat 
zijn jullie toch een fantastische groep!
Lieve familie Huvenaars en van der Heijden, en in het bijzonder Willeke, Mart, Karlijn, Matthijs, 
Thomas, Marleen, Pim, Siem, Mees. Wat een heerlijke grote en warme familie zijn jullie, bedankt 
voor jullie steun en voor wie jullie zijn.
Lieve Alexandra, Han, Anna, Eva, Ans, Han, Michel en Anneloes - de Bosz’jes-, eindelijk is mijn 
‘scriptie’; klaar. Jullie hebben een bijzondere plek in mijn hart. Bedankt voor wie jullie zijn, de aandacht 
die jullie hebben voor de ander en de fijne bbq’s in de achtertuin.
Across the other side of the world there is also family who have a special place in my heart: Patty, 
227
 *
Ben, Oliver, Bronte, Roger, Louise, Nick, Tim, Bernadette, Louise, Sam, Harry - the Dutton’s- you 
mean the world to me. I am touched by the love and care I feel during my visits to Australia and back 
in Holland when we Skype or email. I feel blessed that I am part of your family too.
En deze laatste regels van dit dankwoord, de ere-plaats, zijn natuurlijk voor jou: lieve Andreas. De 
afgelopen jaren hebben we veel moeten trotseren, dat heeft ons samen alleen maar sterker gemaakt. 
Jij bent het allerbeste wat mij is overkomen. Je humor, bemoedigende woorden, vele kopjes thee 
cappuccino’s, de spreekwoordelijke schop onder mijn kont en heerlijke voedzame maaltijden voor 
mijn hersencellen hebben ervoor gezorgd dat we hier samen zijn. 
“I tell you life is sweet, in spite of the misery. There’s so much more, be grateful” - Natalie Merchant
228
229
 *
Donders Graduate School for Cognitive Neuroscience
For a successful research Institute, it is vital to train the next generation of young scientists. To 
achieve this goal, the Donders Institute for Brain, Cognition and Behaviour established the Donders 
Graduate School for Cognitive Neuroscience (DGCN), which was officially recognised as a national 
graduate school in 2009. The Graduate School covers training at both Master’s and PhD level and 
provides an excellent educational context fully aligned with the research programme of the Donders 
Institute. The school successfully attracts highly talented national and international students in 
biology, physics, psycholinguistics, psychology, behavioral science, medicine and related disciplines. 
Selective admission and assessment centers guarantee the enrolment of the best and most motivated 
students. The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni show a 
continuation in academia with postdoc positions at top institutes worldwide, e.g. Stanford University, 
University of Oxford, University of Cambridge, UCL London, MPI Leipzig, Hanyang University in 
South Korea, NTNU Norway, University of Illinois, North Western University, Northeastern University 
in Boston, ETH Zürich, University of Vienna etc.. Positions outside academia spread among the 
following sectors: specialists in a medical environment, mainly in genetics, geriatrics, psychiatry 
and neurology. Specialists in a psychological environment, e.g. as specialist in neuropsychology, 
psychological diagnostics or therapy. Positions in higher education as coordinators or lecturers. 
A smaller percentage enters business as research consultants, analysts or head of research and 
development. Fewer graduates stay in a research environment as lab coordinators, technical support 
or policy advisors. Upcoming possibilities are positions in the IT sector and management position in 
pharmaceutical industry. In general, the PhDs graduates almost invariably continue with high-quality 
positions that play an important role in our knowledge economy. For more information on the DGCN 
as well as past and upcoming defenses please visit:
htttp://www.ru.nl/donders/graduate-school/phd/
230
“I did the things”
